UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K
(Mark One)
☒ ANNUAL REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended: December 31, 2023
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ____________ to
_____________
Commission File No. 001-40077
QUADRO ACQUISITION ONE CORP. |
(Exact name of registrant as specified in its charter) |
Cayman Islands | | N/A |
(State or other jurisdiction of incorporation or organization) | | (I.R.S. Employer Identification No.) |
| | |
850 Library Avenue, Suite 204, Newark, DE | | 19715 |
(Address of principal executive offices) | | (Zip Code) |
(302) 738-6680 |
(Registrant’s telephone number, including area code) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | | Trading Symbol(s) | | Name of each exchange on which registered |
Units, each consisting of one Class A Ordinary Share and one-third of one Redeemable Warrant | | QDROU | | The Nasdaq Stock Market LLC |
Class A Ordinary Shares, par value $0.001 per share | | QDRO | | The Nasdaq Stock Market LLC |
Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50, subject to adjustment | | QDROW | | The Nasdaq Stock Market LLC |
Securities registered pursuant to Section 12(g)
of the Act: None
Indicate by check mark if the registrant is a
well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No
☒
Indicate
by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No
☒
Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Yes ☒ No ☐
Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller
reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer | ☐ | Accelerated filer ☐ | |
| Non-accelerated filer | ☒ | Smaller reporting company ☒ | |
| | Emerging growth company ☒ | |
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate
by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness
of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act by the registered public accounting firm
that prepared or issued its audit report. ☐
If
securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant
included in the filing reflect the correction of an error to previously issued financial statements. ☐
Indicate
by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation
received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐
Indicate
by check mark whether registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒
As of June 30, 2023 (the last business day of
the registrant’s most recently completed second fiscal quarter), the aggregate market value of the registrant’s ordinary shares
held by non-affiliates (based upon the closing price of such shares as reported on the Nasdaq Capital Market) was approximately $26.7
million. Shares held by each executive officer and director and
by each person who owns 10% or more of the outstanding ordinary shares have been excluded from the calculation in that such persons may
be deemed to be affiliates of the registrant. This determination of affiliate status is not necessarily a conclusive determination for
other purposes.
As of April 12, 2024, there were a total of 7,820,680
ordinary shares of the registrant issued and outstanding.
DOCUMENTS
INCORPORATED BY REFERENCE
None.
Quadro Acquisition One Corp.
Annual Report on Form 10-K
Year Ended December 31, 2023
TABLE OF CONTENTS
INTRODUCTORY NOTES
Use of Terms
Except as otherwise indicated by the context and
for the purposes of this report only, references in this report to “we,” “us,” “our” and “our
company” are to Quadro Acquisition One Corp, a Cayman Islands exempted company.
Special Note Regarding Forward-Looking Statements
This report contains forward-looking statements
that are based on our management’s beliefs and assumptions and on information currently available to us. All statements other than
statements of historical facts are forward-looking statements. These statements relate to future events or to our future financial performance
and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance
or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied
by these forward-looking statements. Forward-looking statements include, but are not limited to, statements about:
| ● | our ability to complete our initial business combination; |
| ● | our success in retaining or recruiting, or changes required in, our officers, key employees or directors
following our initial business combination; |
| ● | our officers and directors allocating their time to other businesses and potentially having conflicts
of interest with our business or in approving our initial business combination, as a result of which they would then receive expense reimbursements; |
| ● | our potential ability to obtain additional financing to complete our initial business combination; |
| ● | the ability of our officers and directors to generate a number of potential acquisition opportunities; |
| ● | our pool of prospective target businesses; |
| ● | our public securities’ potential liquidity and trading; |
| ● | the lack of a market for our securities; |
| ● | the use of proceeds not held in the trust account (as defined below) or available to us from interest
income on the trust account balance; or |
| ● | our financial performance. |
In some cases, you can identify forward-looking
statements by terms such as “may,” “could,” “will,” “should,” “would,” “expect,”
“plan,” “intend,” “anticipate,” “believe,” “estimate,” “predict,”
“potential,” “project” or “continue” or the negative of these terms or other comparable terminology.
These statements are only predictions. You should not place undue reliance on forward-looking statements because they involve known and
unknown risks, uncertainties and other factors, which are, in some cases, beyond our control and which could materially affect results.
Factors that may cause actual results to differ materially from current expectations include, among other things, those listed under Item
1A “Risk Factors” and elsewhere in this report. If one or more of these risks or uncertainties occur, or if our underlying
assumptions prove to be incorrect, actual events or results may vary significantly from those implied or projected by the forward-looking
statements. No forward-looking statement is a guarantee of future performance.
In addition, statements that “we believe”
and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available
to us as of the date of this report, and while we believe such information forms a reasonable basis for such statements, such information
may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or
review of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to
unduly rely upon these statements.
The forward-looking statements made in this report
relate only to events or information as of the date on which the statements are made in this report. Except as expressly required by the
federal securities laws, there is no undertaking to publicly update or revise any forward-looking statements, whether as a result of new
information, future events, changed circumstances or any other reason.
PART I
ITEM 1. BUSINESS.
General
We are a blank check company incorporated as a
Cayman Islands exempted company on September 15, 2020. We were incorporated for the purpose of engaging in an initial business combination
with one or more businesses or entities.
On January 12, 2024, we entered into a Business
Combination Agreement relating to an initial business combination. Please see Item 7 “Management’s Discussion and Analysis
of Financial Condition and Results of Operations” for a complete description of the Business Combination Agreement.
Initial Public Offering
On February 22, 2021, we consummated our initial
public offering of 23,000,000 units. Each unit consists of one ordinary share and one-third of one redeemable warrant, or the public warrants,
with each public warrant entitling the holder thereof to purchase one class A ordinary share for $11.50 per whole share. The units were
sold at a price of $10.00 per unit, generating gross proceeds of $230.0 million, and incurring offering costs of approximately $13.1 million,
of which approximately $8.1 million was for deferred underwriting commissions.
Simultaneously with the closing of the initial
public offering, we completed the private sale of an aggregate of 4,400,000 warrants, or the private placement warrants, to Kismet Sponsor
Limited, our prior sponsor, at a purchase price of $1.50 per private placement warrant, generating gross proceeds of $6.6 million, and
incurring offering costs of approximately $7,000.
A total of $230.0 million, consisting of the net
proceeds of the initial public offering and a portion of the proceeds of the private placement, was placed in the trust account maintained
by Continental Stock Transfer & Trust Company, or Continental, acting as trustee.
We originally had up to 24 months from the closing of our initial public
offering, or until February 22, 2023, to consummate an initial business combination. However, on February 20, 2023, we held an extraordinary
general meeting at which our shareholders approved our second amended and restated memorandum and articles of association to extend the
date by which we must consummate an initial business combination to April 22, 2023 and to allow our board, without another shareholder
vote, to extend such date on a monthly basis up to seven times for an additional one month each time until November 22, 2023. On
November 20, 2023, we held an extraordinary general meeting at which shareholders approved another an amendment to our second amended
and restated memorandum and articles of association to extend the date by which we must consummate an initial business combination to
May 22, 2024.
It is the job of our sponsor,
Quadro Sponsor LLC, a Delaware limited liability company, which we refer to in this report as our sponsor, and our management team to
complete our initial business combination. Our management team is led by Dimitri Elkin, our Chief Executive Officer. We must complete
our initial business combination by May 22, 2024. If our initial business combination is not consummated by such date, and we do not obtain
another extension, then our existence will terminate, and we will distribute all amounts in the trust account.
Sponsor Transaction and Name Change
On June 15, 2022, our prior
sponsor transferred the 6,250,000 class B ordinary shares issued to it prior to the initial public offering, which we refer to as the
founder shares, and 4,400,000 private placement warrants it held to our sponsor, a wholly owned subsidiary of our prior sponsor. On June
30, 2022, our prior sponsor transferred all the membership interests of our sponsor to Quadro IH DMCC, a company registered in Dubai Multi
Commodities Centre in the United Arab Emirates, or Quadro IH. In connection with this transaction, our board appointed Dimitri Elkin to
serve as our Chief Executive Officer and principal financial and accounting officer.
At our extraordinary general
meeting held on February 20, 2023, our shareholders also approved the change of our name from Kismet Acquisition Two Corp. to Quadro Acquisition
One Corp.
Business Strategy
We seek to capitalize on the
substantial deal sourcing, investing and operating expertise of our Chief Executive Officer, Dimitri Elkin, and our sponsor. While we
may pursue an acquisition opportunity in any industry or sector and in any region, we have initially focused on industries that complement
our management team’s background and network so we can capitalize on their ability to identify, acquire and operate a business.
We, therefore, have focused on companies in the internet and technology sectors. Due to the current unstable situation, we have not searched
for a business combination in Russia or Belarus, and instead are focusing on the wider area of Europe, the Middle East and Africa, or
the EMEA, especially the Middle East and Africa. We may, however, decide to enter into an initial business combination with a target business
that meets some but not all of these criteria and guidelines.
We believe our sponsor’s
and management team’s deal sourcing, investing and operating expertise, as well as their network of contacts uniquely position us
to take advantage of proprietary opportunities in the internet and technology sectors, where we believe opportunities exist to acquire
high growth companies that are scaling at an unprecedented pace by introducing new business models and disrupting traditional industries.
Moreover, we believe there are opportunities to consolidate assets across fragmented sub-sectors, creating new majors with improved efficiencies
and network effects through scale. We believe this expertise and network of contacts allows us to generate a number of acquisition opportunities.
We have, and intend to continue
to, seek out potential targets that we believe have proven business models and attractive growth profiles. We also believe our sponsor’s
and management team’s extensive experience in deal sourcing from private and public sources, as well as their advisory and consulting
engagements, provide unique insight when identifying potential business combination opportunities and creating value. We believe their
experience and proximity to real-time information positions us to obtain access to differentiated deal flow, frequently in a non-competitive
manner and prior to other parties with an interest in such transactions.
Under conditions where the capital
markets in the EMEA are generally less developed than the U.S. capital markets, we believe we can provide the target company with an attractive
alternative path to a public listing or sale.
Acquisition Criteria
Consistent with this strategy,
we have identified the following general criteria and guidelines that we believe are important in evaluating prospective target businesses.
We use these criteria and guidelines in evaluating acquisition opportunities, but we may decide to enter into our initial business combination
with a target business that meets some but not all of these criteria and guidelines.
We seek to acquire companies
that we believe:
| ● | have strong competitive positions, proven business models and attractive growth prospects; |
| ● | have limited access to capital markets due to external factors; |
| ● | could benefit from the substantial expertise, experience and network of our sponsor and management team,
who could assist with, for example, growth strategy, international expansion, operations and the evaluation and integration of acquisitions; |
| ● | are well positioned to participate in sector consolidation and would benefit from a public acquisition
currency; and |
| ● | offer attractive risk-adjusted returns. |
These criteria and guidelines
are not intended to be exhaustive. Any evaluation relating to the merits of a particular initial business combination may be based, to
the extent relevant, on these general criteria and guidelines as well as other considerations, factors and criteria that our management
may deem relevant.
Initial Business Combination
The rules of The Nasdaq Stock
Market LLC, or Nasdaq, require that our initial business combination must occur with one or more target businesses that together have
an aggregate fair market value of at least 80% of the assets held in the trust account (excluding the deferred underwriting commissions
and taxes payable, if any, on the income earned on the trust account) at the time of the agreement to enter into the initial business
combination. If our board of directors is not able to independently determine the fair market value of the target business or businesses,
we will obtain an opinion from an independent investment banking firm that is a member of the Financial Industry Regulatory Authority,
or FINRA, or from an independent accounting firm, with respect to the satisfaction of such criteria.
We anticipate structuring our
initial business combination so that the post-transaction company in which our shareholders own shares will own or acquire 100% of the
outstanding equity interests or assets of the target business or businesses. We may, however, structure our initial business combination
such that the post-transaction company owns or acquires less than 100% of such interests or assets of the target business in order to
meet certain objectives of the target management team or shareholders or for other reasons, but we will only complete such business combination
if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires
a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment
Company Act of 1940, as amended, or the Investment Company Act. Even if the post-transaction company owns or acquires 50% or more of the
voting securities of the target, our shareholders prior to the business combination may collectively own a minority interest in the post-transaction
company, depending on valuations ascribed to the target and us in the business combination transaction. For example, we could pursue a
transaction in which we issue a substantial number of new shares in exchange for all of the outstanding capital stock of a target. In
this case, we would acquire a 100% controlling interest in the target. However, as a result of the issuance of a substantial number of
new shares, our shareholders immediately prior to our initial business combination could own less than a majority of our outstanding shares
subsequent to our initial business combination. If less than 100% of the outstanding equity interests or assets of a target business or
businesses are owned or acquired by the post-transaction company, the portion of such business or businesses that is owned or acquired
is what will be valued for purposes of the 80% of net assets test. Nasdaq rules require that our initial business combination must occur
with one or more target businesses that together have an aggregate fair market value of at least 80% of the value of the assets held in
the trust account (excluding the deferred underwriting commissions and taxes payable, if any, on the income earned on the trust account)
at the time of the agreement to enter into the initial business combination. If the business combination involves more than one target
business, the 80% of net assets test will be based on the aggregate value of all of the target businesses and we will treat the target
businesses together as our initial business combination for purposes of a tender offer or for seeking shareholder approval, as applicable.
If our securities are not listed on Nasdaq, we would not be required to satisfy the 80% requirement. However, we intend to satisfy the
80% requirement even if our securities are not listed on Nasdaq at the time of our initial business combination.
Our Acquisition Process
In evaluating a prospective
target business, we conduct a thorough due diligence review that encompasses, among other things, meetings with incumbent management and
employees, document reviews, inspection of facilities, as well as a review of financial and other information that is made available to
us. We also utilize our operational and capital planning experience.
Given our experience, we have
the capacity to appropriately source opportunities and conduct a substantial portion of due diligence ourselves, relying less on third
parties than many other similar companies.
We are not prohibited from pursuing
an initial business combination with a company that is affiliated with our sponsor, officers or directors. In the event we seek to complete
our initial business combination with a company that is affiliated with our sponsor, officers or directors, we, or a committee of independent
directors, will obtain an opinion from an independent investment banking firm that is a member of FINRA or from an independent accounting
firm, that our initial business combination is fair to our company from a financial point of view. Additionally, pursuant to Nasdaq rules,
any initial business combination must be approved by a majority of our independent directors.
Post-Acquisition Leadership
After the initial business combination,
we will seek to apply a rigorous approach to enhancing shareholder value through our participation on the board of directors or through
direct involvement with company operations or both. We intend to rely on the extensive professional network of our sponsor, including
long term associates and former employees and will assemble a team of industry experts that have the most relevant expertise to enhance
the shareholder value.
Our Management Team
For a description of our management
team, see Item 10 “Directors, Executive Officers and Corporate Governance” of this report. Members of our management
team are not obligated to devote any specific number of hours to our matters, but they have devoted and will continue to devote as much
of their time as they deem necessary to our affairs until we have completed our initial business combination. The amount of time that
our officers or any other members of our management devote in any time period varies based on whether a target business has been selected
for our initial business combination and the current stage of the business combination process.
Sourcing of Potential Business Combination Targets
We believe our management team’s
operating and transaction experience and relationships with companies will provide us with a substantial number of potential business
combination targets. Over the course of their careers, the members of our management team have developed a broad network of contacts and
corporate relationships around the world. This network has grown through the activities of our management team sourcing, acquiring and
financing businesses, our management team’s relationships with sellers, financing sources and target management teams and the experience
of our management team in executing transactions under varying economic and financial market conditions.
We believe that the network
of contacts and relationships of our management team provides us with important sources of acquisition opportunities.
We are not prohibited from pursuing
an initial business combination with a company that is affiliated with our sponsor, executive officers or directors, or making the acquisition
through a joint venture or other form of shared ownership with our sponsor, executive officers or directors. In the event we seek to complete
our initial business combination with a target that is affiliated with our sponsor, executive officers or directors, we, or a committee
of independent directors, would obtain an opinion from an independent investment banking firm that is a member of FINRA or from an independent
accounting firm that such an initial business combination is fair to our company from a financial point of view. We are not required to
obtain such an opinion in any other context.
If any of our executive officers
becomes aware of an initial business combination opportunity that falls within the line of business of any entity to which he or she has
pre-existing fiduciary or contractual obligations, he or she may be required to present such business combination opportunity to such
entity prior to presenting such business combination opportunity to us. All of our executive officers currently have certain relevant
fiduciary duties or contractual obligations that may take priority over their duties to us.
Status as a Public Company
We believe our structure makes
us an attractive business combination partner to target businesses. As an existing public company, we offer a target business an alternative
to the traditional initial public offering through a merger or other business combination. In this situation, the owners of the target
business would exchange their shares of stock in the target business for shares of our stock or for a combination of shares of our stock
and cash, allowing us to tailor the consideration to the specific needs of the sellers. Although there are various costs and obligations
associated with being a public company, we believe target businesses will find this method a more certain and cost-effective method to
becoming a public company than the typical initial public offering. In a typical initial public offering, there are additional expenses
incurred in marketing, road show and public reporting efforts that may not be present to the same extent in connection with an initial
business combination with us.
Furthermore, once a proposed
business combination is completed, the target business will have effectively become public, whereas an initial public offering is always
subject to the underwriter’s ability to complete the offering, as well as general market conditions, which could prevent the offering
from occurring. Once public, we believe the target business would then have greater access to capital and an additional means of providing
management incentives consistent with shareholders’ interests. It can offer further benefits by augmenting a company’s profile
among potential new customers and vendors and aid in attracting talented employees.
We are an “emerging growth
company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, or the Securities Act, as modified by the Jumpstart
Our Business Startups Act of 2012, or the JOBS Act. As such, we are eligible to take advantage of certain exemptions from various reporting
requirements that are applicable to other public companies that are not “emerging growth companies,” including, but not limited
to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, or the Sarbanes-Oxley
Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from
the requirements of holding a non-binding advisory vote on executive compensation and shareholder approval of any golden parachute payments
not previously approved. If some investors find our securities less attractive as a result, there may be a less active trading market
for our securities and the prices of our securities may be more volatile.
In addition, Section 107 of
the JOBS Act also provides that an “emerging growth company” can take advantage of the extended transition period provided
in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other words, an “emerging
growth company” can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies.
We intend to take advantage of the benefits of this extended transition period.
We will remain an emerging growth
company until the earliest of (i) the last day of the fiscal year following the fifth anniversary of our initial public offering,
(ii) the last day of the first fiscal year in which our total annual gross revenues are $1.235 billion or more, (iii) the
date that we become a “large accelerated filer” as defined in Rule 12b-2 under the Securities Exchange Act of 1934,
as amended, or the Exchange Act, which would occur if the market value of our class A ordinary shares that is held by non-affiliates exceeds
$700 million as of the last business day of our most recently completed second fiscal quarter or (iv) the date on which
we have issued more than $1 billion in non-convertible debt during the preceding three year period.
Financial Position
With funds available in the
trust account for an initial business combination in the amount of approximately $17.25 million as of March 31, 2024, assuming no further
redemptions and prior to taking into account payment of $2,817,500 of remaining deferred underwriting fees, and before fees and expenses
associated with our initial business combination, we offer a target business a variety of options such as creating a liquidity event for
its owners, providing capital for the potential growth and expansion of its operations or strengthening its balance sheet by reducing
its debt ratio. Because we are able to complete our initial business combination using our cash, debt or equity securities, or a combination
of the foregoing, we have the flexibility to use the most efficient combination that will allow us to tailor the consideration to be paid
to the target business to fit its needs and desires. However, we have not taken any steps to secure third party financing and there can
be no assurance it will be available to us.
Effecting our Initial
Business Combination
We are not presently engaged
in any operations, and we will not engage in any operations until the consummation of our initial business combination. We intend to effectuate
our initial business combination using cash from the proceeds of our initial public offering and the private placement of the private
placement warrants, our share capital, debt or a combination of these as the consideration to be paid in our initial business combination.
We may seek to complete our initial business combination with a company or business that may be financially unstable or in its early stages
of development or growth, which would subject us to the numerous risks inherent in such companies and businesses.
If our initial business combination
is paid for using equity or debt securities, or not all of the funds released from the trust account are used for payment of the consideration
in connection with our initial business combination or used for redemptions of our class A ordinary shares not held by our sponsor, or
the public shares, we may apply the balance of the cash released to us from the trust account for general corporate purposes, including
for maintenance or expansion of operations of the post-transaction company, the payment of principal or interest due on indebtedness incurred
in completing our initial business combination, to fund the purchase of other companies or for working capital.
There is no current basis for
investors in our initial public offering to evaluate the possible merits or risks of the target business with which we may ultimately
complete our initial business combination. Although our management will assess the risks inherent in a particular target business with
which we may combine, we cannot assure you that this assessment will result in our identifying all risks that a target business may encounter.
Furthermore, some of those risks may be outside of our control, meaning that we can do nothing to control or reduce the chances that those
risks will adversely impact a target business.
We may seek to raise additional
funds through a private offering of debt or equity securities in connection with the completion of our initial business combination, and
we may effectuate our initial business combination using the proceeds of such offering rather than using the amounts held in the trust
account. Subject to compliance with applicable securities laws, we would complete such financing only simultaneously with the completion
of our initial business combination. In the case of an initial business combination funded with assets other than the trust account assets,
our tender offer documents or proxy materials disclosing the business combination would disclose the terms of the financing and, only
if required by law, we would seek shareholder approval of such financing. There are no prohibitions on our ability to raise funds privately
or through loans in connection with our initial business combination. At this time, we are not a party to any arrangement or understanding
with any third party with respect to raising any additional funds through the sale of securities or otherwise.
Sources of Target Businesses
and Potential Finder’s Fees
Target business candidates have
been, and we expect they will continue to be, brought to our attention from various unaffiliated sources as a result of our management’s
experience, execution history and ability to deploy capital. These sources include, but are not limited to, investment bankers, private
investment funds and other members of our network of business relationships. Target businesses may be brought to our attention by such
unaffiliated sources as a result of being solicited by us through calls or mailings. These sources may also introduce us to target businesses
in which they think we may be interested on an unsolicited basis, since many of these sources will have read the prospectus for our initial
public offering or this report and know what types of businesses we are targeting. Our officers and directors, as well as their affiliates,
may also bring to our attention target business candidates that they become aware of through their business contacts as a result of formal
or informal inquiries or discussions they may have, as well as attending trade shows or conventions. In addition, we expect to receive
a number of proprietary deal flow opportunities that would not otherwise necessarily be available to us as a result of the business relationships
of our officers and directors. While we do not presently anticipate engaging the services of professional firms or other individuals that
specialize in business acquisitions on any formal basis, we may engage these firms or other individuals in the future, in which event
we may pay a finder’s fee, consulting fee or other compensation to be determined in an arm’s length negotiation based on the
terms of the transaction. We will engage a finder only to the extent our management determines that the use of a finder may bring opportunities
to us that may not otherwise be available to us or if finders approach us on an unsolicited basis with a potential transaction that our
management determines is in our best interest to pursue. Payment of finder’s fees is customarily tied to completion of a transaction,
in which case any such fee will be paid out of the funds held in the trust account.
Selection of a Target Business and Structuring
of our Initial Business Combination
Nasdaq rules require that our
initial business combination must occur with one or more target businesses that together have an aggregate fair market value of at least
80% of the assets held in the trust account (excluding the deferred underwriting commissions and taxes payable, if any, on the income
earned on the trust account) at the time of the agreement to enter into the initial business combination. The fair market value of the
target or targets will be determined by our board of directors based upon one or more standards generally accepted by the financial community,
such as actual and potential sales, earnings, cash flow and/or book value, discounted cash flow valuation or value of comparable businesses.
If our board of directors is not able to independently determine the fair market value of the target business or businesses, we will obtain
an opinion from an independent investment banking firm that is a member of FINRA or from an independent accounting firm with respect to
the satisfaction of such criteria. Subject to this requirement, our management will have virtually unrestricted flexibility in identifying
and selecting one or more prospective target businesses, although we will not be permitted to effectuate our initial business combination
with another blank check company or a similar company with nominal operations.
In any case, we will only complete
our initial business combination in which we own or acquire 50% or more of the outstanding voting securities of the target or otherwise
acquire a controlling interest in the target business sufficient for the post-transaction company not to be required to register as an
investment company under the Investment Company Act. If we own or acquire less than 100% of the outstanding equity interests or assets
of a target business or businesses, the portion of such business or businesses that are owned or acquired by the post-transaction company
is what will be valued for purposes of the 80% of net assets test. There is no basis for investors to evaluate the possible merits or
risks of any target business with which we may ultimately complete our initial business combination.
To the extent we effect our
initial business combination with a company or business that may be financially unstable or in its early stages of development or growth,
we may be affected by numerous risks inherent in such company or business. Although our management will endeavor to evaluate the risks
inherent in a particular target business, we cannot assure you that we will properly ascertain or assess all significant risk factors.
In evaluating a prospective
target business, we have conducted and will continue to conduct a thorough due diligence review, which encompasses, among other things,
meetings with incumbent management and employees, document reviews, interviews of customers and suppliers, inspection of facilities, as
well as a review of financial and other information that is made available to us.
The time required to select
and evaluate a target business and to structure and complete our initial business combination, and the costs associated with this process,
are not currently ascertainable with any degree of certainty. Any costs incurred with respect to the identification and evaluation of
a prospective target business with which our initial business combination is not ultimately completed will result in our incurring losses
and will reduce the funds we can use to complete another business combination. We will not pay any finders or consulting fees to members
of our management team, or any of their respective affiliates, for services rendered to or in connection with our initial business combination.
Lack of Business Diversification
For an indefinite period of
time after the completion of our initial business combination, the prospects for our success may depend entirely on the future performance
of a single business. Unlike other entities that have the resources to complete business combinations with multiple entities in one or
several industries, it is probable that we will not have the resources to diversify our operations and mitigate the risks of being in
a single line of business. By completing our initial business combination with only a single entity, our lack of diversification may (i)
subject us to negative economic, competitive and regulatory developments, any or all of which may have a substantial adverse impact on
the particular industry in which we operate after our initial business combination, and (ii) cause us to depend on the marketing and sale
of a single product or limited number of products or services.
Limited Ability to Evaluate the Target’s
Management Team
Although we closely scrutinize
the management of a prospective target business when evaluating the desirability of effecting our initial business combination with that
business, our assessment of the target business’ management may not prove to be correct. In addition, the future management may
not have the necessary skills, qualifications or abilities to manage a public company. Furthermore, the future role of members of our
management team, if any, in the target business cannot presently be stated with any certainty. While it is possible that one or more of
our directors will remain associated in some capacity with us following our initial business combination, it is unlikely that any of them
will devote their full efforts to our affairs subsequent to our initial business combination. Moreover, we cannot assure you that members
of our management team will have significant experience or knowledge relating to the operations of the particular target business.
We cannot assure you that any
of our key personnel will remain in senior management or advisory positions with the combined company. The determination as to whether
any of our key personnel will remain with the combined company will be made at the time of our initial business combination.
Following an initial business
combination, we may seek to recruit additional managers to supplement the incumbent management of the target business. We cannot assure
you that we will have the ability to recruit additional managers, or that additional managers will have the requisite skills, knowledge
or experience necessary to enhance the incumbent management.
Shareholders May Not Have the Ability to Approve
our Initial Business Combination
We may conduct redemptions without
a shareholder vote pursuant to the tender offer rules of the Securities and Exchange Commission, or the SEC, subject to the provisions
of our second amended and restated memorandum and articles of association. However, we will seek shareholder approval if it is required
by law or applicable stock exchange rule, or we may decide to seek shareholder approval for business or other legal reasons. Under Nasdaq’s
listing rules, shareholder approval would be required for our initial business combination if, for example:
| ● | we issue ordinary shares that will be equal to or in excess of 20% of the number of ordinary shares then
outstanding; |
| ● | any of our directors, officers or substantial shareholders (as defined by Nasdaq rules) has a 5% or greater
interest (or such persons collectively have a 10% or greater interest), directly or indirectly, in the target business or assets to be
acquired or otherwise and the present or potential issuance of ordinary shares could result in an increase in outstanding ordinary shares
or voting power of 5% or more; or |
| ● | the issuance or potential issuance of ordinary shares will result in our undergoing a change of control. |
Permitted Purchases of our Securities
In the event we seek shareholder
approval of our initial business combination and we do not conduct redemptions in connection with our initial business combination pursuant
to the tender offer rules, our sponsor, directors, officers, advisors or any of their affiliates may purchase shares in privately negotiated
transactions or in the open market either prior to or following the completion of our initial business combination. There is no limit
on the number of shares such persons may purchase. However, they have no current commitments, plans or intentions to engage in such transactions
and have not formulated any terms or conditions for any such transactions. In the event our sponsor, directors, officers, advisors or
any of their affiliates determine to make any such purchases at the time of a shareholder vote relating to our initial business combination,
such purchases could have the effect of influencing the vote necessary to approve such transaction. None of the funds in the trust account
will be used to purchase shares in such transactions. They will not make any such purchases when they are in possession of any material
non-public information not disclosed to the seller or if such purchases are prohibited by Regulation M under the Exchange Act. Such a
purchase may include a contractual acknowledgement that such shareholder, although still the record holder of our shares is no longer
the beneficial owner thereof and therefore agrees not to exercise its redemption rights. In the event that our sponsor, directors, officers,
advisors or their affiliates purchase shares in privately negotiated transactions from public shareholders who have already elected to
exercise their redemption rights, such selling shareholders would be required to revoke their prior elections to redeem their shares.
We do not currently anticipate that such purchases, if any, would constitute a tender offer subject to the tender offer rules under the
Exchange Act or a going-private transaction subject to the going-private rules under the Exchange Act; however, if the purchasers determine
at the time of any such purchases that the purchases are subject to such rules, the purchasers will comply with such rules.
The purpose of such purchases
would be to (i) vote such shares in favor of our initial business combination and thereby increase the likelihood of obtaining shareholder
approval of the business combination or (ii) to satisfy a closing condition in an agreement with a target that requires us to have a minimum
net worth or a certain amount of cash at the closing of our initial business combination, where it appears that such requirement would
otherwise not be met. This may result in the completion of our initial business combination that may not otherwise have been possible.
In addition, if such purchases
are made, the public “float” of our class A ordinary shares may be reduced and the number of beneficial holders of our securities
may be reduced, which may make it difficult to maintain or obtain the quotation, listing or trading of our securities on a national securities
exchange.
Our sponsor, officers, directors
and/or any of their affiliates anticipate that they may identify the shareholders with whom our sponsor, officers, directors or their
affiliates may pursue privately negotiated purchases by either the shareholders contacting us directly or by our receipt of redemption
requests submitted by shareholders following our mailing of proxy materials in connection with our initial business combination. To the
extent that our sponsor, officers, directors, advisors or their affiliates enter into a private purchase, they would identify and contact
only potential selling shareholders who have expressed their election to redeem their shares for a pro rata share of the trust account
or vote against our initial business combination. Such persons would select the shareholders from whom to acquire shares based on the
number of shares available, the negotiated price per share and such other factors as any such person may deem relevant at the time of
purchase. The price per share paid in any such transaction may be different than the amount per share a public shareholder would receive
if it elected to redeem its shares in connection with our initial business combination. Our sponsor, officers, directors, and/or any of
their affiliates will purchase shares only if such purchases comply with Regulation M under the Exchange Act and the other federal securities
laws.
Any purchases by our sponsor,
officers, directors and/or any of their affiliates who are affiliated purchasers under Rule 10b-18 under the Exchange Act will be made
only to the extent such purchases are able to be made in compliance with Rule 10b-18, which is a safe harbor from liability for manipulation
under Section 9(a)(2) and Rule 10b-5 of the Exchange Act. Rule 10b-18 has certain technical requirements that must be complied with in
order for the safe harbor to be available to the purchaser. Our sponsor, officers, directors and/or any of their affiliates will not make
purchases of class A ordinary shares if the purchases would violate Section 9(a)(2) or Rule 10b-5 of the Exchange Act.
Redemption Rights for Public Shareholders upon
Completion of our Initial Business Combination
We will provide our public shareholders
with the opportunity to redeem all or a portion of their class A ordinary shares upon the completion of our initial business combination
at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account as of two business days prior
to the consummation of the initial business combination, including interest earned on the funds held in the trust account and not previously
released to us to pay our taxes, if any, divided by the number of then outstanding public shares, subject to the limitations described
herein.
As of March 31, 2024, the amount
in the trust account was approximately $10.97 per public share. The per-share amount we will distribute to investors who properly redeem
their shares will not be reduced by the deferred underwriting commissions we will pay to the underwriter. Our sponsor, officers and directors
have entered into respective letter agreements with us, pursuant to which our sponsor has agreed to waive its redemption rights with respect
to its founder shares, and our sponsor, officer and directors have agreed to waive their redemption rights with respect to any public
shares they may acquire, in connection with the completion of our initial business combination. Our directors will also agree to waive
their redemption rights in connection with the completion of our initial business combination with respect to any founder shares transferred
to them by the sponsor.
Manner of Conducting Redemptions
We will provide our public shareholders
with the opportunity to redeem all or a portion of their public shares upon the completion of our initial business combination either
(i) in connection with a shareholder meeting called to approve the business combination or (ii) by means of a tender offer. The decision
as to whether we will seek shareholder approval of a proposed business combination or conduct a tender offer will be made by us, solely
in our discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction
would require us to seek shareholder approval under the law or stock exchange listing requirement. Asset acquisitions and stock purchases
would not typically require shareholder approval while direct mergers with our company where we do not survive and any transactions where
we issue more than 20% of our outstanding ordinary shares or seek to amend our second amended and restated memorandum and articles of
association would require shareholder approval. If we structure an initial business combination transaction with a target company in a
manner that requires shareholder approval, we will not have discretion as to whether to seek a shareholder vote to approve the proposed
business combination. We may conduct redemptions without a shareholder vote pursuant to the tender offer rules of the SEC unless shareholder
approval is required by law or stock exchange listing requirements or we choose to seek shareholder approval for business or other legal
reasons.
If a shareholder vote is not
required and we do not decide to hold a shareholder vote for business or other legal reasons, we will, pursuant to our second amended
and restated memorandum and articles of association (i) conduct the redemptions pursuant to Rule 13e-4 and Regulation 14E of the Exchange
Act, which regulate issuer tender offers, and (ii) file tender offer documents with the SEC prior to completing our initial business combination
which contain substantially the same financial and other information about the initial business combination and the redemption rights
as is required under Regulation 14A of the Exchange Act, which regulates the solicitation of proxies. Upon the public announcement of
our initial business combination, we or our sponsor will terminate any plan established in accordance with Rule 10b5-1 to purchase our
class A ordinary shares in the open market if we elect to redeem our public shares through a tender offer, to comply with Rule 14e-5 under
the Exchange Act.
In the event we conduct redemptions
pursuant to the tender offer rules, our offer to redeem will remain open for at least 20 business days, in accordance with Rule 14e-1(a)
under the Exchange Act, and we will not be permitted to complete our initial business combination until the expiration of the tender offer
period. In addition, the tender offer will be conditioned on public shareholders not tendering more than a specified number of public
shares which are not purchased by our sponsor, which number will be based on the requirement that we may not redeem public shares in an
amount that would cause our net tangible assets to be less than $5,000,001 (so that we do not then become subject to the SEC’s “penny
stock” rules) or any greater net tangible asset or cash requirement which may be contained in the agreement relating to our initial
business combination. If public shareholders tender more shares than we have offered to purchase, we will withdraw the tender offer and
not complete the initial business combination.
If, however, shareholder approval
of the transaction is required by law or stock exchange listing requirement, or we decide to obtain shareholder approval for business
or other legal reasons, we will, pursuant to our second amended and restated memorandum and articles of association: (i) conduct the redemptions
in conjunction with a proxy solicitation pursuant to Regulation 14A of the Exchange Act, which regulates the solicitation of proxies,
and not pursuant to the tender offer rules, and (ii) file proxy materials with the SEC. In the event that we seek shareholder approval
of our initial business combination, we will distribute proxy materials and, in connection therewith, provide our public shareholders
with the redemption rights described above upon completion of the initial business combination.
If we seek shareholder approval,
we will complete our initial business combination only if a majority of the outstanding ordinary shares voted are voted in favor of the
business combination. In such case, our sponsor has agreed to vote its founder shares and any public shares purchased in favor of our
initial business combination. In addition, our officers and directors have agreed to vote any public shares owned by them in favor of
such proposed business combination. Our directors will also agree to vote any founder shares transferred to them by our sponsor in favor
of such proposed business combination. For purposes of seeking approval of the majority of our outstanding ordinary shares, non-votes
will have no effect on the approval of our initial business combination once a quorum is obtained. We intend to give approximately 30
days (but not less than 10 days nor more than 60 days) prior written notice of any such meeting, if required, at which a vote shall be
taken to approve our initial business combination. Each public shareholder may elect to redeem their public shares irrespective of whether
they vote for or against the proposed transaction. In addition, our sponsor, officers and directors have entered into respective letter
agreements with us, pursuant to which our sponsor has agreed to waive its redemption rights with respect to its founder shares, and our
sponsor, officers and directors have agreed to waive their redemption rights with respect to any public shares they may acquire, in connection
with the completion of our initial business combination. Our directors will also agree to waive their redemption rights in connection
with the completion of our initial business combination with respect to any founder shares transferred to them by our sponsor.
Our second amended and restated
memorandum and articles of association provide that in no event will we redeem our public shares in an amount that would cause our net
tangible assets to be less than $5,000,001 (so that we do not then become subject to the SEC’s “penny stock” rules)
or any greater net tangible asset or cash requirement which may be contained in the agreement relating to our initial business combination.
For example, the proposed business combination may require: (i) cash consideration to be paid to the target or its owners, (ii) cash to
be transferred to the target for working capital or other general corporate purposes or (iii) the retention of cash to satisfy other conditions
in accordance with the terms of the proposed business combination. In the event the aggregate cash consideration we would be required
to pay for all public shares that are validly submitted for redemption plus any amount required to satisfy cash conditions pursuant to
the terms of the proposed business combination exceed the aggregate amount of cash available to us, we will not complete the business
combination or redeem any shares, and all public shares submitted for redemption will be returned to the holders thereof.
Limitation on Redemption
upon Completion of our Initial Business Combination if we Seek Shareholder Approval
Notwithstanding the foregoing,
if we seek shareholder approval of our initial business combination and we do not conduct redemptions in connection with our initial business
combination pursuant to the tender offer rules, our second amended and restated memorandum and articles of association provide that a
public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert
or as a “group” (as defined under Section 13 of the Exchange Act), will be restricted from redeeming its shares with respect
to more than an aggregate of 20% of the public shares without our prior consent. We believe this restriction will discourage shareholders
from accumulating large blocks of shares, and subsequent attempts by such holders to use their ability to exercise their redemption rights
against a proposed business combination as a means to force us or our management to purchase their shares at a significant premium to
the then-current market price or on other undesirable terms. Absent this provision, a public shareholder holding more than an aggregate
of 20% of the public shares could threaten to exercise its redemption rights if such holder’s shares are not purchased by us or
our management at a premium to the then-current market price or on other undesirable terms. By limiting our shareholders’ ability
to redeem no more than 20% of the public shares without our consent, we believe we will limit the ability of a small group of shareholders
to unreasonably attempt to block our ability to complete our initial business combination, particularly in connection with an initial
business combination with a target that requires as a closing condition that we have a minimum net worth or a certain amount of cash.
However, we would not be restricting our shareholders’ ability to vote all of their shares for or against our initial business combination.
Tendering Stock Certificates in Connection
with a Tender Offer or Redemption Rights
We may require our public shareholders
seeking to exercise their redemption rights, whether they are record holders or hold their shares in “street name,” to either
tender their certificates to our transfer agent prior to the date set forth in the tender offer documents or proxy materials mailed to
such holders, or up to two business days prior to the vote on the proposal to approve the business combination in the event we distribute
proxy materials, or to deliver their shares to the transfer agent electronically using the DWAC System, at the holder’s option.
The tender offer or proxy materials, as applicable, that we will furnish to holders of our public shares in connection with our initial
business combination will indicate whether we are requiring public shareholders to satisfy such delivery requirements. Accordingly, a
public shareholder would have from the time we send out our tender offer materials until the close of the tender offer period, or up to
two business days prior to the vote on the business combination if we distribute proxy materials, as applicable, to tender its shares
if it wishes to seek to exercise its redemption rights. Given the relatively short exercise period, it is advisable for shareholders to
use electronic delivery of their public shares.
There is a nominal cost associated
with the above-referenced tendering process and the act of certificating the shares or delivering them through the DWAC System. The transfer
agent will typically charge the tendering broker $100.00 and it would be up to the broker whether or not to pass this cost on to the redeeming
holder. However, this fee would be incurred regardless of whether or not we require holders seeking to exercise redemption rights to tender
their shares. The need to deliver shares is a requirement of exercising redemption rights regardless of the timing of when such delivery
must be effectuated.
The foregoing is different from
the procedures used by many blank check companies. In order to perfect redemption rights in connection with their business combinations,
many blank check companies would distribute proxy materials for the shareholders’ vote on an initial business combination, and a
holder could simply vote against a proposed business combination and check a box on the proxy card indicating such holder was seeking
to exercise his or her redemption rights. After the business combination was approved, the company would contact such shareholder to arrange
for him or her to deliver his or her certificate to verify ownership. As a result, the shareholder then had an “option window”
after the completion of the business combination during which he or she could monitor the price of the company’s stock in the market.
If the price rose above the redemption price, he or she could sell his or her shares in the open market before actually delivering his
or her shares to the company for cancellation. As a result, the redemption rights, to which shareholders were aware they needed to commit
before the shareholder meeting, would become “option” rights surviving past the completion of the business combination until
the redeeming holder delivered its certificate. The requirement for physical or electronic delivery prior to the meeting ensures that
a redeeming holder’s election to redeem is irrevocable once the business combination is approved.
Any request to redeem such shares,
once made, may be withdrawn at any time up to the date set forth in the tender offer materials or the date of the shareholder meeting
set forth in our proxy materials, as applicable. Furthermore, if a holder of a public share delivered its certificate in connection with
an election of redemption rights and subsequently decides prior to the applicable date not to elect to exercise such rights, such holder
may simply request that the transfer agent return the certificate (physically or electronically). It is anticipated that the funds to
be distributed to holders of our public shares electing to redeem their shares will be distributed promptly after the completion of our
initial business combination.
If our initial business combination
is not approved or completed for any reason, then our public shareholders who elected to exercise their redemption rights would not be
entitled to redeem their shares for the applicable pro rata share of the trust account. In such case, we will return any certificates
delivered by public holders who elected to redeem their shares.
If our initial proposed business
combination is not completed, we may continue to try to complete our initial business combination with a different target.
Redemption of Public Shares and Liquidation
if no Initial Business Combination
Our sponsor, officers and directors
have agreed that we will have until May 22, 2024 to complete our initial business combination. If we are unable to complete our initial
business combination by such date, or amend our second amended and restated memorandum and articles of association to extend such date
(which such amendment would require shareholder approval), we will: (i) cease all operations except for the purpose of winding up, (ii)
as promptly as reasonably possible but not more than ten business days thereafter, redeem all public shares then outstanding at a per-share
price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including any amounts representing interest
earned on the trust account, less any interest released to us for the payment of taxes, if any (and less up to $100,000 in interest reserved
for expenses in connection with our dissolution), divided by the number of then outstanding public shares, which redemption will completely
extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any),
and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining shareholders and our
board of directors, liquidate and dissolve, subject in the case of clauses (ii) and (iii) to our obligations under Cayman Islands law
to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions
with respect to our founder shares or warrants, which will expire worthless if we fail to consummate our initial business combination
within the above time period. The redemption of public shares from the trust account shall be done automatically by function of our second
amended and restated memorandum and articles of association and prior to any voluntary winding up, although at all times subject to the
Cayman Islands law.
Pursuant to a letter agreement
with us, our sponsor has waived its rights, and our directors will also waive their rights, to liquidating distributions from the trust
account with respect to their founder shares if we fail to complete our initial business combination by required date. However, if our
sponsor acquires public shares, it will be entitled to liquidating distributions from the trust account with respect to such public shares
if we fail to complete our initial business combination by the required date.
Our sponsor, executive officers
and directors have agreed, each pursuant to a written agreement with us, that they will not propose any amendment to our second amended
and restated memorandum and articles of association that would affect the substance or timing of our obligation to redeem 100% of our
public shares if we do not complete our initial business combination by the required date, unless we provide our public shareholders with
the opportunity to redeem their public shares upon approval of any such amendment at a per-share price, payable in cash, equal to the
aggregate amount then on deposit in the trust account including interest earned on the funds held in the trust account and not previously
released to us to pay our taxes, if any (and less up to $100,000 in interest reserved for expenses in connection with our dissolution),
divided by the number of then outstanding public shares. However, we may not redeem our public shares in an amount that would cause our
net tangible assets to be less than $5,000,001 (so that we do not then become subject to the SEC’s “penny stock” rules).
It is possible that the per
share value of the residual assets remaining available for distribution in the trust account will be only $10.00 per share initially held
in the trust account. The proceeds deposited in the trust account could, however, become subject to the claims of our creditors, which
would have higher priority than the claims of our public shareholders. We cannot assure you that the actual per-share redemption amount
received by shareholders will not be substantially less than $10.00 per share.
Although we will seek to have
all vendors, service providers, prospective target businesses or other entities with which we do business (except our independent registered
public accounting firm) execute agreements with us waiving any right, title, interest or claim of any kind in or to any monies held in
the trust account for the benefit of our public shareholders, there is no guarantee that they will execute such agreements or even if
they execute such agreements that they would be prevented from bringing claims against the trust account including but not limited to
fraudulent inducement, breach of fiduciary responsibility or other similar claims, as well as claims challenging the enforceability of
the waiver, in each case in order to gain an advantage with respect to a claim against our assets, including the funds held in the trust
account. If any third party refuses to execute an agreement waiving such claims to the monies held in the trust account, our management
will perform an analysis of the alternatives available to it and will only enter into an agreement with a third party that has not executed
a waiver if management believes that such third party’s engagement would be significantly more beneficial to us than any alternative.
Examples of possible instances where we may engage a third party that refuses to execute a waiver include the engagement of a third party
consultant whose particular expertise or skills are believed by management to be significantly superior to those of other consultants
that would agree to execute a waiver or in cases where we are unable to find a service provider willing to execute a waiver. In addition,
there is no guarantee that such entities will agree to waive any claims they may have in the future as a result of, or arising out of,
any negotiations, contracts or agreements with us and will not seek recourse against the trust account for any reason. In order to protect
the amounts held in the trust account, our sponsor has agreed that it will be liable to us if and to the extent any claims by a vendor
for services rendered or products sold to us, or a prospective target business with which we have discussed entering into a transaction
agreement, reduce the amount of funds in the trust account. This liability will not apply with respect to any claims by a third party
who executed a waiver of any and all rights to seek access to the trust account and except as to any claims under our indemnity of the
underwriters of this offering against certain liabilities, including liabilities under the Securities Act. Moreover, in the event that
an executed waiver is deemed to be unenforceable against a third party, then our sponsor will not be responsible to the extent of any
liability for such third party claims. We have not independently verified whether our sponsor has sufficient funds to satisfy its indemnity
obligations and we have not asked our sponsor to reserve for such indemnification obligations. Therefore, we cannot assure you that our
sponsor would be able to satisfy those obligations. None of our other officers or directors will indemnify us for claims by third parties
including, without limitation, claims by vendors and prospective target businesses.
In the event that the proceeds
in the trust account are reduced and our sponsor asserts that it is unable to satisfy its obligations or that it has no such indemnification
obligations related to a particular claim, our disinterested directors would determine whether to take legal action against our sponsor
to enforce its indemnification obligations. While we currently expect that our disinterested directors would take legal action on our
behalf against our sponsor to enforce its indemnification obligations to us, it is possible that our disinterested directors in exercising
their business judgment may choose not to do so if, for example, the cost of such legal action is deemed by such directors to be too high
relative to the amount recoverable or if the disinterested directors determine that a favorable outcome is not likely. We have not asked
our sponsor to reserve for such indemnification obligations and we cannot assure you that our sponsor would be able to satisfy those obligations.
Accordingly, we cannot assure you that due to claims of creditors the actual value of the per-share redemption price will not be less
than $10.00 per public share.
We will seek to reduce the possibility
that our sponsor will have to indemnify the trust account due to claims of creditors by endeavoring to have all vendors, service providers,
prospective target businesses or other entities with which we do business execute agreements with us waiving any right, title, interest
or claim of any kind in or to monies held in the trust account. Our sponsor will also not be liable as to any claims under our indemnity
of the underwriters of our initial public offering against certain liabilities, including liabilities under the Securities Act. As of
December 31, 2023, we did not have any funds outside the trust account with which to pay any such potential claims plus interest released
to us. In the event that we liquidate and it is subsequently determined that the reserve for claims and liabilities is insufficient, shareholders
who received funds from our trust account could be liable for claims made by creditors.
If we file a bankruptcy petition
or an involuntary bankruptcy petition is filed against us that is not dismissed, the proceeds held in the trust account could be subject
to applicable bankruptcy law, and may be included in our bankruptcy estate and subject to the claims of third parties with priority over
the claims of our shareholders. To the extent any bankruptcy claims deplete the trust account, we cannot assure you we will be able to
return $10.00 per public share to our public shareholders. Additionally, if we file a bankruptcy petition or an involuntary bankruptcy
petition is filed against us that is not dismissed, any distributions received by shareholders could be viewed under applicable debtor/creditor
and/or bankruptcy laws as either a “preferential transfer” or a “fraudulent conveyance.” As a result, a bankruptcy
court could seek to recover some or all amounts received by our shareholders. Furthermore, our board of directors may be viewed as having
breached its fiduciary duty to our creditors and/or may have acted in bad faith, and thereby exposing itself and our company to claims
of punitive damages, by paying public shareholders from the trust account prior to addressing the claims of creditors. We cannot assure
you that claims will not be brought against us for these reasons.
Our public shareholders will
be entitled to receive funds from the trust account only (i) in the event of the redemption of our public shares if we do not complete
an initial business combination by the required date, (ii) in connection with a shareholder vote to amend our second amended and restated
memorandum and articles of association (A) to modify the substance or timing of our obligation to allow redemption in connection with
our initial business combination or to redeem 100% of our public shares if we do not complete an initial business combination by the required
date or (B) with respect to any other provision relating to shareholders’ rights or pre-initial business combination activity, or
(iii) if they redeem their respective shares for cash upon the completion of the initial business combination. Public shareholders who
redeem their public shares in connection with a shareholder vote described in clause (ii) in the preceding sentence shall not be entitled
to funds from the trust account upon the subsequent completion of an initial business combination or liquidation if we have not completed
an initial business combination by the required date, with respect to such public shares so redeemed. In no other circumstances will a
shareholder have any right or interest of any kind to or in the trust account. In the event we seek shareholder approval in connection
with our initial business combination, a shareholder’s voting in connection with the business combination alone will not result
in a shareholder’s redeeming its shares to us for an applicable pro rata share of the trust account. Such shareholder must have
also exercised its redemption rights described above. These provisions of our second amended and restated memorandum and articles of association,
like all provisions of our second amended and restated memorandum and articles of association, may be amended with a shareholder vote.
Competition
In identifying, evaluating and
selecting a target business for our initial business combination, we have encountered and may continue to encounter intense competition
from other entities having a business objective similar to ours, including other blank check companies, private equity groups and leveraged
buyout funds, and operating businesses seeking strategic acquisitions. Many of these entities are well established and have extensive
experience identifying and effecting business combinations directly or through affiliates. Moreover, many of these competitors possess
greater financial, technical, human and other resources than us. Our ability to acquire larger target businesses will be limited by our
available financial resources. This inherent limitation gives others an advantage in pursuing the acquisition of a target business. Furthermore,
our obligation to pay cash to our public shareholders who exercise their redemption rights may reduce the resources available to us for
our initial business combination. Either of these factors may place us at a competitive disadvantage in successfully negotiating an initial
business combination.
Employees
We currently have one executive
officer. Members of our management team are not obligated to devote any specific number of hours to our matters, but they have devoted
and will continue to devote as much of their time as they deem necessary to our affairs until we have completed our initial business combination.
The amount of time that any member of our management team devotes in any time period varies based on whether a target business has been
selected for our initial business combination and the current stage of the business combination process. We do not intend to have any
full-time employees prior to the consummation of our initial business combination.
ITEM 1A. RISK FACTORS.
Risks Relating to Our Business
We are a blank check development
stage company with no operating history and no revenues, and you have no basis on which to evaluate our ability to achieve our business
objective.
We are a blank check development
stage company with no operating results to date. Because we lack an operating history, you have no basis upon which to evaluate our ability
to achieve our business objective of completing our initial business combination with one or more target businesses. We may be unable
to complete our initial business combination. If we fail to complete our initial business combination, we will never generate any operating
revenues.
We may not be able to
complete our initial business combination within the prescribed time frame, in which case we would cease all operations except for the
purpose of winding up and we would redeem our public shares and liquidate, in which case our public shareholders may receive only $10.00
per share, or less than such amount in certain circumstances, and our warrants will expire worthless.
Our sponsor, officers and directors
agreed that we must complete our initial business combination by May 22, 2024. We may not be able to find a suitable target business and
complete our initial business combination within such time period. Our ability to complete our initial business combination may be negatively
impacted by general market conditions, volatility in the capital and debt markets and the other risks described herein.
If we have not completed our
initial business combination within such time period, we will: (i) cease all operations except for the purpose of winding up, (ii) as
promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per share price, payable
in cash, equal to the aggregate amount then on deposit in the trust account including interest earned on the funds held in the trust account
and not previously released to us to pay our taxes, if any (less up to $100,000 of interest to pay dissolution expenses), divided by the
number of then outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders
(including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably
possible following such redemption, subject to the approval of our remaining shareholders and our board of directors, liquidate and dissolve,
subject in the case of clauses (ii) and (iii), to our obligations under Cayman Islands law to provide for claims of creditors and
the requirements of other applicable law. Our second amended and restated memorandum and articles of association provides that, if we
wind up for any other reason prior to the consummation of our initial business combination, we will follow the foregoing procedures with
respect to the liquidation of the trust account as promptly as reasonably possible but not more than ten business days thereafter, subject
to applicable Cayman Islands law. In either case, our public shareholders may receive only $10.00 per share, or less than $10.00
per share, on the redemption of their shares, and our warrants will expire worthless. In certain circumstances, our public shareholders
may receive less than $10.00 per share on the redemption of their shares. See “—If third parties bring claims against us,
the proceeds held in the trust account could be reduced and the per-share redemption amount received by shareholders may be less
than $10.00 per share” and other risk factors herein.
Our proximity to our liquidation
date expresses substantial doubt about our ability to continue as a “going concern.”
In connection with our assessment
of going concern considerations, management has determined that our mandatory liquidation and subsequent dissolution raises substantial
doubt about our company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets
or liabilities should our company be required to liquidate. The financial statements do not include any adjustment that might be necessary
if our company is unable to continue as a going concern.
Our public shareholders
may not be afforded an opportunity to vote on our proposed business combination, which means we may complete our initial business combination
even though a majority of our public shareholders do not support such a combination.
We may not hold a shareholder
vote to approve our initial business combination unless the business combination would require shareholder approval under applicable law
or stock exchange listing requirements or if we decide to hold a shareholder vote for business or other legal reasons. Accordingly, we
may complete our initial business combination even if holders of a majority of our public shares do not approve of the business combination
we complete.
If we seek shareholder
approval of our initial business combination, our sponsor, directors and officers have agreed to vote in favor of such initial business
combination, regardless of how our public shareholders vote.
Unlike many other blank check
companies in which the sponsor agrees to vote its founder shares in accordance with the majority of the votes cast by the public shareholders
in connection with an initial business combination, our sponsor has agreed (and its permitted transferees will agree), pursuant to the
terms of a letter agreement entered into with us, to vote its founder shares as well as any public shares purchased during or after our
initial public offering, in favor of our initial business combination. As of the date of this report, our sponsor owns approximately 80%
of our outstanding ordinary shares. As a result, we would not need any public shareholders to vote in favor of a transaction. Accordingly,
if we seek shareholder approval of our initial business combination, it is more likely that the necessary shareholder approval will be
received than would be the case if our sponsor agreed to vote its founder shares in accordance with the majority of the votes cast by
our public shareholders.
Your only opportunity
to affect the investment decision regarding a potential business combination will be limited to the exercise of your right to redeem your
shares from us for cash, unless we seek shareholder approval of such business combination.
You may not be provided with
an opportunity to evaluate the specific merits or risks of any target businesses. Additionally, since our board of directors may complete
our initial business combination without seeking shareholder approval, public shareholders may not have the right or opportunity to vote
on the business combination, unless we seek such shareholder approval. Accordingly, if we do not seek shareholder approval, your only
opportunity to affect the investment decision regarding a potential business combination may be limited to exercising your redemption
rights within the period of time (which will be at least 20 business days) set forth in our tender offer documents mailed to our public
shareholders in which we describe our initial business combination.
The ability of our public
shareholders to redeem their shares for cash may make our financial condition unattractive to potential business combination targets,
which may make it difficult for us to enter into an initial business combination with a target.
We may seek to enter into a
business combination transaction agreement with a prospective target that requires as a closing condition that we have a minimum net worth
or a certain amount of cash. If too many public shareholders exercise their redemption rights, we would not be able to meet such closing
condition and, as a result, would not be able to proceed with the business combination. Furthermore, in no event will we redeem our public
shares in an amount that would cause our net tangible assets to be less than $5,000,001 (so that we do not then become subject to the
SEC’s “penny stock” rules) or any greater net tangible asset or cash requirement which may be contained in the agreement
relating to our initial business combination. Consequently, if accepting all properly submitted redemption requests would cause our net
tangible assets to be less than $5,000,001 or such greater amount necessary to satisfy a closing condition as described above, we would
not proceed with such redemption and the related business combination and may instead search for an alternate business combination. Prospective
targets will be aware of these risks and, thus, may be reluctant to enter into a business combination transaction with us.
The ability of our public
shareholders to exercise redemption rights with respect to a large number of our shares may not allow us to complete the most desirable
business combination or optimize our capital structure.
At the time we enter into an
agreement for our initial business combination, we will not know how many shareholders may exercise their redemption rights and, therefore,
we will need to structure the transaction based on our expectations as to the number of shares that will be submitted for redemption.
If our initial business combination agreement requires us to use a portion of the cash in the trust account to pay the purchase price,
or requires us to have a minimum amount of cash at closing, we will need to reserve a portion of the cash in the trust account to meet
such requirements, or arrange for third-party financing. In addition, if a larger number of shares is submitted for redemption than
we initially expected, we may need to restructure the transaction to reserve a greater portion of the cash in the trust account or arrange
for third-party financing. Raising additional third-party financing may involve dilutive equity issuances or the incurrence
of indebtedness at higher than desirable levels. The above considerations may limit our ability to complete the most desirable business
combination available to us or optimize our capital structure.
The ability of our public
shareholders to exercise redemption rights with respect to a large number of our shares could increase the probability that our initial
business combination would be unsuccessful and that you would have to wait for liquidation in order to redeem your shares.
If our initial business combination
agreement requires us to use a portion of the cash in the trust account to pay the purchase price, or requires us to have a minimum amount
of cash at closing, the probability that our initial business combination would be unsuccessful increases. If our initial business combination
is unsuccessful, you would not receive your pro rata portion of the trust account until we liquidate the trust account. If you are in
need of immediate liquidity, you could attempt to sell your shares in the open market; however, at such time our shares may trade at a
discount to the pro rata amount per share in the trust account. In either situation, you may suffer a material loss on your investment
or lose the benefit of funds expected in connection with our redemption until we liquidate or you are able to sell your shares in the
open market.
The requirement that we
complete our initial business combination within the prescribed time frame may give potential target businesses leverage over us in negotiating
an initial business combination and may limit the time we have in which to conduct due diligence on potential business combination targets,
in particular as we approach our dissolution deadline, which could undermine our ability to complete our initial business combination
on terms that would produce value for our shareholders.
Any potential target business
with which we enter into negotiations concerning an initial business combination will be aware that we must complete our initial business
combination by May 22, 2024. Consequently, such target business may obtain leverage over us in negotiating an initial business combination,
knowing that if we do not complete our initial business combination with that particular target business, we may be unable to complete
our initial business combination with any target business. This risk will increase as we get closer to the prescribed time frame. In addition,
we may have limited time to conduct due diligence and may enter into our initial business combination on terms that we would have rejected
upon a more comprehensive investigation.
If we seek shareholder
approval of our initial business combination, our sponsor, directors, executive officers, advisors or any of their affiliates may elect
to purchase shares from public shareholders, which may influence a vote on a proposed business combination and reduce the public “float”
of our class A ordinary shares.
If we seek shareholder approval
of our initial business combination and we do not conduct redemptions in connection with our initial business combination pursuant to
the tender offer rules, our sponsor, directors, executive officers, advisors or any of their affiliates may purchase shares in privately
negotiated transactions or in the open market either prior to or following the completion of our initial business combination, although
they are under no obligation to do so. Such a purchase may include a contractual acknowledgement that such shareholder, although still
the record holder of our shares is no longer the beneficial owner thereof and therefore agrees not to exercise its redemption rights.
In the event that our sponsor, directors, executive officers, advisors or any of their affiliates purchase public shares in privately
negotiated transactions from public shareholders who have already elected to exercise their redemption rights, such selling shareholders
would be required to revoke their prior elections to redeem their shares. The purpose of such purchases could be to vote such shares in
favor of our initial business combination and thereby increase the likelihood of obtaining shareholder approval of our initial business
combination, or to satisfy a closing condition in an agreement with a target that requires us to have a minimum net worth or a certain
amount of cash at the closing of our initial business combination, where it appears that such requirement would otherwise not be met.
This may result in the completion of our initial business combination that may not otherwise have been possible.
In addition, if such purchases
are made, the public “float” of our class A ordinary shares and the number of beneficial holders of our securities may
be reduced, possibly making it difficult to maintain or obtain the quotation, listing or trading of our securities on a national securities
exchange.
If third parties bring
claims against us, the proceeds held in the trust account could be reduced and the per-share redemption amount received by shareholders
may be less than $10.00 per share.
Our placing of funds in the
trust account may not protect those funds from third-party claims against us. Although we seek to have all vendors, service providers,
prospective target businesses and other entities with which we do business, except our independent registered public accounting firm,
execute agreements with us waiving any right, title, interest or claim of any kind in or to any monies held in the trust account for the
benefit of our public shareholders, such parties may not execute such agreements, or even if they execute such agreements they may not
be prevented from bringing claims against the trust account, including, but not limited to, fraudulent inducement, breach of fiduciary
responsibility or other similar claims, as well as claims challenging the enforceability of the waiver, in each case in order to gain
advantage with respect to a claim against our assets, including the funds held in the trust account. If any third party refuses to execute
an agreement waiving such claims to the monies held in the trust account, our management will perform an analysis of the alternatives
available to it and will enter into an agreement with a third party that has not executed a waiver only if management believes that such
third party’s engagement would be significantly more beneficial to us than any alternative.
Examples of possible instances
where we may engage a third party that refuses to execute a waiver include the engagement of a third party consultant whose particular
expertise or skills are believed by management to be significantly superior to those of other consultants that would agree to execute
a waiver or in cases where we are unable to find a service provider willing to execute a waiver. In addition, there is no guarantee that
such entities will agree to waive any claims they may have in the future as a result of, or arising out of, any negotiations, contracts
or agreements with us and will not seek recourse against the trust account for any reason. Upon redemption of our public shares, if we
are unable to complete our initial business combination within the prescribed timeframe, or upon the exercise of a redemption right in
connection with our initial business combination, we will be required to provide for payment of claims of creditors that were not waived
that may be brought against us within the 10 years following redemption. Accordingly, the per-share redemption amount received by
public shareholders could be less than the $10.00 per share initially held in the trust account, due to claims of such creditors. In order
to protect the amounts held in the trust account, our sponsor agreed it will be liable to us if and to the extent any claims by a third
party for services rendered or products sold to us, or a prospective target business with which we have discussed entering into a transaction
agreement, reduce the amount of funds in the trust account. This liability will not apply with respect to any claims by a third party
who executed a waiver of any and all rights to seek access to the trust account and except as to any claims under our indemnity of the
underwriters of our initial public offering against certain liabilities, including liabilities under the Securities Act. Moreover, in
the event that an executed waiver is deemed to be unenforceable against a third party, then our sponsor will not be responsible to the
extent of any liability for such third party claims. We have not independently verified whether our sponsor has sufficient funds to satisfy
its indemnity obligations and we have not asked our sponsor to reserve for such indemnification obligations. Therefore, we cannot assure
you that our sponsor would be able to satisfy those obligations. As a result, if any such claims were successfully made against the trust
account, the funds available for our initial business combination and redemptions could be reduced to less than $10.00 per public share.
In such event, we may not be able to complete our initial business combination, and you would receive such lesser amount per share in
connection with any redemption of your public shares. None of our officers or directors will indemnify us for claims by third parties
including, without limitation, claims by vendors and prospective target businesses.
You will not have any
rights or interests in funds from the trust account, except under certain limited circumstances. To liquidate your investment, therefore,
you may be forced to sell your public shares and/or public warrants, potentially at a loss.
Our public shareholders will
be entitled to receive funds from the trust account only upon the earlier to occur of: (i) our completion of an initial business combination,
and then only in connection with those class A ordinary shares that such shareholder properly elected to redeem, subject to the limitations
described herein, (ii) the redemption of any public shares properly tendered in connection with a shareholder vote to amend our second
amended and restated memorandum and articles of association (A) to modify the substance or timing of our obligation to allow redemption
in connection with our initial business combination or to redeem 100% of our public shares if we do not complete an initial business combination
by the required date or (B) with respect to any other provision relating to shareholders’ rights or pre-initial business combination
activity, and (iii) the redemption of our public shares if we have not completed an initial business combination by the required date,
subject to applicable law and as further described herein. Public shareholders who redeem their class A ordinary shares in connection
with a shareholder vote described in clause (ii) in the preceding sentence shall not be entitled to funds from the trust account upon
the subsequent completion of an initial business combination or liquidation if we have not completed an initial business combination by
the required date, with respect to such class A ordinary shares so redeemed. In no other circumstances will a public shareholder have
any right or interest of any kind in the trust account. Holders of public warrants will not have any right to the proceeds held in the
trust account with respect to the public warrants. Accordingly, to liquidate your investment, you may be forced to sell your public shares
or public warrants, potentially at a loss.
If a shareholder fails
to receive notice of our offer to redeem our public shares in connection with our initial business combination, or fails to comply with
the procedures for tendering its shares, such shares may not be redeemed.
We will comply with the tender
offer rules or proxy rules, as applicable, when conducting redemptions in connection with our initial business combination. Despite our
compliance with these rules, if a shareholder fails to receive our tender offer or proxy materials, as applicable, such shareholder may
not become aware of the opportunity to redeem its shares. In addition, the tender offer documents or proxy materials, as applicable, that
we will furnish to holders of our public shares in connection with our initial business combination will describe the various procedures
that must be complied with in order to validly tender or redeem public shares. For example, we may require our public shareholders seeking
to exercise their redemption rights, whether they are record holders or hold their shares in “street name,” to either tender
their certificates to our transfer agent prior to the date set forth in the tender offer documents or proxy materials mailed to such holders,
or up to two business days prior to the vote on the proposal to approve the business combination in the event we distribute proxy materials,
or to deliver their shares to the transfer agent electronically. In the event that a shareholder fails to comply with these or any other
procedures, its shares may not be redeemed.
Our security holders are
not entitled to protections normally afforded to investors of many other blank check companies.
Since the net proceeds of our
initial public offering and the sale of the private placement warrants are intended to be used to complete our initial business combination
with a target business that has not been identified, we may be deemed to be a “blank check” company under the U.S. securities
laws. However, because we had net tangible assets in excess of $5,000,000 upon the completion of our initial public offering and the sale
of the private placement warrants, we are exempt from rules promulgated by the SEC to protect investors in blank check companies, such
as Rule 419. Accordingly, our security holders are not afforded the benefits or protections of those rules. Among other things, this
means our units were immediately tradable upon consummation of our initial public offering and we have a longer period of time to complete
our initial business combination than do companies subject to Rule 419. Moreover, offerings subject to Rule 419 would prohibit
the release of any interest earned on funds held in the trust account to us unless and until the funds in the trust account were released
to us in connection with our completion of an initial business combination.
Because of our limited
resources and the significant competition for business combination opportunities, it may be more difficult for us to complete our initial
business combination. If we are unable to complete our initial business combination within the required time period, our public shareholders
may receive only approximately $10.00 per share, or less in certain circumstances, on our redemption of their shares, and our warrants
will expire worthless.
We expect to encounter intense
competition from other entities having a business objective similar to ours, including private investors (which may be individuals or
investment partnerships), other blank check companies and other entities, domestic and international, competing for the types of businesses
we intend to acquire. Many of these individuals and entities are well-established and have extensive experience in identifying and
effecting, directly or indirectly, acquisitions of companies operating in or providing services to various industries. Many of these competitors
possess greater technical, human and other resources or more local industry knowledge than we do and our financial resources will be relatively
limited when contrasted with those of many of these competitors. While we believe there are numerous target businesses we could potentially
acquire with the net proceeds of our initial public offering and the sale of the private placement warrants, our ability to compete with
respect to the acquisition of certain target businesses that are sizable will be limited by our available financial resources. This inherent
competitive limitation gives others an advantage in pursuing the acquisition of certain target businesses. Furthermore, in the event we
seek shareholder approval of our initial business combination and we are obligated to pay cash for our class A ordinary shares, it
will potentially reduce the resources available to us for our initial business combination. Any of these obligations may place us at a
competitive disadvantage in successfully negotiating our initial business combination. If we are unable to complete our initial business
combination within the required time period, our public shareholders may receive only approximately $10.00 per share, or less in certain
circumstances, on the liquidation of our trust account, and our warrants will expire worthless.
As the number of special
purpose acquisition companies increases, there may be more competition to find an attractive target for an initial business combination.
This could increase the costs associated with completing our initial business combination and may result in our inability to find a suitable
target for our initial business combination.
In recent years, the number
of special purpose acquisition companies that have been formed has increased substantially. Many companies have entered into business
combinations with special purpose acquisition companies, and there are still many special purpose acquisition companies seeking targets
for their initial business combination, as well as many additional special purpose acquisition companies currently in registration. As
a result, at times, fewer attractive targets may be available, and it may require more time, effort and resources to identify a suitable
target for an initial business combination.
In addition, because there are
more special purpose acquisition companies seeking to enter into an initial business combination with available targets, the competition
for available targets with attractive fundamentals or business models may increase, which could cause target companies to demand improved
financial terms. Attractive deals could also become scarcer for other reasons, such as economic or industry sector downturns, geopolitical
tensions or increases in the cost of additional capital needed to close business combinations or operate targets post-business combination.
This could increase the cost of, delay or otherwise complicate or frustrate our ability to find a suitable target for and/or complete
our initial business combination.
If the funds not being
held in the trust account are insufficient to allow us to operate, we may be unable to complete our initial business combination.
As of December 31, 2023, we
did not have any funds outside the trust account. However, on November 17, 2023, we signed a non-binding letter of intent with New Degree
Growth LLC, or NDG, for a proposed transaction between us and NDG. Included in the general terms and conditions of the letter of intent
is a condition where NDG will assume the payment of our operating expenses, including the service fees of our auditors, legal counsel,
accountants, stock transfer agent and others, in the amount of not more than $100,000 (one hundred thousand dollars) per month, including
the payment of our monthly contribution to the trust account. In addition, within five business days upon the signing of the letter of
intent, NDG or its representatives agreed to make a deposit in the amount of $30,000 (thirty thousand dollars) into the trust account.
As of December 31, 2023, a total of $110,000 was advanced by NDG to us. We believe that these funds will be sufficient to allow us to
operate until we complete our initial business combination; however, we cannot assure you that our estimate is accurate.
Furthermore, if the letter of
intent is terminated, we will need to raise additional capital through loans or additional investments from our sponsor, officers or directors
or their affiliates. Our sponsor, officers and directors, or their affiliates, may, but are not obligated to, loan funds to us, from time
to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet our working capital needs. Accordingly,
we may not be able to obtain additional financing. If we are unable to raise additional capital, we may be required to take additional
measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit
of a potential transaction, reducing overhead expenses, and extending the terms and due dates of certain accrued expenses and other liabilities.
We cannot provide any assurance that new financing will be available to us on commercially acceptable terms, if at all. In connection
with our assessment of going concern considerations, management has determined that the liquidity condition, mandatory liquidation and
subsequent dissolution raises substantial doubt about our ability to continue as a going concern. Management continues to seek to complete
a business combination prior to the mandatory liquidation date. No adjustments have been made to the carrying amounts of assets or liabilities
should we be required to liquidate after May 22, 2024. The accompanying financial statements do not include any adjustment that might
be necessary if we are unable to continue as a going concern.
Subsequent to our completion
of our initial business combination, we may be required to take write-downs or write-offs, restructuring and impairment or other charges
that could have a significant negative effect on our financial condition, results of operations and the price of our securities, which
could cause you to lose some or all of your investment.
Even if we conduct extensive
due diligence on a target business with which we combine, we cannot assure you that this diligence will identify all material issues that
may be present with a particular target business, that it would be possible to uncover all material issues through a customary amount
of due diligence, or that factors outside of the target business and outside of our control will not later arise. As a result of these
factors, we may be forced to later write-down or write-off assets, restructure our operations, or incur impairment or other
charges that could result in our reporting losses. Even if our due diligence successfully identifies certain risks, unexpected risks may
arise and previously known risks may materialize in a manner not consistent with our preliminary risk analysis. Even though these charges
may be non-cash items and not have an immediate impact on our liquidity, the fact that we report charges of this nature could contribute
to negative market perceptions about us or our securities. In addition, charges of this nature may cause us to violate net worth or other
covenants to which we may be subject as a result of assuming pre-existing debt held by a target business or by virtue of our obtaining
post-combination debt financing. Accordingly, any shareholder or warrant holder who chooses to remain a shareholder or warrant holder,
respectively, following our initial business combination could suffer a reduction in the value of their securities. Such shareholders
and warrant holders are unlikely to have a remedy for such reduction in value unless they are able to successfully claim that the reduction
was due to the breach by our officers or directors of a duty of care or other fiduciary duty owed by them to our company, or if they are
able to successfully bring a private claim under securities laws that the tender offer materials or proxy statement relating to the business
combination contained an actionable material misstatement or material omission.
We are dependent upon
our executive officers and directors and their departure could adversely affect our ability to operate.
Our operations are dependent
upon a relatively small group of individuals and in particular, Dimitri Elkin, our Chief Executive Officer, and our directors, Messrs.
Jonathan D. Morris, Gregory D. Nelson and Konstantin Tourevski. We believe that our success depends on the continued service of our executive
officers and directors, at least until we have completed our initial business combination. In addition, our executive officers and directors
are not required to commit any specified amount of time to our affairs and, accordingly, will have conflicts of interest in allocating
their time among various business activities and for identifying potential business combinations and monitoring the related due diligence.
We do not have an employment agreement with, or key-man insurance on the life of, any of our directors or executive officers. The
unexpected loss of the services of one or more of our directors or executive officers could have a detrimental effect on us.
Our executive officers
and directors will allocate their time to other businesses thereby causing conflicts of interest in their determination as to how much
time to devote to our affairs. This conflict of interest could have a negative impact on our ability to complete our initial business
combination.
Our executive officers and directors
are not required to, and will not, commit their full time to our affairs, which may result in a conflict of interest in allocating their
time between our operations and our search for an initial business combination and their other businesses. We do not intend to have any
full-time employees prior to the completion of our initial business combination. Each of our executive officers is engaged in several
other business endeavors for which he or she may be entitled to substantial compensation and our executive officers are not obligated
to contribute any specific number of hours per week to our affairs. Our independent directors also serve as officers or board members
for other entities. If our executive officers’ and directors’ other business affairs require them to devote substantial amounts
of time to such affairs in excess of their current commitment levels, it could limit their ability to devote time to our affairs which
may have a negative impact on our ability to complete our initial business combination.
Our executive officers,
directors, security holders and their respective affiliates may have competitive pecuniary interests that conflict with our interests.
We have not adopted a policy
that expressly prohibits our directors, executive officers, security holders or affiliates from having a direct or indirect pecuniary
or financial interest in any investment to be acquired or disposed of by us or in any transaction to which we are a party or have an interest.
In fact, we may enter into a business combination with a target business that is affiliated with our sponsor, our directors or executive
officers, although we do not intend to do so. Nor do we have a policy that expressly prohibits any such persons from engaging for their
own account in business activities of the types conducted by us. Accordingly, such persons or entities may have a conflict between their
interests and ours.
The personal and financial interests
of our directors and officers may influence their motivation in timely identifying and selecting a target business and completing a business
combination. Consequently, our directors’ and officers’ discretion in identifying and selecting a suitable target business
may result in a conflict of interest when determining whether the terms, conditions and timing of a particular business combination are
appropriate and in our shareholders’ best interest. If this were the case, it would be a breach of their fiduciary duties to us
as a matter of Cayman Islands law and we or our shareholders might have a claim against such individuals for infringing on our shareholders’
rights. However, we might not ultimately be successful in any claim we may make against them for such reason.
The shares beneficially
owned by our sponsor, our officers and directors will not participate in liquidation distributions and, therefore, our officers and directors
may have a conflict of interest in determining whether a particular target business is appropriate for our initial business combination.
Our sponsor, officers and directors
have entered into respective letter agreements with us, pursuant to which our sponsor has agreed to waive its redemption rights with respect
to its founder shares, and our sponsor, officers and directors have agreed to waive their redemption rights with respect to any public
shares they may acquire, in connection with the completion of our initial business combination. Our sponsor has also waived its right
to receive distributions with respect to its founder shares upon our liquidation if we are unable to consummate our initial business combination.
Accordingly, the founder shares will be worthless if we do not consummate our initial business combination. The private placement warrants
and any other warrants they acquire will also be worthless if we do not consummate an initial business combination. The personal and financial
interests of our sponsor, officers and directors may influence their motivation in timely identifying and selecting a target business
and completing a business combination. Consequently, our directors’ and officers’ discretion in identifying and selecting
a suitable target business may result in a conflict of interest when determining whether the terms, conditions and timing of a particular
business combination are appropriate and in our shareholders’ best interest.
Our ability to successfully
effect our initial business combination and to be successful thereafter will be totally dependent upon the efforts of our key personnel,
some of whom may join us following our initial business combination. The loss of our or our target’s key personnel could negatively
impact the operations and profitability of our post-combination business.
Our ability to successfully
effect our initial business combination is dependent upon the efforts of our key personnel with regard to our selection of a target company.
The role of our key personnel in the target business, however, cannot presently be ascertained. Although some of our key personnel may
remain with the target business in senior management or advisory positions following our initial business combination, it is likely that
some or all of the management of the target business will remain in place. While we intend to closely scrutinize any individuals we engage
after our initial business combination, we cannot assure you that our assessment of these individuals will prove to be correct. These
individuals may be unfamiliar with the requirements of operating a company regulated by the SEC, which could cause us to have to expend
time and resources helping them become familiar with such requirements.
Our key personnel may
negotiate employment or consulting agreements with a target business in connection with a particular business combination. These agreements
may provide for them to receive compensation following our initial business combination and as a result, may cause them to have conflicts
of interest in determining whether a particular business combination is the most advantageous.
Our key personnel may be able
to remain with our company after the completion of our initial business combination only if they are able to negotiate employment or consulting
agreements in connection with the business combination. Such negotiations would take place simultaneously with the negotiation of the
business combination and could provide for such individuals to receive compensation in the form of cash payments and/or our securities
for services they would render to us after the completion of the business combination. The personal and financial interests of such individuals
may influence their motivation in identifying and selecting a target business, subject to fiduciary duties under Cayman Islands law. However,
we believe the ability of such individuals to remain with us after the completion of our initial business combination will not be the
determining factor in our decision as to whether or not we will proceed with any potential business combination. There is no certainty,
however, that any of our key personnel will remain with us after the completion of our initial business combination. We cannot assure
you that any of our key personnel will remain in senior management or advisory positions with us. The determination as to whether any
of our key personnel will remain with us will be made at the time of our initial business combination.
Our directors may decide
not to enforce the indemnification obligations of our sponsor, resulting in a reduction in the amount of funds in the trust account available
for distribution to our public shareholders.
In the event that the proceeds
in the trust account are reduced and our sponsor asserts that it is unable to satisfy its obligations or that it has no such indemnification
obligations related to a particular claim, our disinterested directors would determine whether to take legal action against our sponsor
to enforce its indemnification obligations. While we currently expect that our disinterested directors would take legal action on our
behalf against our sponsor to enforce its indemnification obligations to us, it is possible that our disinterested directors in exercising
their business judgment may choose not to do so if, for example, the cost of such legal action is deemed by such directors to be too high
relative to the amount recoverable or if the independent directors determine that a favorable outcome is not likely. If our disinterested
directors choose not to enforce these indemnification obligations, the amount of funds in the trust account available for distribution
to our public shareholders may be reduced below $10.00 per share.
Our shareholders may be
held liable for claims by third parties against us to the extent of distributions received by them upon redemption of their shares.
If we are forced to enter into
an insolvent liquidation, any distributions received by shareholders could be viewed as an unlawful payment if it was proved that immediately
following the date on which the distribution was made, we were unable to pay our debts as they fall due in the ordinary course of business.
As a result, a liquidator could seek to recover some or all amounts received by our shareholders. Furthermore, our directors may be viewed
as having breached their fiduciary duties to us or our creditors and/or may have acted in bad faith, thereby exposing themselves and our
company to claims, by paying public shareholders from the trust account prior to addressing the claims of creditors. We cannot assure
you that claims will not be brought against us for these reasons. We and our directors and officers who knowingly and willfully authorized
or permitted any distribution to be paid out of our share premium account while we were unable to pay our debts as they fall due in the
ordinary course of business would be guilty of an offence and may be liable for a fine of $18,293 and imprisonment for five years in the
Cayman Islands.
If we are unable to consummate
our initial business combination by required date, our public shareholders may be forced to wait beyond the ten business day period thereafter
before redemption from our trust account.
If we are unable to consummate
our initial business combination by the required date, we will, as promptly as reasonably possible but not more than ten business days
thereafter, redeem all public shares then outstanding at a per-share price, payable in cash, equal to the aggregate amount then on
deposit in the trust account, including any amounts representing interest earned on the trust account not previously released to us to
pay our taxes, if any, less up to $100,000 of interest for our dissolution expenses, divided by the number of then outstanding public
shares and cease all operations except for the purposes of winding up of our affairs by way of a voluntary liquidation, as further described
elsewhere in this report. Any redemption of public shareholders from the trust account shall be effected automatically by function of
our second amended and restated memorandum and articles of association prior to our commencing any voluntary liquidation. If we are required
to liquidate prior to distributing the aggregate amount then on deposit in the trust account, then such winding up, liquidation and distribution
must comply with the applicable provisions of the Companies Act (Revised) of the Cayman Islands, as amended, or the Companies Act. In
that case, investors may be forced to wait beyond the ten business days following May 22, 2024 before the redemption proceeds of our trust
account become available to them, and they receive the return of their portion of the proceeds from our trust account. We have no obligation
to return funds to investors prior to the date of our redemption or liquidation unless, prior thereto, we consummate our initial business
combination or amend certain provisions of our second amended and restated memorandum and articles of association and then only in cases
where investors have sought to redeem their class A ordinary shares. Only upon our redemption or any liquidation will public shareholders
be entitled to distributions if we are unable to complete our initial business combination.
Because we are not limited
to a particular industry, sector or any specific target businesses with which to pursue our initial business combination, you will be
unable to ascertain the merits or risks of any particular target business’ operations.
We seek to complete our initial
business combination with an operating company, except that we will not, under our second amended and restated memorandum and articles
of association, be permitted to effectuate our initial business combination with another blank check company or similar company with nominal
operations. There is no current basis for you to evaluate the possible merits or risks of the particular industry in which we may ultimately
operate or the target business which we may ultimately acquire. To the extent we complete our initial business combination, we may be
affected by numerous risks inherent in the business operations with which we combine. For example, if we combine with a financially unstable
business or an entity lacking an established record of sales or earnings, we may be affected by the risks inherent in the business and
operations of a financially unstable or a development stage entity. Although our officers and directors will endeavor to evaluate the
risks inherent in a particular target business, we cannot assure you that we will properly ascertain or assess all of the significant
risk factors or that we will have adequate time to complete due diligence. Furthermore, some of these risks may be outside of our control
and leave us with no ability to control or reduce the chances that those risks will adversely impact a target business. We also cannot
assure you that an investment in our securities will ultimately prove to be more favorable to investors than a direct investment, if such
opportunity were available, in a business combination target. Accordingly, any shareholder or warrant holder who chooses to remain a shareholder
or warrant holder, respectively, following the business combination could suffer a reduction in the value of their securities. Such shareholders
and warrant holders are unlikely to have a remedy for such reduction in value unless they are able to successfully claim that the reduction
was due to the breach by our officers or directors of a duty of care or other fiduciary duty owed by them to us, or if they are able to
successfully bring a private claim under securities laws that the tender offer materials or proxy statement relating to the business combination
contained an actionable material misstatement or material omission.
We may seek acquisition
opportunities in industries or sectors outside the technology and internet sectors which may or may not be outside of our management’s
area of expertise.
We will consider an initial
business combination outside of the technology and internet sectors (which sectors may or may not be outside our management’s areas
of expertise) if a business combination candidate is presented to us and we determine that such candidate offers an attractive acquisition
opportunity for our company. Although our management will endeavor to evaluate the risks inherent in any particular business combination
candidate, we cannot assure you that we will adequately ascertain or assess all of the significant risk factors. We also cannot assure
you that an investment in our securities will not ultimately prove to be less favorable to investors than a direct investment, if an opportunity
were available, in a business combination candidate. In the event we elect to pursue an acquisition outside of the areas of our management’s
expertise, our management’s expertise may not be directly applicable to its evaluation or operation, and the information contained
in this report regarding the areas of our management’s expertise would not be relevant to an understanding of the business that
we elect to acquire. As a result, our management may not be able to adequately ascertain or assess all of the significant risk factors.
Accordingly, any shareholder or warrant holder who remains a shareholder or warrant holder following our initial business combination
could suffer a reduction in the value of their securities. Such shareholders and warrant holders are unlikely to have a remedy for such
reduction in value.
Although we have identified
general criteria and guidelines that we believe are important in evaluating prospective target businesses, we may enter into our initial
business combination with a target that does not meet such criteria and guidelines, and as a result, the target business with which we
enter into our initial business combination may not have attributes entirely consistent with our general criteria and guidelines.
Although we have identified
general criteria and guidelines for evaluating prospective target businesses, it is possible that a target business with which we enter
into our initial business combination will not have all of these positive attributes. If we complete our initial business combination
with a target that does not meet some or all of these criteria and guidelines, such combination may not be as successful as a combination
with a business that does meet all of our general criteria and guidelines. In addition, if we announce a prospective business combination
with a target that does not meet our general criteria and guidelines, a greater number of shareholders may exercise their redemption rights,
which may make it difficult for us to meet any closing condition with a target business that requires us to have a minimum net worth or
a certain amount of cash. In addition, if shareholder approval of the transaction is required by law or stock exchange listing requirements,
or we decide to obtain shareholder approval for business or other legal reasons, it may be more difficult for us to attain shareholder
approval of our initial business combination if the target business does not meet our general criteria and guidelines. If we are unable
to complete our initial business combination within the required time period, our public shareholders may receive only approximately $10.00
per share, or less in certain circumstances, on the liquidation of our trust account, and our warrants will expire worthless.
We may seek acquisition
opportunities with an early stage company, a financially unstable business or an entity lacking an established record of revenue or earnings,
which could subject us to volatile revenues or earnings or difficulty in retaining key personnel.
To the extent we complete our
initial business combination with an early stage company, a financially unstable business or an entity lacking an established record of
sales or earnings, we may be affected by numerous risks inherent in the operations of the business with which we combine. These risks
include investing in a business without a proven business model and with limited historical financial data, volatile revenues or earnings,
intense competition and difficulties in obtaining and retaining key personnel. Although our officers and directors will endeavor to evaluate
the risks inherent in a particular target business, we may not be able to properly ascertain or assess all of the significant risk factors
and we may not have adequate time to complete due diligence. Furthermore, some of these risks may be outside of our control and leave
us with no ability to control or reduce the chances that those risks will adversely impact a target business.
Emerging markets are subject
to different risks as compared to more developed markets.
We intend to focus on companies
in EMEA, including emerging markets. Operating a business in emerging markets can involve a greater degree of risk than operating
a business in more developed markets, including, in some cases, increased political, economic and legal risks. Emerging market governments
and judiciaries often exercise broad, unchecked discretion and are susceptible to abuse and corruption. Moreover, financial turmoil in
any emerging market country tends to adversely affect the value of investments in all emerging market countries as investors move their
money to more stable, developed markets. As has happened in the past, financial problems or an increase in the perceived risks associated
with investing in companies in emerging economies could dampen foreign investment in emerging markets. Generally, investment in emerging
markets is only suitable for sophisticated investors who fully appreciate the significance of the risks involved in, and are familiar
with, investing in emerging markets.
We are currently operating in a period of
economic uncertainty and capital markets disruption, which has been significantly impacted by geopolitical instability due to the ongoing
military conflicts between Russia and Ukraine and between Hamas and Israel. Our search for an initial business combination, and any target
business with which we ultimately consummates an initial business combination, may be materially adversely affected by any negative impact
on the global economy and capital markets resulting from the conflicts in Ukraine and Israel or any other geopolitical tensions.
U.S. and global markets are experiencing volatility
and disruption following the escalation of geopolitical tensions and the start of the military conflict between Russia and Ukraine. On
February 24, 2022, a full-scale military invasion of Ukraine by Russian troops was reported. Although the length and impact of the ongoing
military conflict is highly unpredictable, the conflict in Ukraine could lead to market disruptions, including significant volatility
in commodity prices, credit and capital markets, as well as supply chain interruptions. We are continuing to monitor the situation in
Ukraine and globally and assessing the potential impact on our business. Additionally, Russia’s prior annexation of Crimea, recent
recognition of two separatist republics in the Donetsk and Luhansk regions of Ukraine and subsequent military interventions in Ukraine
have led to sanctions and other penalties being levied by the United States, European Union and other countries against Russia, Belarus,
the Crimea Region of Ukraine, the so-called Donetsk People’s Republic, and the so-called Luhansk People’s Republic, including
agreement to remove certain Russian financial institutions from the Society for Worldwide Interbank Financial Telecommunication payment
system, expansive ban on imports and exports of products to and from Russia and ban on exportation of U.S. denominated banknotes to Russia
or persons locates there. Additional potential sanctions and penalties have also been proposed and/or threatened. Russian military actions
and the resulting sanctions could adversely affect the global economy and financial markets and lead to instability and lack of liquidity
in capital markets, potentially making it more difficult for us to obtain additional funds. Any of the abovementioned factors could affect
our ability to search for a target and consummate a business combination. The extent and duration of the military action, sanctions and
resulting market disruptions are impossible to predict, but could be substantial. Any such disruptions may also magnify the impact of
other risks described in this report.
We are not required to
obtain an opinion from an independent investment banking firm that is a member of FINRA or from an independent accounting firm, and consequently,
you may have no assurance from an independent source that the price we are paying for the business is fair to our company from a financial
point of view.
Unless we complete our initial
business combination with an affiliated entity, we are not required to obtain an opinion from an independent investment banking firm that
is a member of FINRA or from an independent accounting firm that the price we are paying is fair to our company from a financial point
of view. If no opinion is obtained, our shareholders will be relying on the judgment of our board of directors, who will determine fair
market value based on one or more standards generally accepted by the financial community, such as actual and potential sales, earnings,
cash flow and/or book value, discounted cash flow valuation or value of comparable businesses. Such standards used will be disclosed in
our tender offer documents or proxy solicitation materials, as applicable, related to our initial business combination.
Resources could be wasted
in researching acquisitions that are not completed, which could materially adversely affect subsequent attempts to locate and acquire
or merge with another business. If we are unable to complete our initial business combination, our public shareholders may receive only
approximately $10.00 per share, or less than such amount in certain circumstances, on the liquidation of our trust account, and our warrants
will expire worthless.
The investigation of each specific
target business and the negotiation, drafting and execution of relevant agreements, disclosure documents and other instruments requires
substantial management time and attention and substantial costs for accountants, attorneys and others. If we decide not to complete a
specific initial business combination, the costs incurred up to that point for the proposed transaction likely would not be recoverable.
Furthermore, if we reach an agreement relating to a specific target business, we may fail to complete our initial business combination
for any number of reasons including those beyond our control. Any such event will result in a loss to us of the related costs incurred
which could materially adversely affect subsequent attempts to locate and acquire or merge with another business. If we are unable to
complete our initial business combination within the required time period, our public shareholders may receive only approximately $10.00
per share, or less in certain circumstances, on the liquidation of our trust account, and our warrants will expire worthless.
We may have limited ability
to assess the management of a prospective target business and, as a result, may effect our initial business combination with a target
business whose management may not have the skills, qualifications or abilities to manage a public company, which could, in turn, negatively
impact the value of our shareholders’ investment in us.
When evaluating the desirability
of effecting our initial business combination with a prospective target business, our ability to assess the target business’ management
may be limited due to a lack of time, resources or information. Our assessment of the capabilities of the target’s management, therefore,
may prove to be incorrect and such management may lack the skills, qualifications or abilities we suspected. Should the target’s
management not possess the skills, qualifications or abilities necessary to manage a public company, the operations and profitability
of the post-combination business may be negatively impacted. Accordingly, shareholders who choose to remain shareholders following
our initial business combination could suffer a reduction in the value of their securities. Such shareholders are unlikely to have a remedy
for such reduction in value unless they are able to successfully claim that the reduction was due to the breach by our officers or directors
of a duty of care or other fiduciary duty owed to us, or if they are able to successfully bring a private claim under securities laws
that the tender offer materials or proxy statement relating to the business combination contained an actionable material misstatement
or material omission.
The officers and directors of
an acquisition candidate may resign upon completion of our initial business combination. The departure of a business combination target’s
key personnel could negatively impact the operations and profitability of our post-combination business. The role of an acquisition
candidate’s key personnel upon the completion of our initial business combination cannot be ascertained at this time. Although we
contemplate that certain members of an acquisition candidate’s management team will remain associated with the acquisition candidate
following our initial business combination, it is possible that members of the management of an acquisition candidate will not wish to
remain in place.
After our initial business
combination, it is possible that a majority of our directors and officers will live outside the United States and all of our assets
will be located outside the United States; therefore investors may not be able to enforce federal securities laws or their other
legal rights.
It is possible that after our
initial business combination, a majority of our directors and officers will reside outside of the United States and all of our assets
will be located outside of the United States. As a result, it may be difficult, or in some cases not possible, for investors in the
United States to enforce their legal rights, to effect service of process upon all of our directors or officers or to enforce judgments
of United States courts predicated upon civil liabilities and criminal penalties on our directors and officers under United States
laws.
We may engage in an initial
business combination with one or more target businesses that have relationships with entities that may be affiliated with our sponsor,
executive officers, directors or existing holders which may raise potential conflicts of interest.
In light of the involvement
of our sponsor, executive officers and directors with other entities, we may decide to acquire one or more businesses affiliated with
our sponsor, executive officers and directors. Our executive officers and directors also serve as officers and/or board members for other
entities. Our sponsor, officers and directors are not currently aware of any specific opportunities for us to complete our initial business
combination with any entities with which they are affiliated, and there have been no preliminary discussions concerning an initial business
combination with any such entity or entities. Although we are not specifically focusing on, or targeting, any transaction with any affiliated
entities, we would pursue such a transaction if we determined that such affiliated entity met our criteria for an initial business combination
and such transaction was approved by a majority of our disinterested directors. Despite our agreement to obtain an opinion from an independent
investment banking firm that is a member of FINRA, or from an independent accounting firm, regarding the fairness to our company from
a financial point of view of an initial business combination with one or more domestic or international businesses affiliated with our
sponsor, executive officers or directors, potential conflicts of interest still may exist and, as a result, the terms of the business
combination may not be as advantageous to our public shareholders as they would be absent any conflicts of interest.
Since our sponsor will
lose its entire investment in us if our initial business combination is not completed, a conflict of interest may arise in determining
whether a particular business combination target is appropriate for our initial business combination.
Our sponsor holds an aggregate
of 6,250,000 founder shares as of the date of this report. The founder shares will be worthless if we do not complete our initial business
combination. In addition, our sponsor has purchased an aggregate of 4,400,000 private placement warrants, each of which such warrants
will be exercisable for one class A ordinary share at $11.50 per share, that will also be worthless if we do not complete a
business combination. The sponsor has agreed (i) to vote any shares owned by it in favor of any proposed business combination and
(ii) not to redeem any shares in connection with a shareholder vote or tender offer to approve or in connection with a proposed initial
business combination. The personal and financial interests of our sponsor may influence its motivation in identifying and selecting a
target business combination, completing an initial business combination and influencing the operation of the business following the initial
business combination. This risk may become more acute as the deadline for the completion of our initial business combination nears.
We may issue notes or
other debt securities, or otherwise incur substantial debt, to complete our initial business combination, which may adversely affect our
leverage and financial condition and thus negatively impact the value of our shareholders’ investment in us.
Although we have no commitments
as of the date of this report to issue any notes or other debt securities, or to otherwise incur outstanding debt, we may choose to incur
substantial debt to complete our initial business combination. We have agreed that we will not incur any indebtedness unless we have obtained
from the lender a waiver of any right, title, interest or claim of any kind in or to the monies held in the trust account. As such, no
issuance of debt will affect the per-share amount available for redemption from the trust account. Nevertheless, the incurrence of
debt could have a variety of negative effects, including:
| ● | default and foreclosure on our assets if our operating revenues after an initial business combination
are insufficient to repay our debt obligations; |
| ● | acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments
when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation
of that covenant; |
| ● | our immediate payment of all principal and accrued interest, if any, if the debt is payable on demand; |
| ● | our inability to obtain necessary additional financing if the debt contains covenants restricting our
ability to obtain such financing while the debt is outstanding; |
| ● | our inability to pay dividends on our class A ordinary shares; |
| ● | using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce
the funds available for dividends on our class A ordinary shares if declared, expenses, capital expenditures, acquisitions and other
general corporate purposes; |
| ● | limitations on our flexibility in planning for and reacting to changes in our business and in the industry
in which we operate; |
| ● | increased vulnerability to adverse changes in general economic, industry and competitive conditions and
adverse changes in government regulation; |
| ● | limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions,
debt service requirements, and execution of our strategy and other purposes; and |
| ● | other disadvantages compared to our competitors who have less debt. |
We may be able to complete
only one business combination, which will cause us to be solely dependent on a single business which may have a limited number of products
or services. This lack of diversification may negatively impact our operations and profitability.
We may effectuate our initial
business combination with a single target business or multiple target businesses simultaneously or within a short period of time. However,
we may not be able to effectuate our initial business combination with more than one target business because of various factors, including
the existence of complex accounting issues and the requirement that we prepare and file pro forma financial statements with the SEC that
present operating results and the financial condition of several target businesses as if they had been operated on a combined basis. By
completing our initial business combination with only a single entity, our lack of diversification may subject us to numerous economic,
competitive and regulatory risks. Further, we would not be able to diversify our operations or benefit from the possible spreading of
risks or offsetting of losses, unlike other entities which may have the resources to complete several business combinations in different
industries or different areas of a single industry. Accordingly, the prospects for our success may be solely dependent upon the performance
of a single business, property or asset, or dependent upon the development or market acceptance of a single or limited number of products,
processes or services. This lack of diversification may subject us to numerous economic, competitive and regulatory risks, any or all
of which may have a substantial adverse impact upon the particular industry in which we may operate subsequent to our initial business
combination.
We may attempt to simultaneously
complete business combinations with multiple prospective targets, which may hinder our ability to complete our initial business combination
and give rise to increased costs and risks that could negatively impact our operations and profitability.
If we determine to simultaneously
acquire several businesses that are owned by different sellers, we will need for each of such sellers to agree that our purchase of its
business is contingent on the simultaneous closings of the other business combinations, which may make it more difficult for us, and delay
our ability, to complete our initial business combination. With multiple business combinations, we could also face additional risks, including
additional burdens and costs with respect to possible multiple negotiations and due diligence investigations (if there are multiple sellers)
and the additional risks associated with the subsequent assimilation of the operations and services or products of the acquired companies
in a single operating business. If we are unable to adequately address these risks, it could negatively impact our profitability and results
of operations.
We may attempt to complete
our initial business combination with a private company about which little information is available, which may result in an initial business
combination with a company that is not as profitable as we suspected, if at all.
In pursuing our acquisition
strategy, we may seek to effectuate our initial business combination with a privately held company. By definition, very little public
information exists about private companies, and we could be required to make our decision on whether to pursue a potential initial business
combination on the basis of limited information, which may result in an initial business combination with a company that is not as profitable
as we suspected, if at all.
We may seek business combination
opportunities with a high degree of complexity that require significant operational improvements, which could delay or prevent us from
achieving our desired results.
We may seek business combination
opportunities with large, highly complex companies that we believe would benefit from operational improvements. While we intend to implement
such improvements, to the extent that our efforts are delayed or we are unable to achieve the desired improvements, the business combination
may not be as successful as we anticipate.
To the extent we complete our
initial business combination with a large complex business or entity with a complex operating structure, we may also be affected by numerous
risks inherent in the operations of the business with which we combine, which could delay or prevent us from implementing our strategy.
Although our management team will endeavor to evaluate the risks inherent in a particular target business and its operations, we may not
be able to properly ascertain or assess all of the significant risk factors until we complete our business combination. If we are not
able to achieve our desired operational improvements, or the improvements take longer to implement than anticipated, we may not achieve
the gains that we anticipate. Furthermore, some of these risks and complexities may be outside of our control and leave us with no ability
to control or reduce the chances that those risks and complexities will adversely impact a target business. Such combination may not be
as successful as a combination with a smaller, less complex organization.
If we effect our initial
business combination with a business located outside of the United States, we would be subject to a variety of additional risks that
may negatively impact our operations.
We may effect an initial business
combination with a business located outside of the United States. If we do, we would be subject to any special considerations or
risks associated with businesses operating in the target’s home jurisdiction, including any of the following:
| ● | rules and regulations or currency conversion or corporate withholding taxes on individuals; |
| ● | laws governing the manner in which future business combinations may be effected; |
| ● | differing laws and regulations regarding exchange listing and delisting requirements; |
| ● | tariffs and trade barriers; |
| ● | regulations related to customs and import/export matters; |
| ● | tax issues, such as tax law changes and variations in tax laws as compared to the United States; |
| ● | currency fluctuations and exchange
controls; |
| ● | inflation greater than that experienced
in the United States; |
| ● | challenges in collecting accounts
receivable; |
| ● | cultural and language differences; |
| ● | crime, strikes, riots, civil disturbances,
terrorist attacks, military conflicts and wars, including the conflicts in Ukraine and Gaza;
and |
| ● | deterioration of political relations
with the United States. |
We may not be able to adequately
address these additional risks. If we are unable to do so, our operations might suffer.
If we effect our initial
business combination with a business located outside of the United States, the laws applicable to such business will likely govern
all of our material agreements and we may not be able to enforce our legal rights.
If we effect our initial business
combination with a business located outside of the United States, the laws of the country in which such business operates will govern
almost all of the material agreements relating to its operations. The target business may not be able to enforce any of its material
agreements or enforce remedies for breaches of those agreements in that jurisdiction. The system of laws and the enforcement of existing
laws in such jurisdiction may not be as certain in implementation and interpretation as in the United States. The inability to enforce
or obtain a remedy under any of our future agreements could result in a significant loss of business, business opportunities or capital.
Additionally, if we acquire a business located outside of the United States, it is likely that substantially all of our assets would
be located outside of the United States and some of our officers and directors might reside outside of the United States. As
a result, it may not be possible for investors in the United States to enforce their legal rights, to effect service of process
upon our directors or officers or to enforce judgments of U.S. courts predicated upon civil liabilities and criminal penalties of our
directors and officers under federal securities laws.
Because of the costs
and difficulties inherent in managing cross-border business operations, our results of operations may be negatively impacted.
Managing a business, operations,
personnel or assets in another country is challenging and costly. Any management that we may have (whether based abroad or in the United States)
may be inexperienced in cross-border business practices and unaware of significant differences in accounting rules, legal regimes
and labor practices. Even with a seasoned and experienced management team, the costs and difficulties inherent in managing cross-border business
operations, personnel and assets can be significant (and much higher than in a purely domestic business) and may negatively impact our
financial and operational performance.
If our initial business
combination involves a company organized under the laws of a state of the United States, it is possible a 1% U.S. federal excise tax
will be imposed on us in connection with redemptions of our shares after or in connection with such initial business combination.
On August 16, 2022, the Inflation
Reduction Act of 2022 became law in the United States, which, among other things, imposes a 1% excise tax on the fair market value of
certain repurchases (including certain redemptions) of stock by publicly traded domestic (i.e., United States) corporations (and certain
non-U.S. corporations treated as “surrogate foreign corporations”). The excise tax will apply to stock repurchases occurring
in 2023 and beyond. The amount of the excise tax is generally 1% of the fair market value of the shares of stock repurchased at the time
of the repurchase. The Treasury Department has been given authority to provide regulations and other guidance to carry out, and prevent
the abuse or avoidance of, the excise tax; however, only limited guidance has been issued to date.
As an entity incorporated as
a Cayman Islands exempted company, the 1% excise tax is not expected to apply to redemptions of our class A ordinary shares (absent any
regulations and other additional guidance that may be issued in the future with retroactive effect).
However, in connection with
an initial business combination involving a company organized under the laws of the United States, it is possible that we domesticate
and continue as a domestic corporation prior to certain redemptions and, because our securities are trading on the Nasdaq Capital Market,
it is possible that we will be subject to the excise tax with respect to any subsequent redemptions, including redemptions in connection
with the initial business combination, that are treated as repurchases for this purpose (other than, pursuant to recently issued guidance
from the Treasury Department, redemptions in complete liquidation of the company). In all cases, the extent of the excise tax that may
be incurred will depend on a number of factors, including the fair market value of our shares redeemed, the extent such redemptions could
be treated as dividends and not repurchases, and the content of any regulations and other additional guidance from the Treasury Department
that may be issued and applicable to the redemptions. Issuances of shares by a repurchasing corporation in a year in which such corporation
repurchases shares may reduce the amount of excise tax imposed with respect to such repurchase. The excise tax is imposed on the repurchasing
corporation itself, not the shareholders from which shares are repurchased. The imposition of the excise tax as a result of redemptions
in connection with the initial business combination could, however, reduce the amount of cash available to pay redemptions or reduce
the cash contribution to the target business in connection with our initial business combination, which could cause the other shareholders
of the combined company to economically bear the impact of such excise tax.
We may migrate to another
jurisdiction in connection with our initial business combination and such migration may result in taxes imposed on shareholders.
We may, in connection with
our initial business combination or earlier, and subject to requisite shareholder approval under the Companies Act, transfer by way of
continuation (migrate) to a different jurisdiction, including, for example, the jurisdiction in which the target company or business
is located. Such a transaction may require a shareholder or warrant holder to recognize taxable income in the jurisdiction in which the
shareholder or warrant holder is a tax resident (and/or the jurisdictions in which its owners are resident if it is a tax transparent
entity under the tax laws of such jurisdictions, including under any anti-deferral regime), in which the target company is located,
or in which we migrate. As a Cayman Islands entity, we do not have access to a network of income tax treaties to protect us from withholding
taxes or gains taxes that may be imposed by other jurisdictions, and it may not be possible to effect repatriation of earnings or the
receipt of income from our investments in a tax efficient manner. We do not intend to make any cash distributions to shareholders or
warrant holders to pay such taxes. Shareholders or warrant holders may also be subject to withholding taxes or other taxes imposed by
the jurisdiction where we are migrated to with respect to their ownership of us.
We may re-domicile into
another foreign jurisdiction in connection with our initial business combination, and the laws of such jurisdiction may govern all of
our material agreements and we may not be able to enforce our legal rights.
In connection with our initial
business combination, we may relocate the home jurisdiction of our business from the Cayman Islands to another foreign jurisdiction.
If we determine to do this, the laws of such jurisdiction would likely govern all of our material agreements. The system of laws and
the enforcement of existing laws in such jurisdiction may not be as certain in implementation and interpretation as in the Cayman Islands
or the United States. The inability to enforce or obtain a remedy under any of our future agreements could result in a significant
loss of business, business opportunities or capital. Any such re-domiciliation and the international nature of our business will
likely subject us to foreign regulation.
Many countries have difficult
and unpredictable legal systems and underdeveloped laws and regulations that are unclear and subject to corruption and inexperience,
which may adversely impact our results of operations and financial condition.
Our ability to seek and enforce
legal protections, including with respect to intellectual property and other property rights, or to defend ourselves with regard to legal
actions taken against us in a given country, may be difficult or impossible, which could adversely impact our operations, assets or financial
condition. Rules and regulations in many countries are often ambiguous or open to differing interpretation by responsible individuals
and agencies at the municipal, state, regional and federal levels. The attitudes and actions of such individuals and agencies are often
difficult to predict and inconsistent. Delay with respect to the enforcement of particular rules and regulations, including those relating
to customs, tax, environmental and labor, could cause serious disruption to operations abroad and negatively impact our results.
If our management following
our initial business combination is unfamiliar with U.S. securities laws, they may have to expend time and resources becoming familiar
with such laws, which could lead to various regulatory issues.
Following our initial business
combination, our management team may resign from their positions as officers or directors of the company and the management of the target
business at the time of the business combination will remain in place. Management of the target business may not be familiar with U.S.
securities laws. If new management is unfamiliar with such laws, they may have to expend time and resources becoming familiar with such
laws. This could be expensive and time-consuming and could lead to various regulatory issues, which may adversely affect our operations.
Our management may not
be able to maintain control of a target business after our initial business combination.
We may structure an initial
business combination so that the post-transaction company in which our public shareholders own shares will own less than 100% of
the outstanding equity interests or assets of a target business, but we will only complete such business combination if the post-transaction company
owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target
business sufficient for us not to be required to register as an investment company under the Investment Company Act. We will not consider
any transaction that does not meet such criteria. Even if the post-transaction company owns 50% or more of the voting securities
of the target, our shareholders prior to the business combination may collectively own a minority interest in the post business combination
company, depending on valuations ascribed to the target and us in the business combination transaction. For example, we could pursue
a transaction in which we issue a substantial number of new Class A ordinary shares in exchange for all of the outstanding capital
stock of a target. In this case, we would acquire a 100% interest in the target. However, as a result of the issuance of a substantial
number of new class A ordinary shares, our shareholders immediately prior to such transaction could own less than a majority of
our outstanding ordinary shares subsequent to such transaction. In addition, other minority shareholders may subsequently combine their
holdings resulting in a single person or group obtaining a larger share of the company’s stock than we initially acquired. Accordingly,
this may make it more likely that our management will not be able to maintain our control of the target business. We cannot provide assurance
that, upon loss of control of a target business, new management will possess the skills, qualifications or abilities necessary to profitably
operate such business.
If we are deemed to be
an investment company under the Investment Company Act, we may be required to institute burdensome compliance requirements and our activities
may be restricted, which may make it difficult for us to complete our initial business combination.
If we are deemed to be an investment
company under the Investment Company Act, our activities may be restricted, including restrictions on the nature of our investments and
restrictions on the issuance of securities, each of which may make it difficult for us to complete our initial business combination.
In addition, we may have imposed upon us burdensome requirements, including: (i) registration as an investment company with the SEC;
(ii) adoption of a specific form of corporate structure; and (iii) reporting, record keeping, voting, proxy and disclosure requirements
and other rules and regulations that we are not currently subject to.
In order not to be regulated
as an investment company under the Investment Company Act, unless we can qualify for an exclusion, we must ensure that we are engaged
primarily in a business other than investing, reinvesting or trading in securities and that our activities do not include investing,
reinvesting, owning, holding or trading “investment securities” constituting more than 40% of our total assets (exclusive
of U.S. government securities and cash items) on an unconsolidated basis. Our business is to identify and complete a business combination
and thereafter to operate the post-transaction business or assets for the long term. We do not plan to buy businesses or assets
with a view to resale or profit from their resale. We do not plan to buy unrelated businesses or assets or to be a passive investor.
We do not believe that our principal
activities subject us to the Investment Company Act. To this end, the proceeds held in the trust account were previously only invested
in U.S. “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of
185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act
which invest only in direct U.S. government treasury obligations. On February 10, 2023, to mitigate the risk of us being deemed to be
an unregistered investment company (including under the subjective test of Section 3(a)(1)(A) of the Investment Company Act) and thus
subject to regulation under the Investment Company Act, we instructed the trustee to liquidate the U.S. government treasury obligations
or money market funds held in the trust account and thereafter to hold all funds in the trust account in an interest bearing demand deposit
account at Morgan Stanley. Pursuant to the trust agreement, the trustee is not permitted to invest in other securities or assets. By restricting
the investment of the proceeds to these instruments, and by having a business plan targeted at acquiring and growing businesses for the
long term (rather than on buying and selling businesses in the manner of a merchant bank or private equity fund), we intend to avoid being
deemed an “investment company” within the meaning of the Investment Company Act. An investment in our securities is not intended
for persons who are seeking a return on investments in government securities or investment securities. The trust account is intended as
a holding place for funds pending the earliest to occur of: (i) the completion of our primary business objective, which is a business
combination; (ii) absent an initial business combination, our return of the funds held in the trust account to our public shareholders
as part of our redemption of the public shares, and (iii) the redemption of any public shares properly tendered in connection with a shareholder
vote to amend our second amended and restated memorandum and articles of association to modify the substance or timing of our obligation
to redeem 100% of our public shares if we do not complete our initial business combination by required date or with respect to any other
provision relating to shareholders’ rights or pre-initial business combination activity. If we do not invest the proceeds as
discussed above, we may be deemed to be subject to the Investment Company Act. If we were deemed to be subject to the Investment Company
Act, compliance with these additional regulatory burdens would require additional expenses for which we have not allotted funds and may
hinder our ability to complete our initial business combination. If we are unable to complete our initial business combination within
the required time period, our public shareholders may receive only approximately $10.00 per share, or less in certain circumstances, on
the liquidation of our trust account, and our warrants will expire worthless.
To mitigate the risk
that we might be deemed to be an investment company for purposes of the Investment Company Act, we have instructed the trustee to liquidate
the investments held in the trust account and instead to hold the funds in the trust account in an interest bearing demand deposit account
at Morgan Stanley. As a result, we may receive less interest on the funds held in the trust account than the interest we would have received
pursuant to our original trust account investments, which could reduce the dollar amount our public shareholders would receive upon any
redemption or liquidation.
The funds in the trust account
had, since our initial public offering, been held only in U.S. government treasury obligations with a maturity of 185 days or less
or in money market funds investing solely in U.S. government treasury obligations and meeting certain conditions under Rule 2a-7 under
the Investment Company Act. However, to mitigate the risk of us being deemed to be an unregistered investment company (including under
the subjective test of Section 3(a)(1)(A) of the Investment Company Act) and thus subject to regulation under the Investment Company
Act, we have instructed the trustee, on February 10, 2023, to liquidate the U.S. government treasury obligations or money market funds
held in the trust account and thereafter to hold all funds in the trust account in an interest bearing demand deposit account at Morgan
Stanley until the earlier of the consummation of our initial business combination or liquidation. Following such liquidation, we may
receive less interest on the funds held in the trust account than the interest we would have received pursuant to our original trust
account investments. However, interest previously earned on the funds held in the trust account still may be released to us to pay our
taxes, if any, and certain other expenses as permitted. As a result, our decision to liquidate the securities held in the trust account
and thereafter to hold all funds in the trust account in an interest bearing demand deposit account at Morgan Stanley could reduce the
dollar amount our public shareholders would receive upon any redemption or liquidation.
We do not have a specified
maximum redemption threshold. The absence of such a redemption threshold may make it possible for us to complete our initial business
combination with which a substantial majority of our shareholders do not agree.
Our second amended and restated
memorandum and articles of association do not provide a specified maximum redemption threshold, except that in no event will we redeem
our public shares in an amount that would cause our net tangible assets to be less than $5,000,001 (such that we do not then become subject
to the SEC’s “penny stock” rules) or any greater net tangible asset or cash requirement which may be contained in the
agreement relating to our initial business combination. As a result, we may be able to complete our initial business combination even
though a substantial majority of our public shareholders do not agree with the transaction and have redeemed their shares or, if we seek
shareholder approval of our initial business combination and do not conduct redemptions in connection with our initial business combination
pursuant to the tender offer rules, have entered into privately negotiated agreements to sell their shares to our sponsor, officers, directors,
advisors or their affiliates. In the event the aggregate cash consideration we would be required to pay for all class A ordinary
shares that are validly submitted for redemption plus any amount required to satisfy cash conditions pursuant to the terms of the proposed
business combination exceed the aggregate amount of cash available to us, we will not complete the business combination or redeem any
shares, all class A ordinary shares submitted for redemption will be returned to the holders thereof, and we instead may search for
an alternate business combination.
In order to effectuate
an initial business combination, blank check companies have, in the past, amended various provisions of their constitutional documents.
We cannot assure you that we will not seek to amend our second amended and restated memorandum and articles of association that will make
it easier for us to consummate an initial business combination that some of our shareholders may not support.
In order to effectuate an initial
business combination, blank check companies have, in the recent past, amended various provisions of their charters and modified governing
instruments. For example, blank check companies have amended the definition of initial business combination, increased redemption thresholds
and changed industry focus. We cannot assure you that we will not seek to amend our second amended and restated memorandum and articles
of association prior to our initial business combination. Amending our second amended and restated memorandum and articles of association
will require at least a special resolution of our shareholders as a matter of Cayman Islands law, being (i) the affirmative vote
of at least a two-thirds (2/3) of the votes cast by the holders of the issued ordinary shares present in person or represented by
proxy at a general meeting of the company and entitled to vote on such matter or (ii) a unanimous written resolution of the shareholders.
Our sponsor, officers and directors
have agreed, each pursuant to a written agreement with us, that they will not propose any amendment to our second amended and restated
memorandum and articles of association that would affect the substance or timing of our obligation to redeem 100% of our public shares
if we do not complete our initial business combination by the deadline, unless we provide our public shareholders with the opportunity
to redeem their class A ordinary shares upon approval of any such amendment at a per-share price, payable in cash, equal to
the aggregate amount then on deposit in the trust account (less any interest released to us for taxes, if any), divided by the number
of then outstanding public shares. These agreements are contained in letter agreements that we have entered into with our sponsor, officers
and directors. Our shareholders are not parties to, or third-party beneficiaries of, these agreements and, as a result, will not
have the ability to pursue remedies against our sponsor, officers and directors for any breach of these agreements. As a result, in the
event of a breach, our shareholders would need to pursue a shareholder derivative action, subject to applicable law.
Our outstanding warrants
may have an adverse effect on the market price of our class A ordinary shares and make it more difficult to effect a business combination.
We issued public warrants to
purchase class A ordinary shares as part of the units sold in our initial public offering, of which 7,666,666 are currently outstanding.
To the extent we issue class A ordinary shares to effect a business combination, the potential for the issuance of a substantial
number of additional shares upon exercise of these public warrants could make us a less attractive acquisition vehicle in the eyes of
a target business. Such securities, when exercised, will increase the number of issued and outstanding class A ordinary shares and
reduce the value of the shares issued to complete the business combination. Accordingly, our public warrants may make it more difficult
to effectuate a business combination or increase the cost of acquiring the target business. Additionally, the sale, or even the possibility
of sale, of the shares underlying the public warrants could have an adverse effect on the market price for our securities or on our ability
to obtain future financing. If and to the extent these public warrants are exercised, you may experience dilution to your holdings.
Compliance obligations
under the Sarbanes-Oxley Act may make it more difficult for us to effectuate our initial business combination, require substantial financial
and management resources, and increase the time and costs of completing an acquisition.
Section 404 of the Sarbanes-Oxley Act
requires that we evaluate and report on our system of internal controls. Only in the event we are deemed to be a large accelerated filer
or an accelerated filer will we be required to comply with the independent registered public accounting firm attestation requirement
on our internal control over financial reporting. Further, for as long as we remain an emerging growth company, we will not be required
to comply with the independent registered public accounting firm attestation requirement on our internal control over financial reporting.
The fact that we are a blank check company makes compliance with the requirements of the Sarbanes-Oxley Act particularly burdensome
on us as compared to other public companies because a target business with which we seek to complete our initial business combination
may not be in compliance with the provisions of the Sarbanes-Oxley Act regarding adequacy of its internal controls. The development
of the internal control of any such entity to achieve compliance with the Sarbanes-Oxley Act may increase the time and costs necessary
to complete any such acquisition.
We have identified material weaknesses
in our internal control over financial reporting. If we fail to develop or maintain an effective system of internal controls, we may
not be able to accurately report our financial results and prevent fraud. As a result, current and potential shareholders could lose
confidence in our financial statements, which would harm the trading price of our common shares.
Companies that file reports with the SEC, including
us, are subject to the requirements of Section 404 of the Sarbanes-Oxley Act. Section 404 of the Sarbanes-Oxley Act requires management
to establish and maintain a system of internal control over financial reporting and annual reports on Form 10-K filed under the Exchange
Act to contain a report from management assessing the effectiveness of a company’s internal control over financial reporting. Separately,
under Section 404 of the Sarbanes-Oxley Act, as amended by the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010,
public companies that are large accelerated filers or accelerated filers must include in their annual reports on Form 10-K an attestation
report of their regular auditors attesting to and reporting on management’s assessment of internal control over financial reporting.
Non-accelerated filers and smaller reporting companies, like us, are not required to include an attestation report of their auditors
in annual reports.
A report of our management is included under
Item 9A. “Controls and Procedures.” We are a smaller reporting company and, consequently, are not required to
include an attestation report of our auditor in our annual report. However, if and when we become subject to the auditor attestation
requirements under SOX 404, we can provide no assurance that we will receive a positive attestation from our independent auditors.
During its evaluation of the effectiveness of
internal control over financial reporting as of December 31, 2023, management identified a material weakness described under Item
9A. “Controls and Procedures.” We are undertaking remedial measures, which measures will take time to implement
and test, to address these material weaknesses. There can be no assurance that such measures will be sufficient to remedy the material
weaknesses identified or that additional material weaknesses or other control or significant deficiencies will not be identified in the
future. If we continue to experience material weaknesses in our internal controls or fail to maintain or implement required new or improved
controls, such circumstances could cause us to fail to meet our periodic reporting obligations or result in material misstatements in
our financial statements, or adversely affect the results of periodic management evaluations and, if required, annual auditor attestation
reports. Each of the foregoing results could cause investors to lose confidence in our reported financial information and lead to a decline
in our share price.
Because our company is incorporated under
the laws of the Cayman Islands, you may face difficulties in protecting your interests, and your ability to protect your rights through
the U.S. Federal courts may be limited.
The Cayman Islands has a different body of securities
laws as compared to the United States and provides less protection to investors. Additionally, Cayman Islands companies may not have
standing to sue before the federal courts of the United States.
The courts of the Cayman Islands are unlikely
(i) to recognize or enforce against us judgments of courts of the United States predicated upon the civil liability provisions of the
federal securities laws of the United States or any state; and (ii) in original actions brought in the Cayman Islands, to impose liabilities
against us predicated upon the civil liability provisions of the federal securities laws of the United States or any state, so far as
the liabilities imposed by those provisions are penal in nature. In those circumstances, although there is no statutory enforcement in
the Cayman Islands of judgments obtained in the United States, the courts of the Cayman Islands will recognize and enforce a foreign
money judgment of a foreign court of competent jurisdiction without retrial on the merits based on the principle that a judgment of a
competent foreign court imposes upon the judgment debtor an obligation to pay the sum for which judgment has been given provided certain
conditions are met. For a foreign judgment to be enforced in the Cayman Islands, such judgment must be final and conclusive and for a
liquidated sum, and must not be in respect of taxes or a fine or penalty, inconsistent with a Cayman Islands judgment in respect of the
same matter, impeachable on the grounds of fraud or obtained in a manner, or be of a kind the enforcement of which is, contrary to natural
justice or the public policy of the Cayman Islands (awards of punitive or multiple damages may well be held to be contrary to public
policy). A Cayman Islands court may stay enforcement proceedings if concurrent proceedings are being brought elsewhere.
We may be a passive foreign
investment company, which could result in adverse U.S. federal income tax consequences to U.S. investors.
If we are a passive foreign investment company,
or PFIC, for any taxable year (or portion thereof) that is included in the holding period of a U.S. holder of our class A ordinary
shares or warrants, the U.S. Holder may be subject to adverse U.S. federal income tax consequences and may be subject to additional
reporting requirements. Our PFIC status for our current and subsequent taxable years may depend upon the status of an acquired company
pursuant to a business combination and whether we qualify for the PFIC start-up exception. Depending on the particular circumstances,
the application of the start-up exception is uncertain, and there can be no assurance that we will qualify for the start-up exception.
Accordingly, there can be no assurances with respect to our status as a PFIC for our current taxable year or any subsequent taxable year.
Our actual PFIC status for any taxable year will not be determinable until after the end of such taxable year. Moreover, if we determine
we are a PFIC for any taxable year, we will endeavor to provide a U.S. Holder such information as the Internal Revenue Service may require,
including a PFIC annual information statement in order to enable the U.S. Holder to make and maintain a “qualified electing
fund” election, but there can be no assurance that we will timely provide such required information, and such election would likely
be unavailable with respect to our warrants in all cases. We urge U.S. holders to consult their tax advisors regarding the possible
application of the PFIC rules to holders of our class A ordinary shares and warrants.
Risks Relating to Ownership
of our Securities
Nasdaq may delist our
securities from trading on its exchange, which could limit investors’ ability to make transactions in our securities and subject
us to additional trading restrictions.
On February 20, 2024, we received a notice from
Nasdaq indicating that, unless we timely requested a hearing before the Nasdaq Hearings Panel, trading of our securities on Nasdaq would
be suspended due to our non-compliance with Nasdaq IM-5101-2, which requires that a special purpose acquisition company complete
one or more business combinations within 36 months of the effectiveness of its registration statement relating to its initial public
offering. We timely requested a hearing before the Nasdaq Hearings Panel, which resulted in a stay of any suspension or delisting action
pending the hearing. The hearing was held on March 26, 2024. At the hearing, we requested an extension until August 19, 2024 to allow
us sufficient time to complete the proposed Business Combination Agreement described elsewhere in this report, which was granted by the
Nasdaq Hearings Panel. Accordingly, trading of our securities will not be suspended if we complete the proposed Business Combination
Agreement by August 19, 2024. No assurance can be given that we will complete the proposed Business Combination Agreement by such date.
Furthermore, although we currently meet Nasdaq’s
other listing standards, our securities may not continue to be listed on Nasdaq in the future prior to an initial business combination.
Generally, we must maintain a minimum amount in shareholders’ equity (generally $2,500,000) and a minimum number of holders of
our securities (generally 300 round-lot holders). Additionally, in connection with our initial business combination, we will be
required to demonstrate compliance with Nasdaq’s initial listing requirements, which are more rigorous than Nasdaq’s continued
listing requirements, in order to continue to maintain the listing of our securities on Nasdaq. We may not be able to meet those initial
listing requirements at that time.
If Nasdaq delists any of our securities from
trading on its exchange and we are not able to list our securities on another national securities exchange, we expect such securities
could be quoted on an over-the-counter market. If this were to occur, we could face significant material adverse consequences, including:
| ● | a limited availability of market
quotations for our securities; |
| ● | reduced liquidity for our securities; |
| ● | a determination that our class A
ordinary shares are a “penny stock” which will require brokers trading in our
class A ordinary shares to adhere to more stringent rules and possibly result in a reduced
level of trading activity in the secondary trading market for our securities; |
| ● | a limited amount of news and analyst
coverage; and |
| ● | a decreased ability to issue additional
securities or obtain additional financing in the future. |
The National Securities Markets Improvement Act
of 1996, which is a federal statute, prevents or preempts the states from regulating the sale of certain securities, which are referred
to as “covered securities.” Because our securities are listed on Nasdaq, our units, class A ordinary shares and public warrants
qualify as covered securities under such statute. Although the states are preempted from regulating the sale of covered securities, the
federal statute does allow the states to investigate companies if there is a suspicion of fraud, and, if there is a finding of fraudulent
activity, then the states can regulate or bar the sale of covered securities in a particular case. While we are not aware of a state
having used these powers to prohibit or restrict the sale of securities issued by blank check companies, other than the State of Idaho,
certain state securities regulators view blank check companies unfavorably and might use these powers, or threaten to use these powers,
to hinder the sale of securities of blank check companies in their states. Further, if we were no longer listed on Nasdaq, our securities
would not qualify as covered securities under such statute and we would be subject to regulation in each state in which we offer our
securities.
A market for our securities
may not fully develop or be sustained, which would adversely affect the liquidity and price of our securities.
The price of our securities may vary significantly
due to one or more potential business combinations and general market or economic conditions, including as a result of the ongoing military
conflict in Ukraine, Gaza and other events (such as terrorist attacks, natural disasters or a significant outbreak of other infectious
diseases). An active trading market for our securities may not fully develop or be sustained. Additionally, if our securities become
delisted from Nasdaq for any reason, and are quoted on the OTC Pink Sheets, an inter-dealer automated quotation system for equity securities
not listed on a national exchange, the liquidity and price of our securities may be more limited than if we were listed on Nasdaq or
another national exchange. You may be unable to sell your securities unless a market can be fully developed and sustained.
Our sponsor and affiliated
entities control a substantial interest in our company and thus may exert a substantial influence on actions requiring shareholder vote,
potentially in a manner that you do not support.
Our sponsor owns approximately 80% of our issued
and outstanding ordinary shares as of the date of this report. Our sponsor, officers, directors or their affiliates could determine in
the future to purchase our securities in the open market or in private transactions, to the extent permitted by law. In connection with
any vote for a proposed business combination, our sponsor has agreed to vote the founder shares owned by it, and our sponsor, officers
and directors have agreed to vote any class A ordinary shares owned by them in favor of such proposed business combination.
Our board of directors is and will be divided
into three classes, each of which will generally serve for a term of three years with only one class of directors being elected in each
year. It is unlikely that there will be an annual meeting of shareholders to elect new directors prior to the consummation of our initial
business combination, in which case all of the current directors will continue in office until at least the consummation of the business
combination. Accordingly, you may not be able to exercise your voting rights under corporate law until an initial business combination
is completed. If there is an annual meeting, as a consequence of our “staggered” board of directors, fewer than half of the
board of directors will be considered for election and our sponsor, because of its ownership position, will have considerable influence
regarding the outcome. Accordingly, our sponsor will continue to exert control at least until the consummation of our initial business
combination.
If we seek shareholder
approval of our initial business combination and we do not conduct redemptions pursuant to the tender offer rules, and if you or a “group”
of shareholders are deemed to hold in excess of 20% of our class A ordinary shares, you will lose the ability to redeem all such shares
in excess of 20% of our class A ordinary shares.
If we seek shareholder approval of our initial
business combination and we do not conduct redemptions in connection with our initial business combination pursuant to the tender offer
rules, our second amended and restated memorandum and articles of association provides that a public shareholder, together with any affiliate
of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under
Section 13 of the Exchange Act), will be restricted from redeeming its shares with respect to more than an aggregate of 20% of the shares
sold in our initial public offering without our prior consent. However, we would not be restricting our shareholders’ ability to
vote all of their shares for or against our initial business combination. Your potential inability to redeem all of our shares will reduce
your influence over our ability to complete our initial business combination and you could suffer a material loss on your investment in
our company if you sell any excess shares in open market transactions. Additionally, you will not receive redemption distributions with
respect to such excess shares if we complete our initial business combination. And as a result, you will continue to hold that number
of shares exceeding 20% and, in order to dispose of such shares, would be required to sell your shares in open market transactions, potentially
at a loss.
We may amend the terms
of the public warrants in a way that may be adverse to holders with the approval by the holders of at least 65% of the then outstanding
warrants.
Our public warrants were issued in registered
form under a warrant agreement between Continental, as warrant agent, and us. The warrant agreement provides that the terms of the public
warrants may be amended without the consent of any holder for the purpose of (i) curing any ambiguity or to correct any mistake, including
to conform the provisions of the warrant agreement to the description of the terms of the public warrants and the warrant agreement,
or defective provision or (ii) adding or changing any provisions with respect to matters or questions arising under the warrant agreement
as the parties to the warrant agreement may deem necessary or desirable and that the parties deem to not adversely affect the rights
of the registered holders of the public warrants, provided that the approval by the holders of at least 65% of the then-outstanding public
warrants is required to make any change that adversely affects the interests of the registered holders of public warrants. Accordingly,
we may amend the terms of the public warrants in a manner adverse to a holder if holders of at least 65% of the then outstanding public
warrants approve of such amendment. Although our ability to amend the terms of the public warrants with the consent of at least 65% of
the then outstanding public warrants is unlimited, examples of such amendments could be amendments to, among other things, increase the
exercise price of the public warrants, shorten the exercise period or decrease the number of class A ordinary shares purchasable upon
exercise of a public warrant.
We may issue additional
class A ordinary shares to complete our initial business combination or under an employee incentive plan after completion of our initial
business combination. Any such issuances could substantially dilute the interest of our shareholders and likely present other risks.
Our second amended and restated memorandum and
articles of association authorizes the issuance of up to 200,000,000 class A ordinary shares, par value $0.001 per share, and 10,000,000
class B ordinary shares, par value $0.001 per share. As of the date of this report there are 192,179,320 class A ordinary shares available
for issuance, which amount does not take into account shares reserved for issuance upon exercise of outstanding warrants. We may issue
a substantial number of additional class A ordinary shares to complete our initial business combination or under an employee incentive
plan after completion of our initial business combination. However, our second amended and restated memorandum and articles of association
provides, among other things, that prior to our initial business combination, we may not issue additional ordinary shares that would entitle
the holders thereof to (i) receive funds from the trust account or (ii) vote on any initial business combination. The issuance of additional
ordinary shares may significantly dilute the equity interest of our shareholders; could cause a change of control if a substantial number
of class A ordinary shares are issued, which may affect, among other things, our ability to use our net operating loss carry forwards,
if any, and could result in the resignation or removal of our present officers and directors; may adversely affect prevailing market prices
for our units, class A ordinary shares and/or warrants; and may not result in adjustment to the exercise price of our warrants.
We may redeem your unexpired
public warrants prior to their exercise at a time that is disadvantageous to you, thereby making your public warrants worthless.
We have the ability to redeem the outstanding
public warrants at any time after they become exercisable and prior to their expiration, at a price of $0.01 per public warrant, provided that
the closing price of our class A ordinary shares equals or exceeds $18.00 per share (as adjusted for share splits, share dividends, rights
issuances, subdivisions, reorganizations, recapitalizations and the like) for any 20 trading days within a 30 trading-day period
ending on the third trading day prior to proper notice of such redemption and provided that certain other conditions are met.
If and when the public warrants become redeemable by us, we may exercise our redemption right even if we are unable to register or qualify
the underlying securities for sale under all applicable state securities laws. As a result, we may redeem the public warrants as set
forth above even if the holders are otherwise unable to exercise the public warrants. Redemption of the outstanding public warrants could
force you to (i) exercise your public warrants and pay the exercise price therefor at a time when it may be disadvantageous for you to
do so, (ii) sell your public warrants at the then-current market price when you might otherwise wish to hold your public warrants
or (iii) accept the nominal redemption price which, at the time the outstanding public warrants are called for redemption, we expect
would be substantially less than the market value of your public warrants.
In addition, we have the ability to redeem the
outstanding public warrants at any time after they become exercisable and prior to their expiration, at a price of $0.10 per warrant,
upon a minimum of 30 days’ prior written notice of redemption provided that the closing price of our class A ordinary
shares equals or exceeds $10.00 per share (as adjusted for share splits, share dividends, rights issuances, subdivisions, reorganizations,
recapitalizations and the like) for any 20 trading days within a 30 trading-day period ending on the third trading day prior to
proper notice of such redemption and provided that certain other conditions are met, including that holders will be able to
exercise their public warrants prior to redemption for a number of class A ordinary shares determined based on the redemption date and
the fair market value of our class A ordinary shares. The value received upon exercise of the public warrants (i) may be less than the
value the holders would have received if they had exercised their public warrants at a later time where the underlying share price is
higher and (ii) may not compensate the holders for the value of the public warrants, including because the number of class A ordinary
shares received is capped at 0.361 class A ordinary shares per public warrant (subject to adjustment) irrespective of the remaining life
of the public warrants.
None of the private placement warrants will be
redeemable by us, except under certain circumstances, so long as they are held by our sponsor or its permitted transferees.
We are an emerging growth
company and a smaller reporting company within the meaning of the Securities Act, and if we take advantage of certain exemptions from
disclosure requirements available to emerging growth companies or smaller reporting companies, this could make our securities less attractive
to investors and may make it more difficult to compare our performance with other public companies.
We are an “emerging growth company”
within the meaning of the Securities Act, as modified by the JOBS Act, and we may take advantage of certain exemptions from various reporting
requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not
being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure
obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding
a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.
As a result, our shareholders may not have access to certain information they may deem important. We will remain an emerging growth company
until the earliest of (i) the last day of the fiscal year following the fifth anniversary of our initial public offering, (ii) the
last day of the first fiscal year in which our total annual gross revenues are $1.235 billion or more, (iii) the date
that we become a “large accelerated filer” as defined in Rule 12b-2 under the Exchange Act, which would occur
if the market value of our class A ordinary shares that is held by non-affiliates exceeds $700 million as of the last
business day of our most recently completed second fiscal quarter or (iv) the date on which we have issued more than $1 billion
in non-convertible debt during the preceding three year period. We cannot predict whether investors will find our securities less
attractive because we will rely on these exemptions. If some investors find our securities less attractive as a result of our reliance
on these exemptions, the trading prices of our securities may be lower than they otherwise would be, there may be a less active trading
market for our securities and the trading prices of our securities may be more volatile.
Further, Section 102(b)(1) of the JOBS Act exempts
emerging growth companies from being required to comply with new or revised financial accounting standards until private companies are
required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out
of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election
to opt out is irrevocable. We have elected not to opt out of such extended transition period which means that when a standard is issued
or revised and it has different application dates for public or private companies, we, as an emerging growth company, can adopt the new
or revised standard at the time private companies adopt the new or revised standard. This may make comparison of our financial statements
with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the
extended transition period difficult or impossible because of the potential differences in accounting standards used.
Additionally, we are a “smaller reporting
company” as defined in Item 10(f)(1) of Regulation S-K. Smaller reporting companies may take advantage of certain reduced disclosure
obligations, including, among other things, providing only two years of audited financial statements. We will remain a smaller reporting
company until the last day of the fiscal year in which (1) the market value of our ordinary shares held by non-affiliates exceeds
$250 million as of the prior June 30, or (2) our annual revenues exceeded $100 million during such completed fiscal year
and the market value of our ordinary shares held by non-affiliates exceeds $700 million as of the prior June 30. To the extent
we take advantage of such reduced disclosure obligations, it may also make comparison of our financial statements with other public companies
difficult or impossible.
ITEM 1B. UNRESOLVED STAFF COMMENTS.
Not applicable.
ITEM 1C. CYBERSECURITY.
As a blank check company, we do not have any
operations and our sole business activity has been to search for and consummate an initial business combination. However, because we
have investments in our trust account and bank deposits and we depend on the digital technologies of third parties, we and third parties
may be subject to attacks on or security breaches in our or their systems. Because of our reliance on the technologies of third parties,
we also depend upon the personnel and the processes of third parties to protect against cybersecurity threats, and we have no personnel
or processes of our own for this purpose. In the event of a cybersecurity incident impacting us, the management team will report to the
board of directors and provide updates on the management team’s incident response plan for addressing and mitigating any risks
associated with such an incident. As an early-stage company without significant investments in data security protection, we may not be
sufficiently protected against such occurrences. We also lack sufficient resources to adequately protect against, or to investigate and
remediate any vulnerability to, cyber incidents. It is possible that any of these occurrences, or a combination of them, could have material
adverse consequences on our business and lead to financial loss. We have not encountered any cybersecurity incidents since our initial
public offering.
ITEM 2. PROPERTIES.
Our executive offices are located at 850
Library Avenue, Suite 204, Newark, DE 19715, and our telephone number is (302) 738-6680.
We consider our current office space adequate for our current operations.
ITEM 3. LEGAL PROCEEDINGS.
From time to time, we may become involved in
various lawsuits and legal proceedings which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties,
and an adverse result in these or other matters may arise from time to time that may harm our business. We are not currently aware of
any such legal proceedings or claims that we believe will have a material adverse effect on our business, financial condition or operating
results.
ITEM 4. MINE SAFETY DISCLOSURES.
Not applicable.
PART II
ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES.
Market Information
Our units, class A ordinary shares and public
warrants are each traded on The Nasdaq Capital Market under the symbols QRDOU, QRDO and QRDOW, respectively. Our units commenced public
trading on February 18, 2021, and our shares and public warrants commenced separate public trading on April 12, 2021.
Holders
As of April 12, 2024, there was one holder of
record of our units, two holders of record of our class A ordinary shares and one holder of record of our public warrants. In computing
the number of holders of record, each broker-dealer and clearing corporation holding shares on behalf of its customers is counted as
a single shareholder.
Dividends
We have not paid any cash dividends on our ordinary
shares to date and do not intend to pay cash dividends prior to the completion of our initial business combination. The payment of cash
dividends in the future will be dependent upon our revenues and earnings, if any, capital requirements and general financial condition
subsequent to completion of our initial business combination. The payment of any cash dividends subsequent to our initial business combination
will be within the discretion of our board of directors at such time, and we will only pay such dividend out of our profits or share
premium (subject to solvency requirements) as permitted under Cayman Islands law. In addition, our board of directors is not currently
contemplating and does not anticipate declaring any share dividends in the foreseeable future. Further, if we incur any indebtedness
in connection with our initial business combination, our ability to declare dividends may be limited by restrictive covenants we may
agree to in connection therewith.
Securities Authorized for Issuance Under Equity
Compensation Plans
As of December 31, 2023, we did not have in effect
any compensation plans under which our equity securities were authorized for issuance and we did not have any outstanding share options.
Recent Sales of Unregistered Securities
We have not sold any equity securities during
the 2023 fiscal year that were not previously disclosed in a quarterly report on Form 10-Q or a current report on Form 8-K that was filed
during the 2023 fiscal year.
Use of Proceeds from our Initial Public Offering
For a description of the use of proceeds generated
in our initial public offering and private placement, see Part II, Item 2 of our Quarterly Report on Form 10-Q for the quarterly period
ended March 31, 2021, as filed with the SEC on June 25, 2021. There has been no material change in the planned use of proceeds from our
initial public offering and private placement as described in the registration statement. Our specific investments in our trust account
may change from time to time.
On February 10, 2023, we instructed Continental
to liquidate the investments held in the trust account and instead to hold the funds in the trust account in an interest-bearing demand
deposit account at Morgan Stanley, with Continental continuing to act as trustee, until the earlier of the consummation of our initial
business combination or our liquidation. As a result, following the liquidation of investments in the trust account, the remaining proceeds
from the initial public offering and private placement are no longer invested in U.S. government securities or money market funds.
Purchases of Equity Securities by the Issuer
and Affiliated Purchasers
In connection with our shareholder meeting held
on November 20, 2023, the holders of 977,473 class A ordinary shares exercised their right to redeem those shares for cash at an approximate
price of $10.77 per share for an aggregate of approximately $10.526 million.
Except for the foregoing, no repurchases of our
equity securities were made during the fourth quarter of 2023.
ITEM 6. [RESERVED]
ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
Overview
We are a blank check company incorporated as
a Cayman Islands exempted company on September 15, 2020. We were incorporated for the purpose of engaging in an initial business combination
with one or more businesses. We are an emerging growth company and, as such, we are subject to all of the risks associated with emerging
growth companies.
The registration statement for our initial public
offering was declared effective on February 17, 2021. On February 22, 2021, we consummated our initial public offering of 23,000,000
units, at $10.00 per unit, generating gross proceeds of $230.0 million, and incurring offering costs of approximately $13.1 million,
of which approximately $8.1 million was for deferred underwriting commissions.
Simultaneously with the closing of our initial
public offering, we consummated the private placement of 4,400,000 private placement warrants, at a price of $1.50 per private placement
warrant, to our prior sponsor, generating gross proceeds of $6.6 million, and incurring offering costs of approximately $7,000.
Upon the closing of the initial public offering
and the private placement, $230.0 million ($10.00 per unit) of the net proceeds of the initial public offering and a portion of the proceeds
of the private placement were placed in a trust account, with Continental acting as trustee, and invested in U.S. government treasury
obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment
Company Act, which invest only in direct U.S. government treasury obligations, as determined by us, until the earlier of: (i) the completion
of a business combination and (ii) the distribution of the trust account as described below. On February 10, 2023, we instructed Continental
to liquidate the investments held in the trust account and instead to hold the funds in the trust account in an interest-bearing
demand deposit account at Morgan Stanley, with Continental continuing to act as trustee, until the earlier of the consummation of our
initial business combination or our liquidation. As a result, following the liquidation of investments in the trust account,
the remaining proceeds from the initial public offering and private placement are no longer invested in U.S. government securities or
money market funds.
Our management has broad discretion with respect
to the specific application of the net proceeds of our initial public offering and the private placement, although substantially all
of the net proceeds are intended to be applied generally toward consummating a business combination. Our initial business combination
must be with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the
trust account (excluding the deferred underwriting commissions and taxes payable, if any, on the income accrued on the trust account)
at the time we sign a definitive agreement in connection with the initial business combination. However, we will only complete a business
combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise
acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment
Company Act.
If we are unable to complete a business combination
by the current deadline, May 22, 2024, we will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably
possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the
aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account and not previously
released to us to pay our taxes that were paid by us or are payable by us, if any (less up to $100,000 of interest to pay dissolution
expenses), divided by the number of the then-outstanding public shares, which redemption will completely extinguish public shareholders’
rights as shareholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably
possible following such redemption, subject to the approval of the remaining shareholders and the board of directors, liquidate and dissolve,
subject in the case of clauses (ii) and (iii) to our obligations under Cayman Islands law to provide for claims of creditors and the
requirements of other applicable law.
On January 31, 2023, we issued an aggregate of
6,250,000 class A ordinary shares to the sponsor, upon the conversion of an equal number of class B ordinary shares held by the sponsor.
The 6,250,000 class A ordinary shares issued in connection with this conversion are subject to the same restrictions as applied to the
class B ordinary shares before the conversion, including, among others, certain transfer restrictions, waiver of redemption rights and
the obligation to vote in favor of an initial business combination as described in the prospectus for the initial public offering.
On February 20, 2023, we held an extraordinary general meeting at which
our shareholders approved our second amended and restated memorandum and articles of association to extend the date by which we must consummate
an initial business combination to April 22, 2023, and to allow our board, without another shareholder vote, to extend the such date on
a monthly basis up to seven times for an additional one month each time until November 22, 2023. In connection with the vote to approve
this extension, the holders of 20,451,847 class A ordinary shares properly exercised their right to redeem their shares for cash at a
redemption price of approximately $10.20 per share, for an aggregate redemption amount of approximately $208.5 million.
On November 20, 2023, we held an extraordinary
general meeting at which our shareholders approved an amendment to our second amended and restated memorandum and articles of association
to extend the date by which we must consummate an initial business combination to May 22, 2024 (or such earlier date as determined by
our board of directors). In connection with the vote to approve this extension, the holders of 977,473 class A ordinary shares properly
exercised their right to redeem their shares for cash at a redemption price of approximately $10.77 per share, for an aggregate redemption
amount of approximately $10.526 million.
Recent Developments
Business Combination
On January 12, 2024, we and Quadro Merger Sub
Inc., a Delaware corporation and newly formed wholly-owned subsidiary of our company, or the Quadro Merger Sub, entered into a Business
Combination Agreement, or the BCA, with NHC Holdings II, Inc., a Delaware corporation, or the Seller, NHC Merger Sub, Inc., a Delaware
corporation and a wholly-owned subsidiary of the Seller, or the Seller Merger Sub, Global Growth Holdings, LLC, a Delaware limited liability
company, or Global Growth, and Greg Lindberg, a resident of the State of Florida, or the Individual Target Sponsor. Global Growth and
the Individual Target Sponsor own, directly or indirectly, beneficial interests in certain affiliates, or the Target Affiliates, conducting
businesses related to collectibles and healthcare software and services, which Target Affiliates will be consolidated prior to closing
as subsidiaries of the Seller Merger Sub, as described in more detail in the BCA. The name and symbol under which the surviving company
will trade following the closing will be determined at a later date.
As the first step in the consummation of the
transactions contemplated by the BCA, we will migrate to and domesticate as a Nevada corporation, or the Domestication, in accordance
with Section 92A.270 of the Nevada Revised Statutes and the Companies Act. In connection with the Domestication, (i) each then-issued
and outstanding class A ordinary share shall convert automatically, on a one-for-one basis, into one share of class A common stock of
our company after the Domestication; (ii) each then-issued and outstanding warrant to purchase one class A ordinary share at an exercise
price of $11.50 shall continue and remain outstanding on a one-for-one basis; and (iii) each then-issued and outstanding unit shall be
canceled and entitle the holder to one share of class A common stock and one warrant.
Following the Domestication, the parties will
effect a merger of the Quadro Merger Sub with and into the Seller Merger Sub, with the Seller Merger Sub surviving such merger as a wholly-owned
subsidiary of our company, or the Merger. As consideration for the Merger, we shall issue an aggregate of 208,715,500 shares of class
A common stock (subject to adjustment) to the Seller and the Individual Target Sponsor, or the Merger Consideration. All class A common
stock issued as part of the Merger Consideration shall be valued at Ten Dollars ($10.00) per share. The Merger Consideration is subject
to adjustment upward or downward by an amount that is equal to the same percentage by which the Consolidated EBITDA (as defined in the
BCA) of the Target Affiliates for the fiscal year ending December 31, 2023, exceeds or falls short of One Hundred Forty-Two Million Four
Hundred Eighteen Thousand Nine Hundred and Ninety-One dollars ($142,418,991).
The BCA contains customary representations and
warranties of our company, the Quadro Merger Sub, the Seller, the Seller Merger Sub, and the Target Affiliates relating to their respective
businesses, in certain cases subject to materiality and “Material Adverse Effect” qualifiers. The BCA also provides for customary
pre-closing covenants of the parties, including a covenant to conduct their respective businesses in all material respects in the ordinary
course consistent with past practice and to refrain from taking certain actions without the other parties’ consent. The parties
have also agreed to, among other things, customary exclusivity provisions for transactions of this type.
The Seller did not deliver completed
disclosure schedules with exceptions to the representations and warranties of the Seller and the Seller Merger Sub at the time of
the signing of the BCA. However, the Seller is required to deliver the fully completed disclosure schedules to us as soon as
reasonably practicable, but in no event later than February 29, 2024 (the parties are currently negotiating an amendment to the BCA
to extend this date). We will then have fifteen (15) business days to review the disclosure schedules. If we object to any material
adverse information contained in the Seller’s disclosure schedules and the parties cannot agree on reasonable and mutually
satisfactory modifications to the BCA to address our objections, then we may terminate the BCA.
We are permitted under the BCA to seek a valuation
presentation, either in the form of a fairness opinion or a valuation report, regarding the Merger Consideration for a period of time
after the signing date. If we choose to seek a valuation, we will engage a financial advisor. We will be required within two (2) business
days after receiving the valuation presentation or fairness opinion from such financial advisor to determine in accordance with its fiduciary
duties, whether the Merger Consideration is substantively fair, taking into account all relevant economic and financial terms of the
transactions, to our shareholders, or a Fairness Determination. If our board of directors is unable in good faith to make a Fairness
Determination, it may terminate the BCA subject to an obligation to seek to negotiate changes to the BCA with the Seller that would allow
our board of directors to make a Fairness Determination.
Consummation of the Merger is subject to various
conditions, including, among others, customary conditions relating to the approval of the Domestication and the BCA by the requisite
vote of our shareholders; effectiveness of a registration statement on Form S-4 that will include our proxy statement and constitute
a prospectus relating to the issuance of the class A common stock upon completion of the Domestication and the Merger Consideration;
absence of an injunction by any court or other tribunal of competent jurisdiction and absence of a law that prevents, enjoins, prohibits,
or makes illegal the consummation of the Merger; and receipt of all consents, approvals, and authorizations legally required to be obtained
to consummate the Merger and of any customary legal opinions from counsel to us and the Seller Merger Sub. In addition, each party’s
obligation to consummate the Merger is subject to the satisfaction (or waiver, to the extent permitted by applicable law) of the following
conditions:
| ● | receipt by us of the Target Affiliates’
audited financial statements, which includes consolidated balance sheets and consolidated
statements of income, shareholders’ equity, and cash flows, as of and for the year
ended December 31, 2023, prepared in accordance with United States generally accepted accounting
principles; |
| ● | the net tangible assets of our company
being valued at $5,000,0001 or more after giving effect to the closing of the Merger and
any related financing transactions; |
| ● | completion of the Target Affiliates
Restructuring (as defined in the BCA), whereby the Seller Merger Sub will acquire ownership
of the Target Affiliates; and |
| ● | completion of the Target Affiliates
Refinancing (as defined in the BCA) and repayment in full of all Target Affiliate Obligations
(as defined in the BCA). |
The obligation of the parties to consummate the
Merger is also conditioned upon the representations and warranties of each other party being true and correct (subject to certain materiality
exceptions), each other party having performed in all material respects its obligations under the BCA and any ancillary documents related
thereto, and the absence of a Material Adverse Effect (as defined in the BCA) on each party, unless stated otherwise in the BCA or waived
upon mutual agreement of our company and the Seller.
The BCA may be terminated, and the transactions
contemplated thereby may be abandoned at any time prior to the closing as follows:
| (a) | by mutual written consent of our company
and the Seller; |
| (b) | by written notice by us or the Seller
if any of the conditions to the closing have not been satisfied or waived by June 30, 2024,
or the Outside Date; provided, however, that this termination right shall not be available
to a party if the breach or violation by such party or its affiliates of any representation,
warranty, covenant or obligation under the BCA was the cause of, or resulted in, the failure
of the closing to occur on or before the Outside Date; |
| (c) | by written notice of either us or the
Seller if a governmental authority of competent jurisdiction shall have issued an order or
taken any other action permanently restraining, enjoining, or otherwise prohibiting the transactions
contemplated by the BCA, and such order or other action has become final and non-appealable; |
| (d) | by written notice by the Seller to us,
if (i) there has been a material breach by us of any of our representations, warranties,
covenants, or agreements contained in the BCA, or if any representation or warranty of our
company becomes materially untrue or materially inaccurate, in any case, which would result
in a failure of one of the BCA’s conditions to be satisfied (treating the closing date
for such purposes as the date of the BCA or, if later, the date of such breach), and (ii)
the breach or inaccuracy is incapable of being cured or is not cured within twenty (20) days
after written notice of such breach or inaccuracy is provided to us by the Seller or the
Seller Merger Sub; provided, that neither the Seller nor the Seller Merger Sub shall have
the right to terminate the BCA under this section if at such time the Seller or the Seller
Merger Sub is in material uncured breach of thereof; |
| (e) | by written notice by us to the Seller,
if (i) there has been a breach by the Seller, the Seller Merger Sub, or any of the Target
Affiliates of any of their respective representations, warranties, covenants, or agreements
contained in the BCA, or if any representation or warranty of such parties become untrue
or inaccurate, in any case, which would result in a failure of one of the BCA’s conditions
to be satisfied (treating the closing date for such purposes as the date of the BCA or, if
later, the date of such breach), (ii) the breach or inaccuracy is incapable of being cured
or is not cured within twenty (20) days after written notice of such breach or inaccuracy
is provided by us to the Seller and the Seller Merger Sub; provided, that we shall not have
the right to terminate the BCA under this section if at such time we are in material uncured
breach thereof, or (iii) we object to any material adverse information contained in the Seller’s
disclosure schedules or our board of directors is unable in good faith to make a determination
in its reasonable discretion whether the Merger Consideration is fair and reasonable compensation
for the acquisition of the Target Affiliates and the parties cannot agree on reasonable and
mutually satisfactory modifications to the BCA to address our objections; |
| (f) | by written notice by us to the Seller
if there shall have been a Material Adverse Effect with respect to the Seller, the Seller
Merger Sub, or the Target Affiliates following the date of the BCA; |
| (g) | by written notice by the Seller to us
if there shall have been a Material Adverse Effect with respect to our company following
the date of the BCA which is uncured; |
| (h) | by written notice by either our company
or the Seller to the other if the Required Shareholder Approval (as defined in the BCA) is
not obtained; or |
| (i) | by written notice by us to the Seller
if by February 6, 2024 our board of directors determines that it cannot make a Fairness Determination
in accordance with the BCA taking into account all relevant economic and financial terms
of the transactions, to our shareholders (the parties are currently negotiating an amendment to the BCA to extend this date). |
Notwithstanding the foregoing, before we terminate
the BCA pursuant to (i) above, we must give the Seller ten (10) business days’ prior written notice of its intention to terminate
the BCA, and during the ten (10) business days following such written notice, our company, if requested by the Seller, shall negotiate
in good faith with the Seller regarding any revisions to the terms of the BCA proposed by us or the Seller. If at the end of the ten
(10) business day period, we conclude in good faith, after consultation with its counsel and financial advisor (and taking into account
any adjustment or modification of the terms of the BCA to which the other party has agreed in writing), that we cannot make a positive
Fairness Determination, then we may terminate the BCA.
The BCA requires the Seller parties to pay a
termination fee to us under certain circumstances as liquidated damages. If the BCA is terminated by either us or the Seller under paragraph
(b) above and the failure of the closing of the Merger to occur on or before the Outside Date was not caused by, or a result of, the
breach or violation by us of any representation, warranty, covenant or obligation under the BCA, or (ii) there is a valid and effective
termination of the BCA under clause (e) above, then the Seller must pay us a termination fee in cash in an aggregate amount of Two Million
Five Hundred Thousand Dollars ($2,500,000), which must be paid within twenty (20) business days after the date of the valid and effective
termination of the BCA by us.
Simultaneously with the execution and delivery
of the BCA, we, our sponsor and the Seller entered into a Sponsor Support Agreement, pursuant to which our sponsor agreed to vote all
its founder shares in favor of the BCA, the Domestication and all related transactions. Our sponsor also agreed to take certain other
actions supporting the BCA and related transactions and refrain from taking actions that would adversely affect its ability to perform
its obligations under the Sponsor Support Agreement.
Factors That May Adversely Affect our Results
of Operations
Our results of operations and our ability to
complete an initial business combination may be adversely affected by various factors that could cause economic uncertainty and volatility
in the financial markets, many of which are beyond our control. Our business could be impacted by, among other things, downturns in the
financial markets or in economic conditions, increases in oil prices, inflation, increases in interest rates, supply chain disruptions,
declines in consumer confidence and spending, and geopolitical instability, such as the military conflicts in Ukraine and the Middle
East. We cannot at this time fully predict the likelihood of one or more of the above events, their duration or magnitude or the extent
to which they may negatively impact our business and our ability to complete an initial business combination.
Emerging Growth Company
We are an “emerging growth
company,” as defined in Section 2(a) of the Securities Act, as modified by the JOBS Act. As such, we are eligible to take advantage
of certain exemptions from various reporting requirements that are applicable to other public companies that are not “emerging
growth companies,” including, but not limited to, not being required to comply with the auditor attestation requirements of Section
404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements,
and exemptions from the requirements of holding a non-binding advisory vote on executive compensation and shareholder approval of any
golden parachute payments not previously approved. If some investors find our securities less attractive as a result, there may be a
less active trading market for our securities and the prices of our securities may be more volatile.
In addition, Section 107 of
the JOBS Act also provides that an “emerging growth company” can take advantage of the extended transition period provided
in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other words, an “emerging
growth company” can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies.
We intend to take advantage of the benefits of this extended transition period.
We will remain an emerging
growth company until the earliest of (i) the last day of the fiscal year following the fifth anniversary of our initial public
offering, (ii) the last day of the first fiscal year in which our total annual gross revenues are $1.235 billion or more,
(iii) the date that we become a “large accelerated filer” as defined in Rule 12b-2 under the Exchange Act,
which would occur if the market value of our class A ordinary shares that is held by non-affiliates exceeds $700 million
as of the last business day of our most recently completed second fiscal quarter or (iv) the date on which we have issued more
than $1 billion in non-convertible debt during the preceding three year period.
Results of Operations
Our entire activity since inception has been
in preparation for our formation and our initial public offering, and since the completion of our initial public offering, the search
for business combination candidates. We will not be generating any operating revenues until the closing and completion of our initial
business combination at the earliest.
For the year ended December 31, 2023, we had
net income of $784,626, which consisted of approximately $2.1 million of income from cash and investments held in trust account, offset
by a non-operating loss of approximately $211,000 resulting from the change in fair value of derivative assets and liabilities and approximately
$1.1 million general and administrative expenses.
For the year ended December 31, 2022, we had
a net income of approximately $8.7 million, which consisted of a non-operating gain of approximately $5.9 million resulting from the
change in the fair value of derivative assets and liabilities, approximately $155,000 gain from settlement of deferred underwiring commissions
allocated to derivative warrant liabilities and approximately $3.3 million of income from investments held in trust account, partially
offset by approximately $614,000 general and administrative expenses.
Liquidity and Capital Resources
As of December 31, 2023, we had $0 in our operating
bank account and working capital deficit of approximately $2.1 million.
Our liquidity needs to date have been satisfied
through a contribution of $25,000 from our prior sponsor to cover certain expenses in exchange for the issuance of its founder shares,
a loan of approximately $111,000 from the prior sponsor, which was repaid in full on February 24, 2021, and a portion of the proceeds
from the consummation of our private placement not held in the trust account. In addition, in order to finance transaction costs in connection
with an initial business combination, our sponsor or an affiliate of our sponsor, or certain of our officers and directors may, but are
not obligated to, provide working capital loans.
On April 13, 2022, we issued an unsecured promissory
note in the amount of up to $200,000 to our prior sponsor, which was amended and restated on May 25, 2022 to increase the principal
amount to $400,000. This note bears no interest and was due on June 7, 2023. On June 30, 2022, our prior sponsor assigned all of its rights
and obligations under this note to our sponsor. On June 7, 2023, this note was amended and restated to extend the maturity date to August
20, 2024. As of December 31, 2023, we have fully drawn $400,000 under this note. As of December 31, 2023 and 2022, approximately
$400,000 and $319,000 were outstanding under this note, respectively.
On November 17, 2023, we signed a non-binding
letter of intent with NDG for a proposed transaction between us and NDG. Included in the general terms and conditions of the letter of
intent is a condition where NDG will assume the payment of our operating expenses, including the service fees of our auditors, legal
counsel, accountants, stock transfer agent and others, in the amount of not more than $100,000 (one hundred thousand dollars) per month,
including the payment of our monthly contribution to the trust account. The expenses shall initially be paid a rate of $20,000 (twenty
thousand dollars) per week, payable on every Monday of the week beginning October 20, 2023, and payable into the account of our sponsor,
with a catch up to the monthly rate after 90 days. In addition, within five business days upon the signing of the letter of intent, NDG
or its representatives agreed to make a deposit in the amount of $30,000 (thirty thousand dollars) into the trust account. As of December
31, 2023, a total of $110,000 was advanced by NDG to us.
We may need to raise additional capital through
loans or additional investments from our sponsor, officers or directors or their affiliates. Our sponsor, officers and directors, or
their affiliates, may, but are not obligated to, loan funds to us, from time to time or at any time, in whatever amount they deem reasonable
in their sole discretion, to meet our working capital needs. Accordingly, we may not be able to obtain additional financing. If we are
unable to raise additional capital, we may be required to take additional measures to conserve liquidity, which could include, but not
necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, reducing overhead expenses, and
extending the terms and due dates of certain accrued expenses and other liabilities. We cannot provide any assurance that new financing
will be available to us on commercially acceptable terms, if at all. In connection with our assessment of going concern considerations,
management has determined that the liquidity condition, mandatory liquidation and subsequent dissolution raises substantial doubt about
our ability to continue as a going concern. Management continues to seek to complete a business combination prior to the mandatory liquidation
date. No adjustments have been made to the carrying amounts of assets or liabilities should we be required to liquidate after May 22,
2024. The accompanying financial statements do not include any adjustment that might be necessary if we are unable to continue as a going
concern.
Contractual Obligations
We do not have any long-term debt, capital lease
obligations, operating lease obligations or long-term liabilities.
Commitments and Contingencies
Registration Rights
The holders of the founder shares, private placement
warrants, and warrants that may be issued upon conversion of working capital loans (and any class A ordinary shares issuable upon the
exercise of the private placement warrants and warrants that may be issued upon conversion of working capital loans) are entitled to
registration rights pursuant to a registration rights agreement dated February 17, 2021. The holders of these securities are entitled
to make up to three demands, excluding short form demands, that we register such securities. In addition, the holders have certain “piggy-back”
registration rights with respect to registration statements filed subsequent to the completion of the initial business combination. We
will bear the expenses incurred in connection with the filing of any such registration statements.
Underwriting Agreement
In connection with our initial public offering,
approximately $8.1 million in the aggregate was payable to the underwriters for deferred underwriting commissions. On August 11, 2022
and September 6, 2022, two of the underwriters in the initial public offering irrevocably waived their rights to receive an aggregate
of approximately $5.2 million of deferred underwriting compensation. We recognized the portion allocated to public shares of approximately
$5.0 million as an adjustment to the carrying value of the class A ordinary shares subject to possible redemption and the remaining balance
of approximately $0.2 million as a gain from extinguishment of deferred underwriting commissions allocated to derivative warrant liabilities.
The remaining deferred fee will become payable
to the underwriters from the amounts held in the trust account solely in the event that we complete an initial business combination,
subject to the terms of the underwriting agreement.
Critical Accounting Policies and Estimates
The following discussion relates to critical
accounting policies. The preparation of financial statements in conformity with United States generally accepted accounting principles,
or GAAP, requires our management to make assumptions, estimates and judgments that affect the amounts reported, including the notes thereto,
and related disclosures of commitments and contingencies, if any. We have identified certain accounting policies that are significant
to the preparation of our financial statements. These accounting policies are important for an understanding of our financial condition
and results of operation. Critical accounting policies are those that are most important to the portrayal of our financial condition
and results of operations and require management’s difficult, subjective, or complex judgment, often as a result of the need to
make estimates about the effect of matters that are inherently uncertain and may change in subsequent periods. Certain accounting estimates
are particularly sensitive because of their significance to financial statements and because of the possibility that future events affecting
the estimate may differ significantly from management’s current judgments. We believe the following critical accounting policies
involve the most significant estimates and judgments used in the preparation of our financial statements:
Derivative Liabilities. We do not
use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. We evaluate all of our financial instruments,
including issued warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives,
pursuant to Accounting Standards Codification, or ASC, Topic 480, “Distinguishing Liabilities from Equity” and ASC 815-15.
The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed
at the end of each reporting period. We account for warrants as derivative liabilities in accordance with ASC 815-40. Accordingly, we
recognize the instruments as liabilities at fair value and adjusts the instruments to fair value at the end of each reporting period.
The liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value of derivative
liabilities is recognized in our statements of operations. The fair value of public warrants was initially measured using Monte-Carlo
simulation and has subsequently been measured on the market price of such public warrants at each measurement date when separately listed
and traded. The fair value of the private placement warrants was initially measured using Black-Scholes Option Pricing Model and subsequently
using the market value of the public warrants.
Class A Ordinary Shares Subject to Possible
Redemption. We account for our class A ordinary shares subject to possible redemption in accordance with the guidance in ASC
Topic 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption (if any) are
classified as liability instruments and are measured at fair value. Conditionally redeemable class A ordinary shares (including class
A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence
of uncertain events not solely within our control) are classified as temporary equity. At all other times, class A ordinary shares are
classified as shareholders’ equity. Our class A ordinary shares feature certain redemption rights that are considered to be outside
of our control and subject to the occurrence of uncertain future events. Accordingly, as of December 31, 2023 and 2022, 1,570,680 and
23,000,000 class ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’
deficit section of the accompanying balance sheets, respectively. We recognize changes in redemption value immediately as they occur
and adjusts the carrying value of the class A ordinary shares subject to possible redemption to equal the redemption value at the end
of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security.
Effective with the closing of our initial public offering, we recognized the accretion from initial book value to redemption amount,
which resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit.
Net Income per Ordinary Share.
We comply with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” We have two classes of
shares, which are referred to as class A ordinary shares and class B ordinary shares. Income and losses are shared pro rata between the
two classes of shares. Net income per ordinary share is calculated by dividing the net income by the weighted average number of ordinary
shares outstanding for the respective period. The calculation of diluted net income per ordinary share does not consider the effect of
the public warrants or the private placement warrants since their exercise is contingent upon future events. As a result, diluted net
income per share is the same as basic net income per share for the years ended December 31, 2023 and 2022. Accretion associated with
the redeemable class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value.
Share-Based Compensation. We comply
with the accounting and disclosure requirement of ASC Topic 718, “Compensation – Stock Compensation.” Share-based compensation
to employees and non-employees is recognized over the requisite service period based on the estimated grant-date fair value of the awards.
Share-based awards with graded-vesting schedules are recognized on a straight-line basis over the requisite service period for each separately
vesting portion of the award. We recognize the expense for share-based compensation awards subject to performance-based milestone vesting
over the remaining service period when management determines that achievement of the milestone is probable. Management evaluates when
the achievement of a performance-based milestone is probable based on the expected satisfaction of the performance conditions at each
reporting date. Share-based compensation will be recognized in general and administrative expense in the statements of operations. We
issued option awards that contain both a performance condition and service condition. The option awards vest upon the consummation of
the initial business combination and will expire in five years after the date on which they first become exercisable. We have determined
that the consummation of an initial business combination is a performance condition subject to significant uncertainty. As such, the
achievement of the performance is not deemed to be probable of achievement until the consummation of the event, and therefore no compensation
has been recognized for the period from inception to December 31, 2023.
ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.
Not applicable.
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA.
The full text of our audited financial statements
begins on page F-1 of this annual report, which are incorporated herein by reference.
ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE.
None.
ITEM 9A. CONTROLS AND PROCEDURES.
Evaluation of Disclosure Controls and Procedures
Disclosure controls and procedures are controls
and other procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange
Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure
controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed
in our reports filed or submitted under the Exchange Act is accumulated and communicated to management, including our Chief Executive
Officer (who also acts as our principal financial and accounting officer), as appropriate, to allow timely decisions regarding required
disclosure.
As required by Rule 13a-15(e) of the Exchange
Act, our management has carried out an evaluation, with the participation and under the supervision of our Chief Executive Officer, of
the effectiveness of the design and operation of our disclosure controls and procedures, as of December 31, 2023. Based upon, and as
of the date of this evaluation, our Chief Executive Officer determined that, because of the material weaknesses described below, our
disclosure controls and procedures were not effective. Specifically, management has concluded that our control around the interpretation
and accounting for extinguishment of a significant contingent obligation was not effectively designed or maintained. In light of this
material weakness, we performed additional analysis as deemed necessary to ensure that our financial statements were prepared in accordance
with GAAP. Accordingly, management believes that the financial statements included in this report present fairly in all material respects
our financial position, results of operations and cash flows for the period presented.
Management’s Annual Report on Internal
Controls over Financial Reporting
As required by SEC rules and regulations implementing
Section 404 of the Sarbanes-Oxley Act, our management is responsible for establishing and maintaining adequate internal control over
financial reporting. Our internal control over financial reporting is designed to provide reasonable assurance regarding the reliability
of financial reporting and the preparation of our financial statements for external reporting purposes in accordance with GAAP. Our internal
control over financial reporting includes those policies and procedures that:
| (1) | pertain to the maintenance of records
that in reasonable detail accurately and fairly reflect the transactions and dispositions
of our assets; |
| (2) | provide reasonable assurance that transactions
are recorded as necessary to permit preparation of financial statements in accordance with
GAAP, and that our receipts and expenditures are being made only in accordance with the authorization
of our management and directors; and |
| (3) | provide reasonable assurance regarding
prevention or timely detection of unauthorized acquisition, use or disposition of our assets
that could have a material effect on the financial statements. |
Our management evaluated the effectiveness of
our internal control over financial reporting as of December 31, 2023. In making this evaluation, management used the framework established
in Internal Control - Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission, or COSO. The
COSO framework summarizes each of the components of a company’s internal control system, including (i) the control environment,
(ii) risk assessment, (iii) control activities, (iv) information and communication, and (v) monitoring. Based on our evaluation, we determined
that, as of December 31, 2023, our internal control over financial reporting was not effective.
Management has implemented remediation steps
to improve our internal control over financial reporting. Specifically, we expanded and improved our review process for complex securities
and related accounting standards. We plan to further improve this process by enhancing access to accounting literature, identification
of third-party professionals with whom to consult regarding complex accounting applications and consideration of additional staff with
the requisite experience and training to supplement existing accounting professionals.
We intend to complete the remediation of the
material weaknesses discussed above as soon as practicable but we can give no assurance that we will be able to do so. Designing and
implementing an effective disclosure controls and procedures is a continuous effort that requires us to anticipate and react to changes
in our business and the economic and regulatory environments and to devote significant resources to maintain a financial reporting system
that adequately satisfies our reporting obligations. The remedial measures that we have taken and intend to take may not fully address
the material weaknesses that we have identified, and material weaknesses in our disclosure controls and procedures may be identified
in the future. Should we discover such conditions, we intend to remediate them as soon as practicable. We are committed to taking appropriate
steps for remediation, as needed.
All internal control systems, no matter how well
designed, have inherent limitations. Therefore, even those systems determined to be effective can provide only reasonable assurance with
respect to financial statement preparation and presentation. Also, projections of any evaluation of effectiveness to future periods are
subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies
or procedures may deteriorate.
Changes in Internal Control over Financial
Reporting
We regularly review our system of internal control
over financial reporting and make changes to our processes and systems to improve controls and increase efficiency, while ensuring that
we maintain an effective internal control environment. Changes may include such activities as implementing new, more efficient systems,
consolidating activities, and migrating processes.
Except for the matters described above, there
have been no changes in our internal control over financial reporting during the fourth quarter of fiscal year 2023 that have materially
affected, or are reasonably likely to materially affect, our internal control over financial reporting.
ITEM 9B. OTHER INFORMATION.
We have no information to disclose that was required
to be in a report on Form 8-K during the fourth quarter of fiscal year 2023 but was not reported.
None of our directors or executive officers
adopted or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement (as defined in Item 408(c) of Regulation
S-K) during the fourth quarter of fiscal year 2023.
ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS.
Not applicable.
PART III
ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE.
Directors and Executive Officers
The following sets forth information about our
directors and executive officers as of the date of this report.
Name |
|
Age |
|
Position |
Dimitri Elkin |
|
55 |
|
Chief Executive Officer |
Konstantin Tourevski |
|
47 |
|
Chairman of the Board |
Jonathan D. Morris |
|
47 |
|
Director |
Gregory D. Nelson |
|
55 |
|
Director |
The experience of our directors and executive
officers is as follows:
Dimitri Elkin. Mr. Elkin has served
as our Chief Executive Officer since June 2022. Mr. Elkin has been serving as Chief Executive Officer and a director of Twelve Seas Investment
Company II since July 2020. From December 2017 until December 2019, he also served as Chief Executive Officer of Twelve Seas Investment
Company. Since April 2013, Mr. Elkin has been a Founding Partner of Twelve Seas Limited. From 2007 to April 2013, Mr. Elkin served as
General Partner of UFG Private Equity, a private-equity firm. From 2003 to 2006, Mr. Elkin was a Founding Partner at GIC Capital, a U.S.
private equity firm. From 1998 to 2003, Mr. Elkin served as an investment executive at Kohlberg Kravis Roberts & Co., heading its
activities in the former Soviet Union and Eastern Europe. From 1996 to 1998, Mr. Elkin served as an investment banker at Lehman Brothers.
Mr. Elkin previously served as a director of multiple corporate entities. Mr. Elkin graduated from Moscow State University and received
an MBA from Harvard Business School.
Konstantin Tourevski. Mr. Tourevski
has served on our board of directors since March 2023 and was appointed as Chairman of the Board in November 2023. Mr. Tourevski is a
managing partner at New Age Alpha, LLC, an asset management firm, where he oversees fixed income and alternative investments. As member
of senior management, he is involved in all aspects of the business including fund management, the firm’s proprietary index offerings
and its custom direct indexing platform as well as general management and business development activities. Prior to joining New Age Alpha,
LLC, Mr. Tourevski spent sixteen years (June 2003 – September 2019) managing investments at Loews Corporation. After joining their
investment team as a research associate, he went on to hold several roles with increased responsibility encompassing research, trading,
and portfolio management. Prior to leaving, Mr. Tourevski was responsible for High Yield Bonds and was part of a small team of senior
portfolio managers tasked with setting the firm’s overall investment strategy. Before joining Loews Corporation, Mr. Tourevski
worked in fixed-income research at JP Morgan Investment Management from June 1999 to August 2001, where he focused on issuers in technology,
telecom, media, gaming, and leisure industries. His other business interests include ownership in a private holding company operating
several childcare staffing franchises and a real estate management and development business with focus on vacation rental properties.
Mr. Tourevski is a CFA charterholder and holds a B.A. in Economics from New York University, summa cum laude, and an MBA with honors
from Columbia Business School. We believe Mr. Tourevski is well-qualified to serve as on our board of directors because of his extensive
investment and management experience.
Jonathan Morris. Mr. Morris has
served on our board of directors since January 2024. Mr. Morris has over 24 years of experience as a finance executive, principal,
operator, and advisor. Since 2022, Mr. Morris has served as the Chief Financial Officer of Global Blockchain Acquisition Corp.
Since 2020, Mr. Morris has served as the Chief Financial Officer of Twelve Seas Investment Company II (where he also serves
as a director), FreeCast, Inc. and Hush Aerospace LLC. Since 2021, Mr. Morris has served as the Chief Development Officer of TLG
Acquisition One Corp. Prior to these roles, in 2020, Mr. Morris served as Chief Financial Officer at Imageware Systems, Inc., and
from 2016 to 2020, led principal investments and structuring as President and Senior Managing Director at a large private family office.
From 2012 to 2016, Mr. Morris served as a Director at Blackstone Group, Inc., where he focused on telecom and technology investments. From
2005 to 2012, Mr. Morris was part of the TMT Investment Banking Group of Credit Suisse. Mr. Morris began his career in 1997
within the private equity division of Lombard, Odier et Cie, a private bank in Switzerland, and subsequently went to work as an associate
at GAIN Capital, a currency hedge fund from 1999 to 2003. Mr. Morris has served on several boards, including on the board of SunGard
AS. Mr. Morris earned his B.S. in Economics and Finance from the University of Virginia and his M.B.A. from Georgetown University.
We believe Mr. Morris is well-qualified to serve on our board of directors because of his extensive investment and management experience.
Gregory Nelson. Mr. Nelson has
served on our board of directors since January 2024. Mr. Nelson has over 30 years of experience as a finance and investment banking
executive and advisor. Since 2014, Mr. Nelson has served as a Managing Director of TAG Financial Institutions Group, LLC, a boutique
investment banking firm focused on the Financial Services industry. Prior to this role, Mr. Nelson served as a Senior Vice
President of U.S. Re Companies from 2007 to 2014, where he oversaw corporate development and managed the day-to-date operations of its
broker-dealer subsidiary. Previously, during the period of 2001 – 2007, Mr. Nelson worked in investment banking positions
of increasing responsibility with Bear Stearns & Company, Friedman, Billings, Ramsey & Co., and Banc of America Securities, respectively. Prior
to entering the investment banking industry, Mr. Nelson worked in corporate accounting and finance positions with the Allstate Corporation
and Amerin Guaranty Corp. (now part of Radian Group). He began his career in public accounting in 1991. Mr. Nelson earned
his BBA in Accounting from Western Michigan University and his M.B.A. from the University of Chicago Booth School of Business. We believe
Mr. Nelson is well-qualified to serve on our board of directors because of his extensive investment experience.
Number and Terms of Office of Officers and
Directors
Our board of directors is divided into three classes with only one
class of directors being elected in each year and each class (except for those directors appointed prior to our first annual meeting of
shareholders) serving a three-year term. The term of office of the first class of directors, consisting of Mr. Nelson, will expire at
our annual meeting of shareholders to be held in 2026. The term of office of the second class of directors, consisting of Mr. Tourevski,
will expire at the annual meeting of shareholders to be held in 2024. The term of office of the third class of directors, consisting of
Mr. Morris, will expire at the annual meeting of shareholders to be held in 2025. We may not hold an annual meeting of shareholders until
after we consummate our initial business combination.
Our officers are appointed by the board of directors
and serve at the discretion of the board of directors, rather than for specific terms of office.
Family Relationships
There are no family relationships among any of
our officers or directors.
Involvement in Certain Legal Proceedings
To the best of our knowledge, except as described
below, none of our directors or executive officers has, during the past ten years:
| ● | been convicted in a criminal proceeding
or been subject to a pending criminal proceeding (excluding traffic violations and other
minor offences); |
| ● | had any bankruptcy petition filed
by or against the business or property of the person, or of any partnership, corporation,
or business association of which he was a general partner or executive officer, either at
the time of the bankruptcy filing or within two years prior to that time; |
| ● | been subject to any order, judgment,
or decree, not subsequently reversed, suspended, or vacated, of any court of competent jurisdiction
or federal or state authority, permanently or temporarily enjoining, barring, suspending
or otherwise limiting, his involvement in any type of business, securities, futures, commodities,
investment, banking, savings and loan, or insurance activities, or to be associated with
persons engaged in any such activity; |
| ● | been found by a court of competent
jurisdiction in a civil action or by the Securities and Exchange Commission or the Commodity
Futures Trading Commission to have violated a federal or state securities or commodities
law, and the judgment has not been reversed, suspended, or vacated; |
| ● | been the subject of, or a party
to, any federal or state judicial or administrative order, judgment, decree, or finding,
not subsequently reversed, suspended or vacated (not including any settlement of a civil
proceeding among private litigants), relating to an alleged violation of any federal or state
securities or commodities law or regulation, any law or regulation respecting financial institutions
or insurance companies including, but not limited to, a temporary or permanent injunction,
order of disgorgement or restitution, civil money penalty or temporary or permanent cease-and-desist
order, or removal or prohibition order, or any law or regulation prohibiting mail or wire
fraud or fraud in connection with any business entity; or |
| ● | been the subject of, or a party
to, any sanction or order, not subsequently reversed, suspended or vacated, of any self-regulatory
organization (as defined in Section 3(a)(26) of the Exchange Act (15 U.S.C. 78c(a)(26))),
any registered entity (as defined in Section 1(a)(29) of the Commodity Exchange Act (7 U.S.C.
1(a)(29))), or any equivalent exchange, association, entity or organization that has disciplinary
authority over its members or persons associated with a member. |
Corporate Governance
Governance Structure
We chose to appoint a separate Chairman of the
Board who is not our Chief Executive Officer. Our board of directors has made this decision based on their belief that a separate Chairman
of the Board can act as a balance to the Chief Executive Officer, who also serves as a non-independent director.
The Board’s Role in Risk Oversight
The board of directors oversees that the assets
of our company are properly safeguarded, that the appropriate financial and other controls are maintained, and that our business is conducted
wisely and in compliance with applicable laws and regulations and proper governance. Included in these responsibilities is the board’s
oversight of the various risks facing our company. In this regard, our board seeks to understand and oversee critical business risks.
Our board does not view risk in isolation. Risks are considered in virtually every business decision and as part of our business strategy.
Our board recognizes that it is neither possible nor prudent to eliminate all risk. Indeed, purposeful, and appropriate risk-taking is
essential for our company to be competitive on a global basis and to achieve its objectives.
While the board oversees risk management, company
management is charged with managing risk. Management communicates routinely with the board and individual directors on the significant
risks identified and how they are being managed. Directors are free to, and indeed often do, communicate directly with senior management.
Our board administers its risk oversight function
as a whole by making risk oversight a matter of collective consideration; however, much of the work is delegated to committees, which
will meet regularly and report back to the full board. Our audit committee oversees risks related to our financial statements, the financial
reporting process, accounting and legal matters, and our compensation committee evaluates the risks and rewards associated with our compensation
philosophy and programs.
Independent Directors
Our board of directors has determined that all
of our directors qualify as “independent” directors in accordance with the rules and regulations of Nasdaq. In making its
independence determinations, the board considered, among other things, relevant transactions between our company and entities associated
with the independent directors, as described under the heading Item 13 “Certain Relationships and Related Party Transactions,
and Director Independence,” and determined that none have any relationship with our company or other relationships that would
impair the directors’ independence.
Committees of the Board of Directors
Our board of directors has two standing committees:
an audit committee and a compensation committee, each of which is composed solely of independent directors. Each committee operates under
a charter that has been approved by our board of directors and has the composition and responsibilities described below. Each committee’s
charter has been filed as an exhibit to this report.
Audit Committee
The members of our audit committee are Messrs. Morris, Nelson and Tourevski,
with Mr. Nelson serving as chairman of the audit committee. Our board has determined that each member of the audit committee is an independent
director under Nasdaq’s rules and under Rule 10A-3 under the Exchange Act. All members of our audit committee meet the requirements
for financial literacy under the applicable rules and regulations of the SEC and Nasdaq. Our board has determined that Mr. Nelson is an
“audit committee financial expert” as defined by applicable SEC rules and has the requisite financial sophistication as defined
under the applicable Nasdaq rules and regulations.
We have adopted an audit committee charter, which
details the purpose and principal functions of the audit committee, including: (i) the appointment, compensation, retention, replacement,
and oversight of the work of the independent registered public accounting firm and any other independent registered public accounting
firm engaged by us; (ii) pre-approving all audit and permitted non-audit services to be provided by the independent registered public
accounting firm or any other registered public accounting firm engaged by us, and establishing pre-approval policies and procedures;
(iii) reviewing and discussing with the independent registered public accounting firm all relationships the independent registered public
accounting firm have with us in order to evaluate their continued independence; (iv) setting clear hiring policies for employees or former
employees of the independent registered public accounting firm; and (v) setting clear policies for audit partner rotation in compliance
with applicable laws and regulations.
Compensation Committee
The members of our compensation committee are
Messrs. Morris and Nelson, with Mr. Morris serving as chairman of the audit committee. Our board has determined that each member of the
compensation committee is independent under the applicable rules and regulations of Nasdaq and is a “non-employee director”
as defined under Rule 16b-3 of the Exchange Act.
We have adopted a compensation committee charter,
which details the purpose and responsibilities of the compensation committee, including: (i) reviewing and approving on an annual basis
the corporate goals and objectives relevant to our Chief Executive Officer’s compensation, evaluating our Chief Executive Officer’s
performance in light of such goals and objectives and determining and approving the remuneration (if any) of our Chief Executive Officer’s
based on such evaluation; (ii) reviewing and approving the compensation of all of our other executive officers; (iii) reviewing our executive
compensation policies and plans; (iv) implementing and administering our incentive compensation equity-based remuneration plans;
(v) approving all special perquisites, special cash payments and other special compensation and benefit arrangements for our executive
officers and employees; and (vi) reviewing, evaluating and recommending changes, if appropriate, to the remuneration for directors.
The compensation committee charter provides that
the compensation committee may, in its sole discretion, retain or obtain the advice of a compensation consultant, legal counsel or other
adviser, and will be directly responsible for the appointment, compensation and oversight of the work of any such adviser. However, before
engaging or receiving advice from a compensation consultant, external legal counsel or any other adviser, the compensation committee
will consider the independence of each such adviser, including the factors required by Nasdaq and the SEC.
Director Nominations
We do not have a standing nominating committee.
In accordance with Rule 5605(e)(2) of the Nasdaq rules, a majority of the independent directors may recommend a director nominee for
selection by the board of directors. The board of directors believes that the independent directors can satisfactorily carry out the
responsibility of properly selecting or approving director nominees without the formation of a standing nominating committee. All of
our directors participate in the consideration and recommendation of director nominees since they are all independent. As there is no
standing nominating committee, we do not have a nominating committee charter in place.
The board of directors will also consider director
candidates recommended for nomination by our shareholders during such times as they are seeking proposed nominees to stand for election
at the next annual meeting of shareholders (or, if applicable, a special meeting of shareholders). Our shareholders that wish to nominate
a director for election to the board should follow the procedures set forth in our second amended and restated memorandum and articles
of association.
We have not formally established any specific,
minimum qualifications that must be met or skills that are necessary for directors to possess. In general, in identifying and evaluating
nominees for director, the board of directors considers educational background, diversity of professional experience, knowledge of our
business, integrity, professional reputation, independence, wisdom, and the ability to represent the best interests of our shareholders.
Code of Ethics
We have adopted a code of ethics that applies
to all of our directors, officers, and employees, including our principal executive officer, principal financial officer and principal
accounting officer. Such code of ethics addresses, among other things, honesty and ethical conduct, conflicts of interest, compliance
with laws, regulations, and policies, including disclosure requirements under the federal securities laws, and reporting of violations
of the code. A copy of the code of ethics has been filed as an exhibit to this report.
We are required to disclose any amendment to,
or waiver from, a provision of our code of ethics applicable to our principal executive officer, principal financial officer, principal
accounting officer, controller, or persons performing similar functions. We intend to disclose any amendments to or waivers of certain
provisions of our code of ethics in a Current Report on Form 8-K.
Insider Trading Policy
We have adopted an insider trading policy which
prohibits our directors, officers, and employees from engaging in transactions in our common stock while in the possession of material
non-public information; engaging in transactions in the stock of other companies while in possession of material non-public information
that they become aware of in performing their duties; and disclosing material non-public information to unauthorized persons outside
our company.
Our insider trading policy restricts trading
by directors, officers, and certain key employees during blackout periods, which generally begin 15 calendar days before the end of each
fiscal quarter and end two business days after the issuance of our earnings release for the quarter. Additional blackout periods may
be imposed with or without notice, as the circumstances require.
Our insider trading policy also prohibits our
directors, officers, and employees from purchasing financial instruments (such as prepaid variable forward contracts, equity swaps, collars
and exchange funds) designed to hedge or offset any decrease in the market value of our common stock they hold, directly or indirectly.
In addition, directors, officers, and employees are expressly prohibited from pledging our common stock to secure personal loans or other
obligations, including by holding their common stock in a margin account, unless such arrangement is specifically approved in advance
by the administrator of our insider trading policy, or making short-sale transactions in our common stock.
A copy of the insider trading policy has been
filed as an exhibit to this report.
Section 16(a) Beneficial Ownership Reporting
Compliance
Section 16(a) of the Exchange Act requires our
directors and executive officers and beneficial holders of more than 10% of our class A ordinary shares to file with the SEC initial
reports of ownership and reports of changes in ownership of our equity securities. We believe, based solely on a review of the copies
of such reports furnished to us and representations of these persons, that all of the reports were timely filed for the year ended December
31, 2023.
ITEM 11. EXECUTIVE COMPENSATION.
None of our executive officers has received any
cash (or non-cash) compensation for services rendered to us.
We have granted two of our former
independent directors, Messrs. Tompsett and Zilber, an option each to purchase 40,000 class A ordinary shares at an exercise price
of $10.00 per share, which will vest upon the consummation of our initial business combination and will expire five years after the
date on which it first became exercisable. All of the options that we granted to our directors provide for vesting in full if such
individuals are not retained by us (or any successor entity resulting from our initial business combination) upon the consummation
of our initial business combination. Further, our compensation committee has approved the transfers by our sponsor of (a) 15,000
founder shares to each of Mr. Zilber, a former director, and Mr. Tourevski and (b) 20,000 founder shares to Mr. Tompsett, a former
director, as additional compensation, which transfers will take place prior to the closing of our initial business combination. Both
the founder shares and the options granted to our directors are subject to forfeiture in the event a director ceases to serve on our
board prior to the closing of a business combination. Accordingly, the options and founder shares were forfeited by Messrs. Tompsett
and Zilber upon their resignations in November 2023.
In addition, our sponsor, executive officers
and directors, or any of their respective affiliates are reimbursed for any out-of-pocket expenses incurred in connection with activities
on our behalf such as identifying potential target businesses and performing due diligence on suitable business combinations. Our audit
committee reviews on a quarterly basis all payments that were made to our sponsor, officers or directors, or our or their affiliates.
After the completion of our initial business
combination, directors or members of our management team who remain with us may be paid consulting or management fees from the combined
company. All of these fees will be fully disclosed to shareholders, to the extent then known, in the tender offer materials or proxy
solicitation materials furnished to our shareholders in connection with a proposed business combination. We have not established any
limit on the amount of such fees that may be paid by the combined company to our directors or members of management. It is unlikely the
amount of such compensation will be known at the time of the proposed business combination because the directors of the post-combination
business will be responsible for determining executive officer and director compensation. Any compensation to be paid to our executive
officers will be determined, or recommended to the board of directors for determination, either by a compensation committee constituted
solely of independent directors or by a majority of the independent directors on our board of directors.
We do not intend to take any action to ensure
that members of our management team maintain their positions with us after the consummation of our initial business combination, although
it is possible that some or all of our executive officers and directors may negotiate employment or consulting arrangements to remain
with us after our initial business combination. The existence or terms of any such employment or consulting arrangements to retain their
positions with us may influence our management’s motivation in identifying or selecting a target business but we do not believe
that the ability of our management to remain with us after the consummation of our initial business combination will be a determining
factor in our decision to proceed with any potential business combination. We are not party to any agreements with our executive officers
and directors that provide for benefits upon termination of employment.
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS.
The following table sets forth information regarding
beneficial ownership of our ordinary shares as of April 12, 2024 by (i) each of our executive officers and directors; (ii) all of our
executive officers and directors as a group; and (iii) each person who is known by us to beneficially own more than 5% of our ordinary
shares. Unless otherwise specified, the address of each of the persons set forth below is in care of our company, 850 Library Avenue, Suite
204, Newark, DE 19715.
Name and Address of Beneficial Owner | |
Title of Class | |
Amount and
Nature of
Beneficial
Ownership(1) | | |
Percent of
Voting
Stock(2) | |
Dimitri Elkin, Chief Executive Officer(3) | |
Class A Ordinary Shares | |
| 6,250,000 | | |
| 79.92 | % |
Konstantin Tourevski, Chairman of the Board | |
Class A Ordinary Shares | |
| - | | |
| * | |
Jonathan D. Morris, Director(4) | |
Class A Ordinary Shares | |
| 50,000 | | |
| * | |
Gregory D. Nelson, Director(4) | |
Class A Ordinary Shares | |
| 50,000 | | |
| * | |
All executive officers and directors (4 persons) | |
Class A Ordinary Shares | |
| 6,250,000 | | |
| 79.92 | % |
Quadro Sponsor LLC(3) | |
Class A Ordinary Shares | |
| 6,250,000 | | |
| 79.92 | % |
| (1) | Beneficial ownership is determined in
accordance with SEC rules and generally includes voting or investment power with respect
to securities. For purposes of this table, a person or group of persons is deemed to have
“beneficial ownership” of any shares that such person or any member of such group
has the right to acquire within sixty (60) days. For purposes of computing the percentage
of outstanding shares held by each person or group of persons named above, any shares that
such person or persons has the right to acquire within sixty (60) days of the date set forth
above are deemed to be outstanding for such person, but not deemed to be outstanding for
the purpose of computing the percentage ownership of any other person. The inclusion herein
of any shares listed as beneficially owned does not constitute an admission of beneficial
ownership by any person. |
| (2) | Based on 7,820,680 class A ordinary shares issued and outstanding as
of April 12, 2024. |
| (3) | Represents founder shares held by our
sponsor. According to a Schedule 13D/A filed with the SEC on February 24, 2023, Quadro
IH and Twelve Seas Management Company LLC, or Twelve Seas, are the two managing members of
our sponsor and may therefore be deemed to be the beneficial owners of the securities held
by our sponsor and to have shared voting and dispositive control over such securities. Messrs.
Dimitri Elkin and Giedrius Pukas each has control over the voting and investment decisions
made by Twelve Seas and Quadro IH, respectively, and as such may be deemed to have beneficial
ownership over such securities. The business address of our sponsor is 228 Park Avenue S.,
Suite 89898, New York, NY 10003. The business address of Quadro IH is DMCC Business
Centre, 3029, Dubai, UAE. The business address of Twelve Seas is 228 Park Avenue S.,
Suite 89898, New York, NY 10003. The business address of Mr. Elkin is 2685
Nottingham Avenue, Los Angeles, CA 90027. The business address of Mr. Pukas is
DMCC Business Centre, 3029, Dubai, UAE. |
| (4) | Our sponsor has granted each of Jonathan
D. Morris and Gregory D. Nelson 50,000 membership interests of our sponsor, which entitle
them to receive 50,000 class A ordinary shares currently held by our sponsor upon the closing
of the BCA. |
Except pursuant to the BCA, we do not currently
have any arrangements which if consummated may result in a change of control of our company.
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE.
Transactions with Related Persons
The following includes a summary of transactions
since the beginning of our 2022 fiscal year, or any currently proposed transaction, in which we were or are to be a participant and the
amount involved exceeded or exceeds the lesser of $120,000 or one percent of the average of our total assets at year-end for the last
two completed fiscal years, and in which any related person had or will have a direct or indirect material interest (other than compensation
described under Item 11 “Executive Compensation” above). We believe the terms obtained or consideration that we paid
or received, as applicable, in connection with the transactions described below were comparable to terms available or the amounts that
would be paid or received, as applicable, in arm’s-length transactions.
Founder Shares
On September 21, 2020, we issued 4,812,500 founder
shares to our prior sponsor, which were issued in exchange for the payment of $25,000 for certain expenses on behalf of our company.
On January 25, 2021, we effected a share dividend of 1,437,500 shares with respect to the founder, resulting in an aggregate of 6,250,000
founder shares outstanding.
On June 15, 2022, the prior sponsor transferred
all 6,250,000 founder shares to our sponsor. Our Sponsor agreed not to transfer, assign or sell any of its founder shares until the earlier
to occur of (i) one year after the date of the consummation of the initial business combination, or (ii) earlier if, subsequent to the
initial business combination, (x) the last reported sale price of the class A ordinary shares equals or exceeds $12.00 per share (as
adjusted for share splits, share dividends, reorganizations and recapitalizations) for any 20 trading days within any 30-trading day
period commencing at least 150 days after the initial business combination or (y) we consummate a subsequent liquidation, merger, stock
exchange or other similar transaction which results in all of the shareholders having the right to exchange their ordinary shares for
cash, securities or other property.
Related Party Loan
On April 13, 2022, we issued an unsecured promissory note in the amount
of up to $200,000 to our prior sponsor, which was amended and restated on May 25, 2022 to increase the principal amount to $400,000.
This note bears no interest and was due on June 7, 2023. On June 30, 2022, our prior sponsor assigned all of its rights and obligations
under this note to our sponsor. On June 7, 2023, this note was amended and restated to extend the maturity date to August 20, 2024. As
of December 31, 2023, we have fully drawn $400,000 under this note. As of December 31, 2023 and 2022, approximately $400,000 and
$319,000 were outstanding under this note, respectively.
Extension Loans
On February 20, 2023, we held an extraordinary
general meeting at which the shareholders approved an extension of the date by which we must consummate an initial business combination
to April 22, 2023, and to allow our board, without another shareholder vote, to extend such date on a monthly basis up to seven times
for an additional one month each time until November 22, 2023. In connection with this extension, our sponsor or its designees contributed
to us as a loan an initial contribution of $120,000 in February 2023 for the portion of the extension ending on April 22, 2023. Our sponsor
also agreed to loan extension contributions of $60,000 per month for each subsequent calendar month (commencing on April 22, 2023 and
on the 22nd day of each subsequent month) until November 22, 2023, or portion thereof, that is needed to complete an initial business
combination, which amount will be deposited into the trust account. As of December 31, 2023, our sponsor or its affiliates have loaned
$470,000 in connection with this extension.
Related Party Advance
For the year ended December 31, 2023, our sponsor
paid $666,760 of expenses on behalf our company.
Director Independence
Nasdaq listing standards require that a majority
of our board of directors be independent. An “independent director” is defined generally as a person other than an officer
or employee of a company or its subsidiaries or any other individual having a relationship which, in the opinion of such company’s
board of directors, would interfere with the director’s exercise of independent judgment in carrying out the responsibilities of
a director. Our board of directors has determined that all of our directors qualify as an “independent director” as defined
in the Nasdaq listing standards and applicable SEC rules. Our independent directors have regularly scheduled meetings at which only independent
directors are present.
ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES.
The following is a summary of the fees billed
to us for professional services rendered for the fiscal years ended December 31, 2023 and 2022.
| |
Year Ended December 31, | |
| |
2023 | | |
2022 | |
Audit Fees | |
$ | 74,620 | | |
$ | 63,081 | |
Audit-Related Fees | |
| - | | |
| - | |
Tax Fees | |
| - | | |
| - | |
All Other Fees | |
| - | | |
| - | |
TOTAL | |
$ | 74,620 | | |
$ | 63,081 | |
“Audit Fees” consisted of fees billed
for professional services rendered by the principal accountant for the audit of our annual financial statements and review of the financial
statements included in our Form 10-K and 10-Q or services that are normally provided by the accountant in connection with statutory and
regulatory filings or engagements.
“Audit-Related Fees” consisted of
fees billed for assurance and related services by the principal accountant that were reasonably related to the performance of the audit
or review of our financial statements and are not reported under the paragraph captioned “Audit Fees” above.
“Tax Fees” consisted of fees billed
for professional services rendered by the principal accountant for tax returns preparation.
“All Other Fees” consisted of fees
billed for products and services provided by the principal accountant, other than the services reported above under other captions of
this Item 14.
Pre-Approval Policies and Procedures
Under the Sarbanes-Oxley Act of 2002, all audit
and non-audit services performed by our auditors must be approved in advance by our board of directors to assure that such services do
not impair the auditors’ independence from us. In accordance with its policies and procedures, our board of directors pre-approved
the audit service performed by WithumSmith+Brown, PC for our financial statements as of and for the year ended December 31, 2023.
PART IV
ITEM 15. EXHIBIT AND FINANCIAL STATEMENT SCHEDULES.
| (a) | List of Documents Filed as a Part of This Report: |
| (1) | Index to Financial Statements: |
| (2) | Index to Financial
Statement Schedules: |
All schedules have been omitted because the required information
is included in the financial statements or the notes thereto, or because it is not required.
See exhibits listed under Part (b) below.
Exhibit No. |
|
Description |
3.1 |
|
Second Amended and Restated Memorandum and Articles of Association (incorporated by reference to Exhibit 3.1 to the Annual Report on Form 10-K filed on April 18, 2023) |
3.2* |
|
Amendment to Second Amended and Restated Memorandum and Articles of Association |
4.1* |
|
Description of Securities of Quadro Acquisition One Corp. |
4.2 |
|
Warrant Agreement, dated February 17, 2021, between Quadro Acquisition One Corp. and Continental Stock Transfer & Trust Company (incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K filed on February 23, 2021) |
10.1 |
|
Business Combination Agreement dated January 12, 2024, by and among Quadro Acquisition One Corp., Quadro Merger Sub Inc., NHC Holdings II, Inc., NHC Merger Sub, Inc., Global Growth Holdings, LLC, and Greg Lindberg (incorporated by reference to Exhibit 2.1 to the Current Report on Form 8-K filed on January 17, 2024) |
10.2 |
|
Sponsor Support Agreement dated January 12, 2024, by and among Quadro Acquisition One Corp., NHC Holdings II, Inc., and Quadro Sponsor LLC (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed on January 17, 2024) |
10.3 |
|
Investment Management Trust Agreement, dated February 17, 2021, between Quadro Acquisition One Corp. Continental Stock Transfer & Trust Company (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed on February 23, 2021) |
10.4 |
|
Registration Rights Agreement, dated February 17, 2021, between Quadro Acquisition One Corp. and Kismet Sponsor Limited (incorporated by reference to Exhibit 10.3 to the Current Report on Form 8-K filed on February 23, 2021) |
10.5 |
|
Letter Agreement, dated February 17, 2021, between Quadro Acquisition One Corp. and Kismet Sponsor Limited (incorporated by reference to Exhibit 10.6 to the Current Report on Form 8-K filed on February 23, 2021) |
ITEM 16. FORM 10-K SUMMARY.
Not applicable.
QUADRO
ACQUISITION ONE CORP.
INDEX
TO FINANCIAL STATEMENTS
Report
of Independent Registered Public Accounting Firm
To
the Shareholders and the Board of Directors of
Quadro
Acquisition One Corp.
Opinion
on the Financial Statements
We
have audited the accompanying balance sheets of Quadro Acquisition One Corp. (the “Company”) as of December 31, 2023 and
2022, the related statements of operations, changes in shareholders’ deficit and cash flows for the years then ended, and the related
notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly,
in all material respects, the financial position of the Company as of December 31, 2023 and 2022, and the results of its operations and
its cash flows for the years then ended, in conformity with accounting principles generally accepted in the United States of America.
Going
Concern
The
accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note
1 to the financial statements, if the Company is unable to raise additional funds to alleviate liquidity needs and complete a business
combination by April 22, 2024 then the Company will cease all operations except for the purpose of liquidating. The liquidity condition
and date for mandatory liquidation and subsequent dissolution raise substantial doubt about the Company’s ability to continue as
a going concern. Management’s plans in regard to these matters are also described in Note 1. The financial statements do not include
any adjustments that might result from the outcome of this uncertainty.
Basis
for Opinion
These
financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s
financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board
(United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal
securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We
conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain
reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company
is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits
we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion
on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.
Our
audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error
or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding
the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant
estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits
provide a reasonable basis for our opinion.
/s/
WithumSmith+Brown, PC
We
have served as the Company’s auditor since 2020.
New
York, New York
April
17, 2024
PCAOB
ID Number 100
QUADRO ACQUISITION ONE CORP.
BALANCE SHEETS
| |
December 31,
2023 | | |
December 31,
2022 | |
Assets | |
| | |
| |
Current assets: | |
| | |
| |
Cash | |
$ | — | | |
$ | 964 | |
Prepaid expenses | |
| 833 | | |
| 33,402 | |
Total current assets | |
| 833 | | |
| 34,366 | |
| |
| | | |
| | |
Cash and investments held in Trust Account | |
| 16,962,817 | | |
| 233,304,515 | |
Total Assets | |
$ | 16,963,650 | | |
$ | 233,338,881 | |
| |
| | | |
| | |
Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit | |
| | | |
| | |
Current liabilities: | |
| | | |
| | |
Accounts payable | |
$ | 369,604 | | |
$ | 107,269 | |
Accrued expenses | |
| 119,079 | | |
| 29,718 | |
Loans payable | |
| 110,000 | | |
| — | |
Extension loan - related party | |
| 470,000 | | |
| — | |
Advances from related party | |
| 666,760 | | |
| — | |
Note payable - related party | |
| 400,000 | | |
| 318,700 | |
Total current liabilities | |
| 2,135,443 | | |
| 455,687 | |
Derivative liabilities - warrants | |
| 241,334 | | |
| 30,167 | |
Deferred underwriting commissions | |
| 2,817,500 | | |
| 2,817,500 | |
Total liabilities | |
| 5,194,277 | | |
| 3,303,354 | |
| |
| | | |
| | |
Commitments and Contingencies | |
| | | |
| | |
| |
| | | |
| | |
Class A ordinary shares subject to possible redemption, $0.001 par value; 1,570,680 and 23,000,000 shares at approximately $10.74 and $10.14 per share redemption value as of December 31, 2023 and 2022, respectively | |
| 16,862,817 | | |
| 233,204,515 | |
| |
| | | |
| | |
Shareholders’ Deficit: | |
| | | |
| | |
Class A ordinary shares, $0.001 par value; 200,000,000 shares authorized; 6,250,000 and 0 non-redeemable shares issued or outstanding as of December 31, 2023 and 2022, respectively (net of 1,570,680 and 23,000,000 shares subject to possible redemption as of December 31, 2023 and 2022, respectively) | |
| 6,250 | | |
| — | |
Class B ordinary shares, $0.001 par value; 10,000,000 shares authorized; 0 and 6,250,000 shares issued and outstanding as of December 31, 2023 and 2022, respectively | |
| — | | |
| 6,250 | |
Accumulated deficit | |
| (5,099,694 | ) | |
| (3,175,238 | ) |
Total shareholders’ deficit | |
| (5,093,444 | ) | |
| (3,168,988 | ) |
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit | |
$ | 16,963,650 | | |
$ | 233,338,881 | |
The
accompanying notes are an integral part of these financial statements.
QUADRO ACQUISITION ONE CORP.
STATEMENTS OF OPERATIONS
| |
For the Years Ended December 31, | |
| |
2023 | | |
2022 | |
Operating expenses | |
| | |
| |
General and administrative expenses | |
$ | 1,146,648 | | |
$ | 613,919 | |
Loss from operations | |
| (1,146,648 | ) | |
| (613,919 | ) |
| |
| | | |
| | |
Change in fair value of derivative assets and liabilities | |
| (211,167 | ) | |
| 5,914,197 | |
Gain from extinguishment of deferred underwriting commissions allocated to derivative warrant liabilities | |
| — | | |
| 155,283 | |
Income from cash and investments held in Trust Account | |
| 2,142,441 | | |
| 3,266,003 | |
Net income | |
$ | 784,626 | | |
$ | 8,721,564 | |
| |
| | | |
| | |
Weighted average shares outstanding of Class A ordinary shares, basic and diluted | |
| 11,071,221 | | |
| 23,000,000 | |
| |
| | | |
| | |
Basic and diluted net income per share, Class A ordinary shares | |
$ | 0.07 | | |
$ | 0.30 | |
| |
| | | |
| | |
Weighted average shares outstanding of Class B ordinary shares, basic and diluted | |
| 530,822 | | |
| 6,250,000 | |
| |
| | | |
| | |
Basic and diluted net income per share, Class B ordinary shares | |
$ | 0.07 | | |
$ | 0.30 | |
The
accompanying notes are an integral part of these financial statements.
QUADRO ACQUISITION ONE CORP.
STATEMENTS OF CHANGES IN SHAREHOLDERS’ DEFICIT
FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022
| |
Ordinary Shares | | |
Additional | | |
| | |
Total | |
| |
Class A | | |
Class B | | |
Paid-in | | |
Accumulated | | |
Shareholders’ | |
| |
Shares | | |
Amount | | |
Shares | | |
Amount | | |
Capital | | |
Deficit | | |
Deficit | |
Balance - December 31, 2021 | |
| — | | |
$ | — | | |
| 6,250,000 | | |
$ | 6,250 | | |
$ | — | | |
$ | (13,769,504 | ) | |
$ | (13,763,254 | ) |
Adjustment for accretion on
Class A ordinary shares subject to possible redemption | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 1,872,702 | | |
| 1,872,702 | |
Net income | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 8,721,564 | | |
| 8,721,564 | |
Balance - December 31, 2022 | |
| — | | |
$ | — | | |
| 6,250,000 | | |
$ | 6,250 | | |
$ | — | | |
$ | (3,175,238 | ) | |
$ | (3,168,988 | ) |
Conversion of Class B ordinary shares to Class A ordinary shares | |
| 6,250,000 | | |
| 6,250 | | |
| (6,250,000 | ) | |
| (6,250 | ) | |
| — | | |
| — | | |
| — | |
Adjustment for accretion on
Class A ordinary shares subject to possible redemption | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (2,709,082 | ) | |
| (2,709,082 | ) |
Net income | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 784,626 | | |
| 784,626 | |
Balance - December 31, 2023 | |
| 6,250,000 | | |
$ | 6,250 | | |
| — | | |
$ | — | | |
$ | — | | |
$ | (5,099,694 | ) | |
$ | (5,093,444 | ) |
The
accompanying notes are an integral part of these financial statements.
QUADRO
ACQUISITION ONE CORP.
STATEMENTS OF CASH FLOWS
| |
For the Years Ended December 31, | |
| |
2023 | | |
2022 | |
Cash Flows from Operating Activities: | |
| | |
| |
Net income | |
$ | 784,626 | | |
$ | 8,721,564 | |
Adjustments to reconcile net income to net cash used in operating activities: | |
| | | |
| | |
Change in fair value of derivative assets and liabilities | |
| 211,167 | | |
| (5,914,197 | ) |
Gain from extinguishment of deferred underwriting commissions allocated to derivative warrant liabilities | |
| — | | |
| (155,283 | ) |
Income from cash and investments held in Trust Account | |
| (2,142,441 | ) | |
| (3,266,003 | ) |
Changes in operating assets and liabilities: | |
| | | |
| | |
Prepaid expenses | |
| 32,569 | | |
| 282,250 | |
Accounts payable | |
| 279,656 | | |
| 67,954 | |
Note payable - related party | |
| (17,321 | ) | |
| (17,321 | ) |
Accrued expenses | |
| 89,361 | | |
| (30,376 | ) |
Net cash used in operating activities | |
| (762,383 | ) | |
| (311,412 | ) |
| |
| | | |
| | |
Cash Flows from Investing Activities: | |
| | | |
| | |
Cash deposited in Trust Account | |
| (566,641 | ) | |
| — | |
Cash withdrawn from Trust Account in connection with redemptions | |
| 219,050,780 | | |
| — | |
Net cash provided by investing activities | |
| 218,484,139 | | |
| — | |
| |
| | | |
| | |
Cash Flows from Financing Activities: | |
| | | |
| | |
Proceeds from note payable to related party | |
| 81,300 | | |
| 318,700 | |
Proceeds from advance from related party | |
| 666,760 | | |
| — | |
Proceeds from extension loan | |
| 470,000 | | |
| — | |
Redemption of Ordinary shares | |
| (219,050,780 | ) | |
| — | |
Proceeds from loans payable | |
| 110,000 | | |
| — | |
Offering costs paid | |
| — | | |
| (70,000 | ) |
Net cash (used in) provided by financing activities | |
| (217,722,720 | ) | |
| 248,700 | |
| |
| | | |
| | |
Net change in cash | |
| (964 | ) | |
| (62,712 | ) |
Cash - beginning of the year | |
| 964 | | |
| 63,676 | |
Cash - end of the year | |
$ | — | | |
$ | 964 | |
| |
| | | |
| | |
Supplemental disclosure of noncash activities: | |
| | | |
| | |
Extinguishment of deferred underwriting commissions allocated to public shares | |
$ | — | | |
$ | 5,077,217 | |
The
accompanying notes are an integral part of these financial statements.
QUADRO ACQUISITION ONE
CORP.
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2023 AND 2022
Note
1 - Description of Organization, Business Operations and Going Concern
Quadro Acquisition One Corp., formerly Kismet
Acquisition Two Corp. (the “Company”), is a blank check company incorporated as a Cayman Islands exempted company on September
15, 2020. The Company was incorporated for the purpose of acquiring, engaging in a share exchange, share reconstruction and amalgamation,
contractual control arrangement with, purchasing all or substantially all of the assets of, or engaging in any other similar initial business
combination with one or more businesses or entities (“Business Combination”).
As
of December 31, 2023, the Company had not yet commenced operations. All activity for the period from September 15, 2020 (inception) through
December 31, 2023, relates to the Company’s formation and the initial public offering (the “Initial Public Offering”),
which is described below, and since the Initial Public Offering, the search for a potential target. The Company will not generate any
operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating
income in the form of interest income on investments held in the Trust Account (as defined below) from the proceeds derived from the
Initial Public Offering and the sale of the Private Placement Warrants (as defined below).
The
Company’s sponsor was Kismet Sponsor Limited, a British Virgin Islands company (the “Prior Sponsor”). The Registration
Statement for the Initial Public Offering on Form S-1 initially filed with the U.S. Securities and Exchange Commission (“SEC”)
on January 26, 2021, as amended (File No. 333- 252419), was declared effective on February 17, 2021 (the “Registration Statement”).
On February 22, 2021, the Company consummated its Initial Public Offering of 23,000,000 units (the “Units” and, with respect
to the Class A ordinary shares included in the Units sold, the “Public Shares,” and, with respect to the warrants included
in the Units sold, the “Public Warrants”), at $10.00 per Unit, generating gross proceeds of $230.0 million, and incurring
offering costs of approximately $13.1 million, of which approximately $8.1 million was for deferred underwriting commissions (see Note
6).
Simultaneously
with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 4,400,000
warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”), at a price
of $1.50 per Private Placement Warrant with the Prior Sponsor, generating gross proceeds of $6.6 million, and incurring offering costs
of approximately $7,000 (see Note 4).
On
June 15, 2022, the Prior Sponsor transferred 6,250,000 Class B ordinary shares and 4,400,000 Private Placement Warrants held by the Prior
Sponsor to Quadro Sponsor LLC, a Delaware limited liability company and wholly owned subsidiary of the Prior Sponsor (the “Sponsor”).
On June 30, 2022, the Prior Sponsor transferred all the membership interests of the Sponsor to Quadro IH DMCC (“Quadro”),
a company registered in Dubai Multi Commodities Centre in the United Arab Emirates (the “Sponsor Transaction”). In connection
with the Sponsor Transaction, the Prior Sponsor also assigned to the Sponsor all of its rights and obligations under the (i) Letter Agreement,
dated as of February 17, 2021, (ii) Registration Rights Agreement (as defined in Note 6) and (iii) Promissory Note (as defined below).
In addition, the Company and Kismet Capital Group LLC (“Kismet LLC”) mutually terminated the Administrative Services Agreement,
dated February 17, 2021 (the “Administrative Services Agreement”). As a result, the Company is no longer obligated to pay
a $10,000 monthly fee to Kismet LLC pursuant to the Administrative Services Agreement.
Upon
the closing of the Initial Public Offering and the Private Placement, $230.0 million ($10.00 per Unit) of the net proceeds
of the Initial Public Offering and certain of the proceeds of the Private Placement were placed in a trust account (“Trust Account”)
with Continental Stock Transfer & Trust Company (“Continental”) acting as trustee and invested in U.S. government treasury
obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment
Company Act of 1940 (the “Investment Company Act”), which invest only in direct U.S. government treasury obligations, as
determined by the Company, until the earlier of (i) the completion of a Business Combination and (ii) the distribution of the Trust Account
as described below.
QUADRO
ACQUISITION ONE CORP.
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2023 AND 2022
The
Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering
and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward
consummating a Business Combination. The Company’s initial Business Combination must be with one or more operating businesses or
assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (excluding the deferred underwriting
commissions and taxes payable, if any, on the income accrued on the Trust Account) at the time the Company signs a definitive agreement
in connection with the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction
company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest
in the target sufficient for it not to be required to register as an investment company under the Investment Company Act.
The Company will provide its holders of the Public
Shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion
of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means
of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender
offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for
a pro rata portion of the amount then in the Trust Account (initially at $10.00 per share, plus any pro rata interest earned on the
funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The per-share amount to be distributed
to Public Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay
to the underwriters (see Note 6). These Public Shares were recorded at a redemption value and classified as temporary equity upon the
completion of the Initial Public Offering, in accordance with the Financial Accounting Standards Board (“FASB”) Accounting
Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity” (“ASC 480”). In
such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon
such consummation of a Business Combination and a majority of the shares are voted in favor of the Business Combination. If a shareholder
vote is not required by law and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company
will, pursuant to the Company’s second amended and restated memorandum and articles of association, as amended (the “Memorandum
and Articles of Association”), conduct the redemptions pursuant to the tender offer rules of the SEC, and file tender offer documents
with the SEC prior to completing a Business Combination. If, however, a shareholder approval of the transactions is required by law, or
the Company decides to obtain shareholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction
with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Shareholder
may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks
shareholder approval in connection with a Business Combination, the holder of the Founder Shares (as defined in Note 5) prior to the Initial
Public Offering (the “Initial Shareholder”) agreed to vote its Founder Shares and any Public Shares purchased during or after
the Initial Public Offering in favor of a Business Combination. In addition, the Initial Shareholder agreed to waive its redemption rights
with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination.
Notwithstanding
the foregoing, the Memorandum and Articles of Association provides that a Public Shareholder, together with any affiliate of such shareholder
or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities
Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more
than an aggregate of 20% or more of the Class A ordinary shares sold in the Initial Public Offering, without the prior consent of
the Company.
The
Sponsor and the Company’s executive officers, directors and director nominees agreed not to propose an amendment to the Memorandum
and Articles of Association that would affect the substance or timing of the Company’s obligation to provide for the redemption
of its Public Shares in connection with a Business Combination or to redeem 100% of its Public Shares if the Company does not complete
a Business Combination, unless the Company provides the Public Shareholders with the opportunity to redeem their Class A ordinary shares
in conjunction with any such amendment.
QUADRO
ACQUISITION ONE CORP.
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2023 AND 2022
The
Company initially had until February 22, 2023 to complete the initial Business Combination. On February 20, 2023, the Company held an
Extraordinary General Meeting at which the shareholders of the Company approved an extension of the date by which the Company must consummate
an initial Business Combination to April 22, 2023 and to allow the Company’s board, without another shareholder vote, to extend
such date on a monthly basis up to seven times for an additional one month each time until November 22, 2023 (the “Extension”).
On November 20, 2023, the Company held an Extraordinary General Meeting at which the shareholders of the Company approved an extension
of the date by which the Company must consummate an initial Business Combination without another shareholder vote to May 22, 2024.
In
connection with the Extension, shareholders holding 20,451,847 Class A ordinary shares exercised their right to redeem those shares for
cash at an approximate price of $10.20 per share for an aggregate of approximately $208.5 million.
In
connection with the vote to approve the extension on November 20, 2023, the holders of 977,473 Class A ordinary shares exercised their
right to redeem those shares for cash at an approximate price of $10.77 per share for an aggregate of approximately $10.526 million.
In
connection with the Extension, the Sponsor or its designees contributed to the Company as a loan the initial contribution of $120,000
in February 2023 for the portion of the extension ending on April 22, 2023. The Sponsor also agreed to loan the Company extension contributions
of $60,000 per month for each subsequent calendar month (commencing on April 22, 2023 and on the 22nd day of each subsequent month) until
November 22, 2023, or portion thereof, that is needed to complete an initial Business Combination, which amount will be deposited into
the Trust Account. On each of May 11, 2023 and June 6, 2023, the Company deposited an additional $60,000, for an aggregate of $120,000
into the Trust Account to extend the date by which it has to consummate an initial Business Combination to June 22, 2023. On each of
June 30, 2023 and July 11, 2023, the Company deposited an additional $30,000, for an aggregate of $60,000 into the Trust Account to extend
the date by which it has to consummate an initial Business Combination to July 22, 2023. On August 7, 2023, the Company deposited an
additional $60,000 into the Trust Account to extend the date by which it has to consummate an initial business combination to August
22, 2023. On October 12, 2023, the Company deposited an additional $60,000 into the Trust Account to extend the date by which it has
to consummate an initial business combination to September 22, 2023. On December 7, 2023, the Company deposited an additional $120,000
into the Trust Account to extend the date by which it has to consummate an initial business combination to November 22, 2023. As of the
filing of these financial statements, the Company has extended through April 22, 2024 with the commitment to deposit a total of $200,000
to cover extension deposits for December 22, 2023 and April 22, 2024.
On
January 31, 2023, the Company issued an aggregate of 6,250,000 Class A ordinary shares to the Sponsor upon the conversion of an equal
number of Class B ordinary shares held by the Sponsor. The 6,250,000 Class A ordinary shares issued in connection with such conversion
are subject to the same restrictions as applied to the Class B ordinary shares before the conversion, including, among others, certain
transfer restrictions, waiver of redemption rights and the obligation to vote in favor of an initial Business Combination as described
in the prospectus for Initial Public Offering.
On
February 10, 2023, the Company instructed Continental to liquidate the investments held in the Trust Account and instead to
hold the funds in the Trust Account in an interest-bearing demand deposit account at Morgan Stanley, with Continental continuing to act
as trustee, until the earlier of the consummation of the Company’s initial Business Combination or the Company’s liquidation.
As a result, following the liquidation of investments in the Trust Account, the remaining proceeds from the Initial Public
Offering and Private Placement are no longer invested in U.S. government securities or money market funds.
QUADRO
ACQUISITION ONE CORP.
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2023 AND 2022
If
the Company is unable to complete a Business Combination by April 22, 2024 (or May 22, 2024 if the Company fully extends the time to
complete a Business Combination, the “Combination Period”), the Company will (i) cease all operations except for the purpose
of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem all Public Shares then
outstanding at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including any
amounts representing interest earned on the Trust Account, less any interest released to the Company for the payment of taxes, if any
(and less up to $100,000 in interest reserved for expenses in connection with the Company’s dissolution), divided by the number
of then outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including
the right to receive further liquidation distributions, if any), and (iii) as promptly as reasonably possible following such redemption,
subject to the approval of the remaining shareholders and the Company’s board of directors, liquidate and dissolve, subject in
the case of clauses (ii) and (iii) to the Company’s obligations under Cayman Islands law to provide for claims of creditors and
the requirements of other applicable law.
In
connection with the redemption of 100% of the Company’s outstanding Public Shares for a portion of the funds held in the Trust
Account, each holder will receive a full pro rata portion of the amount then in the Trust Account, plus any pro rata interest earned
on the funds held in the Trust Account and not previously released to the Company to pay the Company’s taxes payable (less up to
$100,000 of interest to pay dissolution expenses).
The
Initial Shareholder agreed to waive its liquidation rights with respect to the Founder Shares if the Company fails to complete a Business
Combination within the Combination Period. However, if the Initial Shareholder should acquire Public Shares in or after the Initial Public
Offering, it will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails
to complete a Business Combination within the Combination Period. The underwriters agreed to waive their rights to their deferred underwriting
commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination
Period, and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the
redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets
remaining available for distribution (including Trust Account assets) will be only $10.00 per share initially held in the Trust Account.
In order to protect the amounts held in the Trust Account, the Sponsor agreed that it will be liable to the Company if and to the extent
any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company
has entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the
amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held
in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value
of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target
business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable)
nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain
liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event
that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any
liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust
Account due to claims of creditors by endeavoring to have vendors, service providers (except the Company’s independent registered
public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with
the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.
On
February 20, 2024, the Company received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, unless the
Company timely requested a hearing before the Nasdaq Hearings Panel, trading of the Company’s securities on Nasdaq would be suspended
due to the Company’s non-compliance with Nasdaq IM-5101-2, which requires that a special purpose acquisition company complete
one or more business combinations within 36 months of the effectiveness of its registration statement relating to its initial public
offering. The Company timely requested a hearing before the Nasdaq Hearings Panel, which resulted in a stay of any suspension or delisting
action pending the hearing. The hearing was held on March 26, 2024. At the hearing, the Company requested an extension until August 19,
2024 to allow it sufficient time to complete the proposed business combination described elsewhere in Note 11, which request was granted
by the Nasdaq Hearings Panel. Accordingly, trading of the Company’s securities will not be suspended if it completes the proposed
business combination by August 19, 2024.
Liquidity
and Going Concern
As
of December 31, 2023, the Company had $0 in its operating bank account and working capital deficit of approximately $2.1 million.
The Company’s liquidity needs to date have
been satisfied through a contribution of $25,000 from the Prior Sponsor to cover certain expenses in exchange for the issuance of
the Founder Shares, a loan of approximately $111,000 from the Prior Sponsor pursuant to a promissory note, and
a portion of the proceeds from the consummation of the Private Placement not held in the Trust Account. The Company repaid the promissory note
in full on February 24, 2021. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor
or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company
Working Capital Loans (as defined in Note 5). As of December 31, 2023 and 2022, there were no amounts outstanding under any Working Capital
Loans.
QUADRO
ACQUISITION ONE CORP.
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2023 AND 2022
On April 13, 2022, the Company issued an
unsecured promissory note in the amount of up to $200,000 to the Prior Sponsor, which was amended and restated on May 25, 2022
to increase the principal amount to $400,000 (the “Promissory Note”).The Promissory Note bears no interest and was due
and on June 7, 2023. On June 30, 2022, the Prior Sponsor assigned all of its rights and obligations under the Promissory Note to the
Sponsor in connection with the Sponsor Transaction. On June 7, 2023, the Promissory Note was amended and restated to extend the
maturity date to August 20, 2024. As of December 31, 2023, the Company has fully drawn $400,000 under the Promissory Note. As
of December 31, 2023 and 2022, approximately $400,000 and $319,000 were outstanding under the Promissory Note, respectively.
On November 17, 2023 the Company signed a non-binding
letter of intent (“LOI”) with New Degree Growth LLC (“NDG”) for a proposed transaction between the Company and
NDG. Included in the general terms and conditions of the LOI is a condition where NDG will assume the payment of the Company’s operating
expenses, including the service fees of the Company’s auditors, legal counsel, accountants, stock transfer agent and others, in
the amount of not more than $100,000 (one hundred thousand dollars) per month, including the payment of the Company’s monthly contribution
to the Trust Account. The expenses shall initially be paid a rate of $20,000 (twenty thousand dollars) per week, payable on every Monday
of the week beginning October 20, 2023, and payable into the account of the Sponsor, which is then transferred to the Company’s
account, with a catch up to the monthly rate after 90 days. In addition, within five business days upon the signing of the LOI by the
Company, NDG or its representatives agreed to make a deposit in the amount of $30,000 (thirty thousand dollars) into the Trust Account.
If after the signing of the LOI the Company unilaterally elects not to pursue the transaction, the Company will reimburse to NDG all amounts
paid to the Company. As of December 31, 2023, a total of $110,000 was advanced by NDG to the Company, which was reported as loans payable
in the accompanying balance sheet.
The Company may need to raise additional capital
through loans or additional investments from its Sponsor, its officers or directors or their affiliates. The Company’s officers,
directors and the Sponsor, or their affiliates, may, but are not obligated to, loan the Company funds, from time to time or at any time,
in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the
Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take
additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the
pursuit of a potential transaction, reducing overhead expenses, and extending the terms and due dates of certain accrued expenses and
other liabilities. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms,
if at all. In connection with the Company’s assessment of going concern considerations in accordance with FASB ASC Topic 205-40,
“Presentation of Financial Statements - Going Concern”, management has determined that the liquidity condition, mandatory
liquidation and subsequent dissolution raise substantial doubt about the Company’s ability to continue as a going concern. Management
continues to seek to complete a Business Combination prior to the mandatory liquidation date. No adjustments have been made to the carrying
amounts of assets or liabilities should the Company be required to liquidate after April 22, 2024 (or until May 22, 2024 if the Company
fully extends the Combination Period). The accompanying financial statements do not include any adjustment that might be necessary if
the Company is unable to continue as a going concern.
Note
2 - Basis of Presentation and Summary of Significant Accounting Policies
Basis
of Presentation
The
accompanying financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United
States of America (“GAAP”) and pursuant to the rules and regulations of the SEC.
Emerging
Growth Company
The
Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our
Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements
that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required
to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced
disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements
of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously
approved.
QUADRO
ACQUISITION ONE CORP.
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2023 AND 2022
Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with
the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected
not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application
dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time
private companies adopt the new or revised standard. This may make comparison of the accompanying financial statements with another public
company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition
period difficult or impossible because of the potential differences in accounting standards used.
Use
of Estimates
The
preparation of the accompanying financial statements in conformity with GAAP requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the reporting periods. Making estimates requires management to exercise
significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances
that existed at the date of the accompanying financial statements, which management considered in formulating its estimate, could change
in the near term due to one or more future confirming events. One of the more significant accounting estimates included in the accompanying
financial statements is the determination of the fair value of the derivative liabilities. Accordingly, the actual results could differ
from those estimates.
Cash
and Cash Equivalents
The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company had no cash equivalents as of December 31, 2023 and 2022.
Concentration
of Credit Risk
Financial
instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution,
which, regularly exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to
such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.
Cash
and Investments Held in the Trust Account
The
Company classifies its U.S. Treasury and equivalent securities as held to maturity in accordance with FASB ASC Topic 320, “Investments
– Debt and Equity Securities.” Held-to-maturity securities are those securities which the Company has the ability and intent
to hold until maturity. Held-to-maturity treasury securities are recorded at amortized cost on the accompanying balance sheets and adjusted
for the amortization or accretion of premiums or discounts.
At
December 31, 2023, substantially all of the assets held in the Trust Account were held in cash. At December 31, 2022, substantially all
of the assets held in the Trust Account were held in money market funds which invest primarily in U.S. Treasury securities. The money
market funds are presented at fair value within the accompanying balance sheets, and fair value of the investments in the Trust Account
is equal to the amortized cost basis of the money market funds.
Fair
Value of Financial Instruments
The fair value of the Company’s assets and
liabilities, which qualify as financial instruments under the FASB ASC Topic 820, “Fair Value Measurements,” equals or approximates
the carrying amounts represented in the balance sheets.
QUADRO
ACQUISITION ONE CORP.
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2023 AND 2022
Fair
Value Measurements
Fair
value is defined as the price that would be received for sale of an asset or paid for transfer of a liability in an orderly
transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes
inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical
assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist
of:
| ● | Level
1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments
in active markets; |
| ● | Level
2, defined as inputs other than quoted prices in active markets that are either directly
or indirectly observable such as quoted prices for similar instruments in active markets
or quoted prices for identical or similar instruments in markets that are not active; and |
| ● | Level
3, defined as unobservable inputs in which little or no market data exists, therefore requiring
an entity to develop its own assumptions, such as valuations derived from valuation techniques
in which one or more significant inputs or significant value drivers are unobservable. |
In
some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In
those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input
that is significant to the fair value measurement.
Derivative
Liabilities
The
Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates
all of its financial instruments, including issued warrants, to determine if such instruments are derivatives or contain features that
qualify as embedded derivatives, pursuant to ASC 480 and ASC 815-15. The classification of derivative instruments, including whether
such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.
The Company accounts for the Public Warrant, the
Private Placement Warrants and units that could have been issued in connection with a forward purchase agreement (the “Forward Purchase
Units”) as derivative liabilities in accordance with ASC 815-40. Accordingly, the Company recognizes the instruments as liabilities
at fair value and adjusts the instruments to fair value at the end of each reporting period. The liabilities are subject to re-measurement
at each balance sheet date until exercised, and any change in fair value of derivative liabilities is recognized in the Company’s
statements of operations. The fair value of Public Warrants was initially measured using Monte-Carlo simulation and has subsequently been
measured on the market price of such Public Warrants at each measurement date when separately listed and traded. The fair value of the
Private Placement Warrants was initially measured using Black-Scholes Option Pricing Model and has subsequently been measured using the
market value of the Public Warrants. The fair value of the Forward Purchase Units has been measured using the John C Hull’s Options,
Futures and Other Derivatives model at each measurement date.
Offering
Costs Associated with the Initial Public Offering
Offering costs consisted of legal, accounting,
underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering.
Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value
basis, compared to total proceeds received. Offering costs associated with derivative liabilities are expensed as incurred, and are presented
as non-operating expenses in the statements of operations in the period that the costs occurred. Offering costs associated with the Class
A ordinary shares were charged against the carrying value of the Class A ordinary shares upon the completion of the Initial Public Offering.
The Company classifies deferred underwriting commissions as non-current liabilities, as their liquidation is not reasonably expected to
require the use of current assets or require the creation of current liabilities.
QUADRO ACQUISITION ONE CORP.
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2023 AND 2022
Class
A Ordinary Shares Subject to Possible Redemption
The Company accounts for its Class A ordinary
shares subject to possible redemption in accordance with the guidance in ASC Topic 480, “Distinguishing Liabilities from Equity.”
Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value.
Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within
the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control)
are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s
Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject
to the occurrence of uncertain future events. Accordingly, as of December 31, 2023 and 2022, 1,570,680 and 23,000,000 Class A ordinary
shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ deficit section of the accompanying
balance sheets, respectively.
The
Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the Class A ordinary shares
subject to possible redemption to equal the redemption value at the end of each reporting period. This method would view the end of the
reporting period as if it were also the redemption date for the security. Effective with the closing of the Initial Public Offering,
the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in
capital (to the extent available) and accumulated deficit.
Share-Based
Compensation
The
Company complies with the accounting and disclosure requirement of ASC Topic 718, “Compensation – Stock
Compensation.” Share-based compensation to employees and non-employees is recognized over the requisite service period based
on the estimated grant-date fair value of the awards. Share-based awards with graded-vesting schedules are recognized on a
straight-line basis over the requisite service period for each separately vesting portion of the award. The Company recognizes the
expense for share-based compensation awards subject to performance-based milestone vesting over the remaining service period when
management determines that achievement of the milestone is probable. Management evaluates when the achievement of a
performance-based milestone is probable based on the expected satisfaction of the performance conditions at each reporting date.
Share-based compensation will be recognized in general and administrative expense in the statements of operations. The Company
issued option awards that contain both a performance condition and service condition. The option awards vest upon the consummation
of the initial Business Combination and will expire in five years after the date on which they first become exercisable. The Company
has determined that the consummation of an initial Business Combination is a performance condition subject to significant
uncertainty. As such, the achievement of the performance is not deemed to be probable of achievement until the consummation of the
event, and therefore no compensation has been recognized for the period from inception to December 31, 2023. The awards previously
issued were forfeited upon resignation of the recipients prior to the consummation of an initial Business Combination and there are
no such arrangements in existence as of December 31, 2023.
Income
Taxes
FASB ASC Topic 740, “Income Taxes,”
prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions
taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be
sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s
only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax
expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2023 and 2022. The
Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from
its position.
There is currently no taxation imposed on income
by the government of the Cayman Islands. In accordance with Cayman Islands federal income tax regulations, income taxes are not levied
on the Company. Consequently, income taxes are not reflected in the accompanying financial statements. The Company’s management
does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
QUADRO
ACQUISITION ONE CORP.
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2023 AND 2022
Net
Income per Ordinary Share
The
Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has
two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro
rata between the two classes of shares. Net income per ordinary share is calculated by dividing the net income by the weighted average
number of ordinary shares outstanding for the respective period.
The calculation of diluted net income per ordinary
share does not consider the effect of the Public Warrants or the Private Placement Warrants since their exercise is contingent upon future
events. As a result, diluted net income per share is the same as basic net income per share for the years ended December 31, 2023 and
2022. Accretion associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates
fair value.
The table below presents a reconciliation of the
numerator and denominator used to compute basic and diluted net income per share for each class of ordinary shares.
| |
For the Years Ended December 31, | |
| |
2023 | | |
2022 | |
| |
Class A | | |
Class B | | |
Class A | | |
Class B | |
Numerator: | |
| | |
| | |
| | |
| |
Allocation of net income – basic and diluted | |
$ | 748,727 | | |
$ | 35,899 | | |
$ | 6,857,982 | | |
$ | 1,863,582 | |
| |
| | | |
| | | |
| | | |
| | |
Denominator: | |
| | | |
| | | |
| | | |
| | |
Weighted average ordinary shares outstanding, basic and diluted | |
| 11,071,221 | | |
| 530,822 | | |
| 23,000,000 | | |
| 6,250,000 | |
| |
| | | |
| | | |
| | | |
| | |
Basic and diluted net income per ordinary share | |
$ | 0.07 | | |
$ | 0.07 | | |
$ | 0.30 | | |
$ | 0.30 | |
Recent
Accounting Pronouncements
The
Company’s management does not believe that any recently issued, but not yet effective, accounting standards updates, if currently
adopted, would have a material effect on the accompanying financial statements.
Note
3 - Initial Public Offering
On
February 22, 2021, the Company consummated its Initial Public Offering of 23,000,000 Units, at $10.00 per Unit, generating gross proceeds
of $230.0 million, and incurring offering costs of approximately $13.1 million, of which approximately $8.1 million was for deferred
underwriting commissions.
Each
Unit consists of one Class A ordinary share and one-third of one Public Warrant. Each whole Public Warrant will entitle the holder to
purchase one Class A ordinary share at an exercise price of $11.50 per share, subject to adjustment (see Note 7).
Note
4 - Private Placement
Simultaneously
with the closing of the Initial Public Offering, the Company consummated the Private Placement of 4,400,000 Private Placement Warrants,
at a price of $1.50 per Private Placement Warrant, with the Prior Sponsor, generating gross proceeds of $6.6 million, and incurring offering
costs of approximately $7,000. On June 15, 2022, the Prior Sponsor transferred 4,400,000 Private Placement Warrants to the Sponsor.
Each
whole Private Placement Warrant is exercisable for one whole Class A ordinary share at a price of $11.50 per share. A portion of the
proceeds from the sale of the Private Placement Warrants to the Prior Sponsor was added to the proceeds from the Initial Public Offering
held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement
Warrants will expire worthless. The Private Placement Warrants will be non-redeemable for cash and exercisable on a cashless basis so
long as they are held by the Sponsor or its permitted transferees.
QUADRO
ACQUISITION ONE CORP.
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2023 AND 2022
The
Sponsor agreed, subject to limited exceptions, not to transfer, assign or sell any of its Private Placement Warrants until 30 days after
the completion of the initial Business Combination.
Note
5 - Related Party Transactions
Forward
Purchase Agreement
In connection with the consummation of the Initial
Public Offering, the Company entered into a forward purchase agreement with the Prior Sponsor, which provided for the purchase of $20.0
million Forward Purchase Units, which at the option of the Prior Sponsor, could be increased to $50.0 million, with each Forward Purchase
Unit consisting of one Class A ordinary share and one-third of one warrant to purchase one Class A ordinary share at $11.50 per share,
for a purchase price of $10.00 per Forward Purchase Unit, in a private placement to occur concurrently with the closing of the initial
Business Combination. The Company does not intend to implement the forward purchase agreement, and on April 17, 2023, the Company
sent a notice of mutual termination of the forward purchase agreement to the Prior Sponsor. The Company classified the Forward Purchase
Units as derivative instruments on the accompanying balance sheets. The initial value of the Forward Purchase Units was insignificant,
and the Company recognized a loss in the change in the fair value of the derivative assets (liabilities) of approximately $0 for the year
ended December 31, 2023, and approximately $(89,000) for the year ended December 31, 2022.
Founder
Shares
On
September 21, 2020, the Company issued 4,812,500 Class B ordinary shares, par value $0.001 per share (the “Founder Shares”)
to the Prior Sponsor. On September 23, 2020, the Prior Sponsor paid an aggregate of $25,000 for certain expenses on behalf of the Company
in exchange for issuance of the Founder Shares. On January 25, 2021, the Company effected a stock dividend of 1,437,500 shares with respect
to Class B ordinary shares, resulting in an aggregate of 6,250,000 Founder Shares outstanding.
On
June 15, 2022, the Prior Sponsor transferred all 6,250,000 Founder Shares to the Sponsor. The Sponsor agreed not to transfer, assign
or sell any of its Founder Shares until the earlier to occur of (i) one year after the date of the consummation of the initial Business
Combination, or (ii) earlier if, subsequent to the initial Business Combination, (x) the last reported sale price of the Class A ordinary
shares equals or exceeds $12.00 per share (as adjusted for share splits, share dividends, reorganizations and recapitalizations) for
any 20 trading days within any 30-trading day period commencing at least 150 days after the initial Business Combination or (y) the Company
consummates a subsequent liquidation, merger, stock exchange or other similar transaction which results in all of the shareholders having
the right to exchange their ordinary shares for cash, securities or other property.
Related
Party Loans
In
order to finance transaction costs in connection with a Business Combination, the Sponsor, members of the Company’s founding team
or any of their affiliates may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”).
If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account
released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the
event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the
Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital
Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lenders’ discretion, up
to $1.5 million of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price
of $1.50 per warrant. The warrants would be identical to the Private Placement Warrants. Except for the foregoing, the terms of
such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. As of December
31, 2023 and 2022, the Company had no borrowings under any Working Capital Loans.
QUADRO
ACQUISITION ONE CORP.
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2023 AND 2022
On April 13, 2022, the Company issued the
Promissory Note to the Prior Sponsor for an aggregate of up to $200,000 which was amended and restated on May 25, 2022 to increase
the principal amount to $400,000. The Promissory Note bears no interest, may be prepaid at any time and was due and payable on June
7, 2023. On June 30, 2022, the Prior Sponsor assigned all of its rights and obligations under the Promissory Note to the Sponsor in
connection with the Sponsor Transaction. On June 7, 2023, the Promissory Note was amended and restated to extend the maturity date
to August 20, 2024. As of December 31, 2023, the Company has fully drawn $400,000 under the Promissory Note. As of December 31,
2023 and 2022, approximately $400,000 and $319,000 were outstanding under the Promissory Note, respectively.
Extension
Loan
Pursuant
to the Extension, as described in Note 1, the Sponsor or its designees contributed to the Company as a loan the initial contribution
of $120,000 in February 2023 for the portion of the extension ending on April 22, 2023. The Sponsor also agreed to loan the Company extension
contributions of $60,000 per month for each subsequent calendar month (commencing on April 22, 2023 and on the 22nd day of each subsequent
month) until November 22, 2023, or portion thereof, that is needed to complete an initial Business Combination, which amount will be
deposited into the Trust Account. As of December 31, 2023, the Company has drawn $470,000 and deposited it into the Trust Account.
Related
Party Advance
For the year ended December 31, 2023, the Sponsor
had paid $666,760 of expenses on behalf of the Company, which is included in advances from related party in the accompanying balance sheet
as of December 31, 2023. These advances are unsecured, bear no interest, and do not have formal repayment terms or arrangements.
Administrative
Services Agreement
Commencing
on February 17, 2021, through the earlier of consummation of the initial Business Combination and the liquidation, the Company agreed
to pay Kismet LLC, an affiliate of the Prior Sponsor, $10,000 per month for office space, utilities, secretarial support and administrative
services.
On
June 30, 2022, in connection with the Sponsor Transaction, the Company and Kismet LLC mutually terminated the Administrative Services
Agreement. As a result, the Company is no longer obligated to pay a $10,000 monthly fee pursuant to the Administrative Services
Agreement.
Director
Compensation
Commencing
on February 18, 2021, the Company paid its initial directors $40,000 each. On May 25, 2022, Mr. Verdi Israelyan, a former director,
waived his right to receive a payment of $40,000. The Company also granted two of its former independent directors, Messrs. Tompsett
and Zilber, an option each to purchase 40,000 Class A ordinary shares at an exercise price of $10.00 per share, which
will vest upon the consummation of the initial Business Combination and will expire five years after the date on which it first
became exercisable. Further, following the approval of the Extension, the compensation committee of the Company’s board of directors
approved the transfers by the Sponsor of (a) 15,000 Founder Shares to each of Mr. Zilber, a former director, and Mr. Tourevski and (b)
20,000 Founder Shares to Mr. Tompsett, a former director, as additional compensation, which transfers will take place prior to the closing
of the initial Business Combination. Both the Founder Shares and the options granted to the directors are subject to forfeiture in the
event a director ceases to serve on the Company’s board prior to the closing of a Business Combination. Messrs. Tompsett and Zilber
resigned from the board of directors in November 2023. Accordingly, both the Founder Shares and options were forfeited by Messrs. Tompsett.
In
addition, the Sponsor, executive officers and directors, or any of their respective affiliates will be reimbursed for any out-of-pocket
expenses incurred in connection with activities on the Company’s behalf such as identifying potential target businesses and performing
due diligence on suitable Business Combinations. The Company’s audit committee reviews, on a quarterly basis, all payments that
are made to the Sponsor, officers or directors, or the Company’s or their affiliates.
On May 25, 2022, one of the Company’s former
directors waived his right to receive a payment of $40,000, and the Company recorded approximately $0 of director compensation
during the year ended December 31, 2023, and approximately $23,000 of director compensation during the year ended December 31, 2022. As
of December 31, 2023 and 2022, the Company had no amounts outstanding in relation to the director compensation.
QUADRO
ACQUISITION ONE CORP.
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2023 AND 2022
Note
6 - Commitments and Contingencies
Registration
Rights
The holders of the Founder Shares and Private
Placement Warrants (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may
be issued upon conversion of Working Capital Loans) are entitled to registration rights pursuant to a registration rights agreement dated
February 17, 2021 (the “Registration Rights Agreement”). The holders of these securities are entitled to make up to three
demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggyback”
registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination. The
Company will bear the expenses incurred in connection with the filing of any such registration statements. On June 30, 2022, in connection
with the Sponsor Transaction, the Prior Sponsor assigned to the Sponsor all of its rights and obligations under the Registration Rights
Agreement.
Underwriting
Agreement
In
connection with the Initial Public Offering, $0.35 per Unit, or approximately $8.1 million in the aggregate, will be payable to the underwriters
for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust
Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. On
August 11, 2022 and September 6, 2022, two of the underwriters in the Initial Public Offering irrevocably waived their rights to receive
an aggregate of approximately $5.2 million of deferred underwriting discounts. The Company recognized the portion allocated to the Public
Shares of approximately $5.0 million as an adjustment to the carrying value of the Class A ordinary shares subject to possible redemption
and the remaining balance of approximately $0.2 million as a gain from extinguishment of deferred underwriting commissions allocated
to derivative warrant liabilities.
Risks
and Uncertainties
Management
continues to evaluate the impact of increases in inflation and rising interest rates, financial market instability, including the recent
bank failures and certain geopolitical events, including the military conflicts in Ukraine and the surrounding region and in the Middle
East, and has concluded that while it is reasonably possible that these events could have a negative effect on the Company’s financial
position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date
of these financial statements. The accompanying financial statements do not include any adjustments that might result from the outcome
of this uncertainty.
Note
7 - Warrants
As
of December 31, 2023 and 2022, 7,666,667 Public Warrants and 4,400,000 Private Placement Warrants were outstanding.
QUADRO
ACQUISITION ONE CORP.
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2023 AND 2022
The
Public Warrants may only be exercised for a whole number of Class A Ordinary shares. The Public Warrants will become exercisable on the
later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering;
provided in each case that the Company has an effective registration statement under the Securities Act covering the Class A ordinary
shares issuable upon exercise of the Public Warrants and a current prospectus relating to them is available and such shares are registered,
qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder (or the Company
permits holders to exercise their warrants on a cashless basis under certain circumstances). The Company agreed that as soon as practicable,
but in no event later than 15 business days after the closing of the initial Business Combination, the Company will use commercially
reasonable efforts to file with the SEC and have an effective registration statement covering the Class A ordinary shares issuable upon
exercise of the Public Warrants and to maintain a current prospectus relating to those Class A ordinary shares until the Public Warrants
expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the Class A ordinary shares issuable
upon exercise of the Public Warrants is not effective by the 60th day after the closing of the initial Business Combination, holders
may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain
an effective registration statement, exercise the Public Warrants on a “cashless basis” in accordance with Section 3(a)(9)
of the Securities Act or another exemption. Notwithstanding the above, if the Class A ordinary shares are at the time of any exercise
of a Public Warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security”
under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their Public
Warrants to do so on a “cashless basis” and, in the event the Company so elects, the Company will not be required to file
or maintain in effect a registration statement, and in the event the Company does not so elect, it will use commercially reasonable efforts
to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.
The
Public Warrants have an exercise price of $11.50 per share, subject to adjustments, and will expire five years after the completion of
a Business Combination or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional Class A ordinary
shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at
an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price
to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or an affiliate
of the Sponsor, without taking into account any Founder Shares held by the Sponsor or an affiliate of the Sponsor, as applicable, prior
to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60%
of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the
completion of the initial Business Combination (net of redemptions), and (z) the volume-weighted average trading price of the Class A
ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company completes its initial
Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the Public Warrants
will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $10.00
and $18.00 per share redemption trigger prices described under “Redemption of warrants when the price per Class A Ordinary Share
equals or exceeds $18.00” and “Redemption of warrants when the price per Class A Ordinary Share equals or exceeds $10.00”
will be adjusted (to the nearest cent) to be equal to 100% and 180% of the higher of the Market Value and the Newly Issued Price, respectively.
The
Private Placement Warrants are identical to the Public Warrants, except that the Private Placement Warrants and the Class A ordinary
shares issuable upon exercise of the Private Placement Warrants will not be transferable, assignable or sellable until 30 days after
the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be
non-redeemable so long as they are held by the initial purchaser or such purchaser’s permitted transferees. If the Private Placement
Warrants are held by someone other than the Initial Shareholder or its permitted transferees, the Private Placement Warrants will be
redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.
QUADRO
ACQUISITION ONE CORP.
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2023 AND 2022
Redemption
of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00
Once
the Public Warrants become exercisable, the Company may call the outstanding Public warrants, in whole and not in part, at a price of
$0.01 per Public Warrant:
| ● | upon
a minimum of 30 days’ prior written notice of redemption; and |
| ● | if, and only if, the last reported sale price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30 trading day period ending three business days before the Company sends the notice of redemption to the warrant holders (the “Reference Value”). |
The
Company will not redeem the Public Warrants as described above unless a registration statement under the Securities Act covering the
Class A ordinary shares issuable upon exercise of the Public Warrants is then effective and a current prospectus relating to those Class
A ordinary shares is available throughout the 30-trading day redemption period.
Redemption
of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $10.00
Once
the warrants become exercisable, the Company may redeem the outstanding warrants, in whole and not in part, at a price of $0.10 per warrant:
| ● | upon
a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless
basis prior to redemption and receive that number of Class A ordinary shares to be determined by reference to an agreed table based on
the redemption date and the “fair market value” of Class A ordinary shares; |
| ● | if, and only if, and only if, the Reference Value equals or exceeds $10.00 per Public Share (as adjusted), and |
| ● | if the Reference Value is less than $18.00 per share (as adjusted), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above. |
The
“fair market value” of Class A ordinary shares for the above purpose shall mean the volume-weighted average price of the
Class A ordinary shares for the 10 trading days immediately following the date on which the notice of redemption is sent to the holders
of warrants. In no event will the warrants be exercisable in connection with this redemption feature for more than 0.361 Class A ordinary
shares per warrant (subject to adjustment).
In
no event will the Company be required to net cash settle any warrant. If the Company is unable to complete a Business Combination within
the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such
funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust
Account with the respect to such warrants. Accordingly, the warrants may expire worthless.
Note
8 - Class A Ordinary Shares Subject to Possible Redemption
The
Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject
to the occurrence of future events. The Company is authorized to issue 200,000,000 Class A ordinary shares with a par value
of $0.001 per share. Holders of the Class A ordinary shares are entitled to one vote for each share.
In
connection with the shareholders meeting held on February 20, 2023, shareholders holding 20,451,847 Class A ordinary shares
exercised their right to redeem those shares for cash at an approximate price of $10.20 per share for an aggregate of approximately
$208.5 million.
In
connection with the shareholders meeting held on November 20, 2023, the holders of 977,473 Class A ordinary shares exercised their right
to redeem those shares for cash at an approximate price of $10.77 per share for an aggregate of approximately $10.526 million.
As
of December 31, 2023 and 2022, there were 1,570,680 and 23,000,000 Class A ordinary shares subject to possible redemption outstanding,
respectively, which are classified outside of permanent equity in the accompanying balance sheets.
QUADRO
ACQUISITION ONE CORP.
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2023 AND 2022
The
Class A ordinary shares subject to possible redemption reflected on the accompanying balance sheets are reconciled on the following table:
Gross proceeds received from Initial Public Offering | |
$ | 230,000,000 | |
Less: | |
| | |
Fair value of Public Warrants at issuance | |
| (6,823,334 | ) |
Offering costs allocated to Class A ordinary shares | |
| (12,685,596 | ) |
Plus: | |
| | |
Accretion on Class A ordinary shares subject to possible redemption | |
| 19,508,930 | |
Class A ordinary shares subject to possible redemption as of December 31, 2021 | |
| 230,000,000 | |
Plus: | |
| | |
Waiver of Class A ordinary shares issuance costs | |
| 5,077,217 | |
Less: | |
| | |
Accretion on Class A ordinary shares subject to possible redemption | |
| (1,872,702 | ) |
Class A ordinary shares subject to possible redemption as of December 31, 2022 | |
| 233,204,515 | |
Less: | |
| | |
Redemptions | |
| (219,050,780 | ) |
Plus: | |
| | |
Accretion on Class A ordinary shares subject to possible redemption | |
| 2,709,082 | |
Class A ordinary shares subject to possible redemption as of December 31, 2023 | |
$ | 16,862,817 | |
Note
9 - Shareholders’ Deficit
The
Company is authorized to issue 200,000,000 Class A ordinary Shares with a par value of $0.001 per share and 10,000,000 Class B ordinary
shares with a par value of $0.001 per share. Ordinary shareholders of record are entitled to one vote for each share held on all matters
to be voted on by shareholders. Except as described below, holders of Class A ordinary shares and holders of Class B ordinary shares
vote together as a single class on all matters submitted to a vote of the shareholders except as required by law.
Class
A Ordinary Shares
The
Company is authorized to issue 200,000,000 Class A ordinary shares with a par value of $0.001 per share.
On
January 31, 2023, the Company issued 6,250,000 Class A ordinary shares to the Sponsor upon the conversion of an equal number of Class
B ordinary shares held by the Sponsor. These 6,250,000 Class A ordinary shares are subject to the same restrictions as applied to the
Class B ordinary shares before the conversion, including, among others, certain transfer restrictions, waiver of redemption rights and
the obligation to vote in favor of an initial Business Combination.
As
of December 31, 2023 and 2022, there were 6,250,000 and 0 Class A ordinary shares issued and outstanding, excluding 1,570,680 and 23,000,000
which were subject to possible redemption and included as temporary equity, respectively (see Note 8).
Class
B Ordinary Shares
The
Company is authorized to issue 10,000,000 Class B ordinary shares with a par value of $0.001 per share.
As
noted above, on January 31, 2023, the Sponsor converted all 6,250,000 Class B ordinary shares into 6,250,000 Class A ordinary shares.
As
of December 31, 2023 and 2022, there were 0 and 6,250,000 Class B ordinary shares issued and outstanding, respectively.
QUADRO
ACQUISITION ONE CORP.
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2023 AND 2022
Note
10 - Fair Value Measurements
The following tables present information about
the Company’s assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2023 and 2022 and indicate
the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value:
| |
Fair Value Measured as of December 31, 2023 | |
| |
Level 1 | | |
Level 2 | | |
Level 3 | |
Liabilities: | |
| | |
| | |
| |
Derivative liabilities - Public Warrants | |
$ | — | | |
$ | 153,334 | | |
$ | — | |
Derivative liabilities - Private Placement Warrants | |
$ | — | | |
$ | 88,000 | | |
$ | — | |
| |
Fair Value Measured as of December 31, 2022 | |
| |
Level 1 | | |
Level 2 | | |
Level 3 | |
Assets | |
| | |
| | |
| |
Investments held in Trust Account - U.S. Treasury Securities | |
$ | 233,304,515 | | |
$ | — | | |
$ | — | |
Liabilities: | |
| | | |
| | | |
| | |
Derivative liabilities - Public Warrants | |
$ | — | | |
$ | 19,167 | | |
$ | — | |
Derivative liabilities - Private Placement Warrants | |
$ | — | | |
$ | 11,000 | | |
$ | — | |
Transfers
to/from Levels 1, 2, and 3 are recognized in the beginning of the reporting period. The estimated fair value of the Public Warrants was
transferred from a Level 3 measurement to a Level 1 fair value measurement in April 2021, when the Public Warrants were separately listed
and traded. The estimated fair value of the Private Placement Warrants was transferred from a Level 3 measurement to a Level 2 fair value
measurement during the year ended December 31, 2021. The estimated fair value of the Public Warrants was transferred to a Level 2 measurement
during the quarter ending December 31, 2022 due to low trading volume. There were no transfers to/from Levels 1, 2, and 3 during the
year ended December 31, 2023.
Level
1 assets include investments in mutual funds that invest solely in U.S. government securities. The Company uses inputs such as actual
trade data, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments.
The fair value of the Public Warrants was initially
measured using a Monte-Carlo simulation and has subsequently been measured based on the market price of such Public warrants at each measurement
date when separately listed and traded. The fair value of the Private Placement Warrants was initially measured using a Black-Scholes
Option Pricing Model and subsequently using the market value of the Public Warrants. For the years ended December 31, 2023 and 2022, the
Company recognized a change in fair value of derivative assets and liabilities of approximately $0.2 million and $5.9 million, respectively,
in the accompanying statements of operations.
The
Company utilized John C. Hull’s Options, Futures, and Other Derivatives model to estimate the fair value of the Forward Purchase
Units at each measurement date up until December 31, 2023. As the Company does not intend to implement the forward purchase agreement,
the Company determined the fair value of the Forward Purchase Units as of December 31, 2023 and 2022 was de minimis. There was no change
in fair value of the Forward Purchase Units for the year ended December 31, 2023. The Company recognized expense in the change in fair
value of the Forward Purchase Units of approximately $(89,000) for the year ended December 31, 2022.
The
change in the fair value of the Level 3 derivative warrant liabilities for year ended December 31, 2022 is summarized as follows:
Derivative (assets) as of December 31, 2021 | |
| (88,970 | ) |
Change in fair value of derivative assets and liabilities | |
| 88,970 | |
Derivative liabilities as of December 31, 2022 | |
$ | — | |
Note
11 - Subsequent Events
Management
has evaluated subsequent events to determine if events or transactions occurring after the balance sheet date through the date the accompanying
financial statements were issued. Based upon this review, the Company, other than as described below, did not identify any subsequent
event that would have required adjustment or disclosure in the accompanying financial statements.
QUADRO
ACQUISITION ONE CORP.
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2023 AND 2022
Creation
of Subsidiary
On January 4, 2024, the Company incorporated Quadro
Merger Sub Inc. (“Quadro Merger Sub”), a direct wholly owned subsidiary of the Company, in the State of Delaware in anticipation
of the Business Combination described below.
Business
Combination
On January 12, 2024, the Company and Quadro Merger
entered into a Business Combination Agreement (the “BCA”) with NHC Holdings II, Inc., a Delaware corporation (the “Seller”),
NHC Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Seller (the “Seller Merger Sub”), Global
Growth Holdings, LLC, a Delaware limited liability company (“Global Growth”), and Greg Lindberg, a resident of the State of
Florida (the “Individual Target Sponsor”). Global Growth and the Individual Target Sponsor own, directly or indirectly, beneficial
interests in certain affiliates (the “Target Affiliates”) conducting businesses related to collectibles and healthcare software
and services, which Target Affiliates will be consolidated prior to closing as subsidiaries of the Seller Merger Sub, as described in
more detail in the BCA. The name and symbol under which the surviving company will trade following the closing will be determined at a
later date.
As
the first step in the consummation of the transactions contemplated by the BCA, the Company will migrate to and domesticate as a Nevada
corporation (the “Domestication”) in accordance with Section 92A.270 of the Nevada Revised Statutes and the Cayman Islands
Companies Act (As Revised). In connection with the Domestication, (i) each then-issued and outstanding Class A ordinary share shall convert
automatically, on a one-for-one basis, into one share of class A common stock of the Company after the Domestication; (ii) each then-issued
and outstanding Public Warrant shall continue and remain outstanding on a one-for-one basis; and (iii) each then-issued and outstanding
Unit shall be canceled and entitle the holder to one share of class A common stock and one warrant.
Following the Domestication, the parties will
effect a merger of the Quadro Merger Sub with and into the Seller Merger Sub, with the Seller Merger Sub surviving such merger as a wholly
owned subsidiary of the Company (the “Merger”). As consideration for the Merger, the Company shall issue an aggregate of 208,715,500
shares of class A common stock (subject to adjustment) to the Seller and the Individual Target Sponsor (the “Merger Consideration”).
All class A common stock issued as part of the Merger Consideration shall be valued at Ten Dollars ($10.00) per share. The Merger Consideration
is subject to adjustment upward or downward by an amount that is equal to the same percentage by which the Consolidated EBITDA (as defined
in the BCA) of the Target Affiliates for the fiscal year ending December 31, 2023, exceeds or falls short of One Hundred Forty-Two Million
Four Hundred Eighteen Thousand Nine Hundred and Ninety-One dollars ($142,418,991).
The
BCA contains customary representations and warranties of the Company, the Quadro Merger Sub, the Seller, the Seller Merger Sub, and the
Target Affiliates relating to their respective businesses, in certain cases subject to materiality and “Material Adverse Effect”
qualifiers. The BCA also provides for customary pre-closing covenants of the parties, including a covenant to conduct their respective
businesses in all material respects in the ordinary course consistent with past practice and to refrain from taking certain actions without
the other parties’ consent. The parties have also agreed to, among other things, customary exclusivity provisions for transactions
of this type.
The Seller did not deliver completed disclosure
schedules with exceptions to the representations and warranties of the Seller and the Seller Merger Sub at the time of the signing of
the BCA. However, the Seller is required to deliver the fully completed disclosure schedules to the Company as soon as reasonably practicable,
but in no event later than February 29, 2024 (the parties are currently negotiating an amendment to the BCA to extend this date). The
Company will then have fifteen (15) business days to review the disclosure schedules. If the Company objects to any material adverse information
contained in the Seller’s disclosure schedules and the parties cannot agree on reasonable and mutually satisfactory modifications
to the BCA to address the Company’s objections, then the Company may terminate the BCA.
The
Company is permitted under the BCA to seek a valuation presentation, either in the form of a fairness opinion or a valuation report,
regarding the Merger Consideration for a period of time after the signing date. If the Company chooses to seek a valuation, it will engage
a financial advisor. The Company will be required within two (2) business days after receiving the valuation presentation or fairness
opinion from such financial advisor to determine in accordance with its fiduciary duties, whether the Merger Consideration is substantively
fair, taking into account all relevant economic and financial terms of the transactions, to shareholders (a “Fairness Determination”).
If the board of directors is unable in good faith to make a Fairness Determination, the Company may terminate the BCA subject to an obligation
to seek to negotiate changes to the BCA with the Seller that would allow the board of directors to make a Fairness Determination.
QUADRO
ACQUISITION ONE CORP.
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2023 AND 2022
Consummation
of the Merger is subject to various conditions, including, among others, customary conditions relating to the approval of the Domestication
and the BCA by the requisite vote of the Company’s shareholders; effectiveness of a registration statement on Form S-4 that will
include the Company’s proxy statement and constitute a prospectus relating to the issuance of the class A common stock upon completion
of the Domestication and the Merger Consideration; absence of an injunction by any court or other tribunal of competent jurisdiction
and absence of a law that prevents, enjoins, prohibits, or makes illegal the consummation of the Merger; and receipt of all consents,
approvals, and authorizations legally required to be obtained to consummate the Merger and of any customary legal opinions from counsel
to the Company and the Seller Merger Sub. In addition, each party’s obligation to consummate the Merger is subject to the satisfaction
(or waiver, to the extent permitted by applicable law) of the following conditions:
| ● | receipt
by the Company of the Target Affiliates’ audited financial statements, which includes
consolidated balance sheets and consolidated statements of income, shareholders’ equity,
and cash flows, as of and for the year ended December 31, 2023, prepared in accordance with
GAAP; |
| ● | the net tangible assets of the Company being valued at $5,000,001 or more after giving effect to the closing of the Merger and any related financing transactions; |
| ● | completion
of the Target Affiliates Restructuring (as defined in the BCA), whereby the Seller Merger
Sub will acquire ownership of the Target Affiliates; and |
| ● | completion
of the Target Affiliates Refinancing (as defined in the BCA) and repayment in full of all
Target Affiliate Obligations (as defined in the BCA). |
The
obligation of the parties to consummate the Merger is also conditioned upon the representations and warranties of each other party being
true and correct (subject to certain materiality exceptions), each other party having performed in all material respects its obligations
under the BCA and any ancillary documents related thereto, and the absence of a Material Adverse Effect (as defined in the BCA) on each
party, unless stated otherwise in the BCA or waived upon mutual agreement of the Company and the Seller.
The
BCA may be terminated, and the transactions contemplated thereby may be abandoned at any time prior to the closing as follows:
| (a) | by
mutual written consent of the Company and the Seller; |
| (b) | by
written notice by the Company or the Seller if any of the conditions to the closing have
not been satisfied or waived by June 30, 2024 (the “Outside Date”); provided,
however, that this termination right shall not be available to a party if the breach or violation
by such party or its affiliates of any representation, warranty, covenant or obligation under
the BCA was the cause of, or resulted in, the failure of the closing to occur on or before
the Outside Date; |
| (c) | by
written notice of either the Company or the Seller if a governmental authority of competent
jurisdiction shall have issued an order or taken any other action permanently restraining,
enjoining, or otherwise prohibiting the transactions contemplated by the BCA, and such order
or other action has become final and non-appealable; |
| (d) | by written notice by the Seller to the Company, if (i) there has been a material breach by the Company of any of its representations, warranties, covenants, or agreements contained in the BCA, or if any representation or warranty of the Company becomes materially untrue or materially inaccurate, in any case, which would result in a failure of one of the BCA’s conditions to be satisfied (treating the closing date for such purposes as the date of the BCA or, if later, the date of such breach), and (ii) the breach or inaccuracy is incapable of being cured or is not cured within twenty (20) days after written notice of such breach or inaccuracy is provided to the Company by the Seller or the Seller Merger Sub; provided, that neither the Seller nor the Seller Merger Sub shall have the right to terminate the BCA under this section if at such time the Seller or the Seller Merger Sub is in material uncured breach of thereof; |
QUADRO
ACQUISITION ONE CORP.
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2023 AND 2022
| (e) | by written notice by the Company to the Seller, if (i) there has been a breach by the Seller, the Seller Merger Sub, or any of the Target Affiliates of any of their respective representations, warranties, covenants, or agreements contained in the BCA, or if any representation or warranty of such parties become untrue or inaccurate, in any case, which would result in a failure of one of the BCA’s conditions to be satisfied (treating the closing date for such purposes as the date of the BCA or, if later, the date of such breach), (ii) the breach or inaccuracy is incapable of being cured or is not cured within twenty (20) days after written notice of such breach or inaccuracy is provided by the Company to the Seller and the Seller Merger Sub; provided, that the Company shall not have the right to terminate the BCA under this section if at such time the Company is in material uncured breach thereof, or (iii) the Company objects to any material adverse information contained in the Seller’s disclosure schedules or the Company’s board of directors is unable in good faith to make a determination in its reasonable discretion whether the Merger Consideration is fair and reasonable compensation for the acquisition of the Target Affiliates and the parties cannot agree on reasonable and mutually satisfactory modifications to the BCA to address the Company’s objections; |
| (f) | by
written notice by the Company to the Seller if there shall have been a Material Adverse Effect
with respect to the Seller, the Seller Merger Sub, or the Target Affiliates following the
date of the BCA; |
| (g) | by
written notice by the Seller to the Company if there shall have been a Material Adverse Effect
with respect to the Company following the date of the BCA which is uncured; |
| (h) | by
written notice by either the Company or the Seller to the other if the Required Shareholder
Approval (as defined in the BCA) is not obtained; or |
| (i) | by
written notice by the Company to the Seller if by February 6, 2024 the board of directors
determines that it cannot make a Fairness Determination in accordance with the BCA taking
into account all relevant economic and financial terms of the transactions, to the Company’s
shareholders (the parties are currently negotiating an amendment to the BCA to extend this date). |
Notwithstanding
the foregoing, before the Company terminates the BCA pursuant to (i) above, the Company must give the Seller ten (10) business days’
prior written notice of its intention to terminate the BCA, and during the ten (10) business days following such written notice, the
Company, if requested by the Seller, shall negotiate in good faith with the Seller regarding any revisions to the terms of the BCA proposed
by the Company or the Seller. If at the end of the ten (10) business day period, the Company concludes in good faith, after consultation
with its counsel and financial advisor (and taking into account any adjustment or modification of the terms of the BCA to which the other
party has agreed in writing), that the Company cannot make a positive Fairness Determination, then the Company may terminate the BCA.
The
BCA requires the Seller parties to pay a termination fee to the Company under certain circumstances as liquidated damages. If the BCA
is terminated by either the Company or the Seller under paragraph (b) above and the failure of the closing of the Merger to occur on
or before the Outside Date was not caused by, or a result of, the breach or violation by the Company of any representation, warranty,
covenant or obligation under the BCA, or (ii) there is a valid and effective termination of the BCA under clause (e) above, then the
Seller must pay the Company a termination fee in cash in an aggregate amount of Two Million Five Hundred Thousand Dollars ($2,500,000),
which must be paid within twenty (20) business days after the date of the valid and effective termination of the BCA by the Company.
Simultaneously
with the execution and delivery of the BCA, the Company, the Sponsor and the Seller entered into a Sponsor Support Agreement, pursuant
to which the Sponsor agreed to vote all its Founder Shares in favor of the BCA, the Domestication and all related transactions. The Sponsor
also agreed to take certain other actions supporting the BCA and related transactions and refrain from taking actions that would adversely
affect its ability to perform its obligations under the Sponsor Support Agreement.
SIGNATURES
Pursuant
to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned, thereunto duly authorized.
Date: April 17, 2024 |
QUADRO ACQUISITION ONE CORP. |
|
|
|
/s/ Dimitri
Elkin |
|
Name: Dimitri Elkin |
|
Title: Chief Executive Officer |
|
(Principal Executive Officer and Principal Financial
and Account Officer) |
Pursuant
to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the
registrant and in the capacities and on the dates indicated.
SIGNATURE |
|
TITLE |
|
DATE |
|
|
|
|
|
/s/ Dimitri Elkin |
|
Chief Executive Officer |
|
April 17, 2024 |
Dimitri Elkin |
|
(principal executive officer and principal financial and accounting officer) |
|
|
|
|
|
|
|
/s/ Jonathan D. Morris |
|
Director |
|
April 17, 2024 |
Jonathan D. Morris |
|
|
|
|
|
|
|
|
|
/s/ Gregory D. Nelson |
|
Director |
|
April 17, 2024 |
Gregory D. Nelson |
|
|
|
|
|
|
|
|
|
/s/ Konstantin Tourevski |
|
Director |
|
April 17, 2024 |
Konstantin Tourevski |
|
|
|
|
00-0000000
11071221
23000000
0.07
0.30
6250000
530822
0.07
0.30
1863582
6857982
748727
35899
11071221
23000000
6250000
530822
0.07
0.07
0.30
0.30
false
FY
0001825962
0001825962
2023-01-01
2023-12-31
0001825962
qdro:UnitsEachConsistingOfOneClassAOrdinaryShareParValue0001PerShareMember
2023-01-01
2023-12-31
0001825962
qdro:ClassAOrdinarySharesParValue0001PerShareIncludedAsPartOfTheUnitsMember
2023-01-01
2023-12-31
0001825962
qdro:RedeemableWarrantsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExercisePriceOf1150SubjectToAdjustmentMember
2023-01-01
2023-12-31
0001825962
2023-06-30
0001825962
2024-04-12
0001825962
2023-12-31
0001825962
2022-12-31
0001825962
us-gaap:RelatedPartyMember
2023-12-31
0001825962
us-gaap:RelatedPartyMember
2022-12-31
0001825962
us-gaap:CommonClassAMember
2023-12-31
0001825962
us-gaap:CommonClassAMember
2022-12-31
0001825962
us-gaap:CommonClassBMember
2023-12-31
0001825962
us-gaap:CommonClassBMember
2022-12-31
0001825962
2022-01-01
2022-12-31
0001825962
us-gaap:CommonClassAMember
2023-01-01
2023-12-31
0001825962
us-gaap:CommonClassAMember
2022-01-01
2022-12-31
0001825962
us-gaap:CommonClassBMember
2023-01-01
2023-12-31
0001825962
us-gaap:CommonClassBMember
2022-01-01
2022-12-31
0001825962
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2021-12-31
0001825962
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2021-12-31
0001825962
us-gaap:AdditionalPaidInCapitalMember
2021-12-31
0001825962
us-gaap:RetainedEarningsMember
2021-12-31
0001825962
2021-12-31
0001825962
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2022-01-01
2022-12-31
0001825962
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2022-01-01
2022-12-31
0001825962
us-gaap:AdditionalPaidInCapitalMember
2022-01-01
2022-12-31
0001825962
us-gaap:RetainedEarningsMember
2022-01-01
2022-12-31
0001825962
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2022-12-31
0001825962
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2022-12-31
0001825962
us-gaap:AdditionalPaidInCapitalMember
2022-12-31
0001825962
us-gaap:RetainedEarningsMember
2022-12-31
0001825962
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2023-01-01
2023-12-31
0001825962
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2023-01-01
2023-12-31
0001825962
us-gaap:AdditionalPaidInCapitalMember
2023-01-01
2023-12-31
0001825962
us-gaap:RetainedEarningsMember
2023-01-01
2023-12-31
0001825962
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2023-12-31
0001825962
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2023-12-31
0001825962
us-gaap:AdditionalPaidInCapitalMember
2023-12-31
0001825962
us-gaap:RetainedEarningsMember
2023-12-31
0001825962
2023-10-01
2023-12-31
0001825962
us-gaap:IPOMember
2021-02-22
0001825962
us-gaap:IPOMember
2021-02-17
2021-02-22
0001825962
us-gaap:PrivatePlacementMember
2023-12-31
0001825962
us-gaap:PrivatePlacementMember
2023-01-01
2023-12-31
0001825962
us-gaap:CommonClassBMember
2022-06-15
0001825962
us-gaap:PrivatePlacementMember
2022-06-15
0001825962
2022-06-30
2022-06-30
0001825962
qdro:BusinessCombinationMember
2023-01-01
2023-12-31
0001825962
qdro:BusinessCombinationMember
2023-12-31
0001825962
2023-11-20
2023-11-20
0001825962
2023-11-20
0001825962
2023-02-01
2023-02-28
0001825962
2023-04-01
2023-04-22
0001825962
2023-05-11
0001825962
2023-06-06
0001825962
2023-07-11
0001825962
2023-08-07
0001825962
2023-10-12
0001825962
2023-12-07
0001825962
srt:ScenarioForecastMember
2024-04-22
0001825962
us-gaap:CommonClassBMember
qdro:SponsorMember
2023-01-31
2023-01-31
0001825962
us-gaap:CommonClassAMember
2023-01-31
2023-01-31
0001825962
qdro:PublicSharesMember
2023-01-01
2023-12-31
0001825962
qdro:TrustAccountMember
2023-12-31
0001825962
qdro:SponsorMember
2023-12-31
0001825962
qdro:PromissoryNoteMember
2022-04-13
0001825962
2022-05-25
0001825962
2023-11-10
2023-11-17
0001825962
2023-10-15
2023-10-20
0001825962
us-gaap:OverAllotmentOptionMember
2021-02-22
0001825962
2021-02-17
2021-02-22
0001825962
qdro:SponsorMember
us-gaap:PrivatePlacementMember
2022-06-15
0001825962
us-gaap:CommonClassAMember
us-gaap:PrivatePlacementMember
2023-12-31
0001825962
qdro:ForwardPurchaseAgreementMember
2023-01-01
2023-12-31
0001825962
qdro:ForwardPurchaseAgreementMember
qdro:SponsorMember
2023-01-01
2023-12-31
0001825962
qdro:FounderSharesMember
2020-09-21
2020-09-21
0001825962
qdro:FounderSharesMember
2020-09-21
0001825962
qdro:FounderSharesMember
2020-09-23
2020-09-23
0001825962
qdro:FounderSharesMember
2021-01-25
2021-01-25
0001825962
us-gaap:CommonClassBMember
qdro:FounderSharesMember
2021-01-25
0001825962
2022-06-15
2022-06-15
0001825962
us-gaap:CommonClassAMember
qdro:SponsorMember
2023-01-01
2023-12-31
0001825962
2022-04-22
2022-04-22
0001825962
qdro:SponsorMember
2023-02-28
0001825962
qdro:SponsorMember
2023-11-22
0001825962
2021-02-17
2021-02-17
0001825962
qdro:KismetLLCMember
2022-06-01
2022-06-30
0001825962
2021-02-18
2021-02-18
0001825962
2022-05-25
2022-05-25
0001825962
qdro:FounderSharesMember
2023-12-31
0001825962
us-gaap:IPOMember
2023-01-01
2023-12-31
0001825962
2022-08-11
0001825962
2022-10-06
0001825962
qdro:PublicWarrantsMember
2023-12-31
0001825962
qdro:PublicWarrantsMember
2022-12-31
0001825962
us-gaap:PrivatePlacementMember
2022-12-31
0001825962
us-gaap:WarrantMember
us-gaap:CommonClassAMember
2023-12-31
0001825962
us-gaap:WarrantMember
2023-12-31
0001825962
us-gaap:CommonClassAMember
qdro:PublicWarrantsMember
2023-12-31
0001825962
us-gaap:WarrantMember
us-gaap:CommonClassAMember
2023-01-01
2023-12-31
0001825962
us-gaap:CommonClassAMember
2023-02-20
2023-02-20
0001825962
us-gaap:CommonClassAMember
2023-02-20
0001825962
us-gaap:CommonClassAMember
2023-11-20
2023-11-20
0001825962
us-gaap:CommonClassAMember
2023-11-20
0001825962
2021-01-01
2021-12-31
0001825962
us-gaap:CommonClassAMember
qdro:SponsorMember
2023-01-31
0001825962
us-gaap:CommonClassAMember
qdro:SponsorMember
2023-01-31
2023-01-31
0001825962
qdro:PublicWarrantsMember
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2023-12-31
0001825962
qdro:PublicWarrantsMember
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2023-12-31
0001825962
qdro:PublicWarrantsMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2023-12-31
0001825962
qdro:PrivatePlacementWarrantsMember
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2023-12-31
0001825962
qdro:PrivatePlacementWarrantsMember
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2023-12-31
0001825962
qdro:PrivatePlacementWarrantsMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2023-12-31
0001825962
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2022-12-31
0001825962
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2022-12-31
0001825962
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2022-12-31
0001825962
qdro:PublicWarrantsMember
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2022-12-31
0001825962
qdro:PublicWarrantsMember
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2022-12-31
0001825962
qdro:PublicWarrantsMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2022-12-31
0001825962
qdro:PrivatePlacementWarrantsMember
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2022-12-31
0001825962
qdro:PrivatePlacementWarrantsMember
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2022-12-31
0001825962
qdro:PrivatePlacementWarrantsMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2022-12-31
0001825962
us-gaap:FairValueInputsLevel3Member
2021-12-31
0001825962
us-gaap:FairValueInputsLevel3Member
2022-01-01
2022-12-31
0001825962
us-gaap:FairValueInputsLevel3Member
2022-12-31
0001825962
qdro:BusinessCombinationAgreementMember
2023-01-01
2023-12-31
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
xbrli:pure
Capitalised terms not defined herein
shall have the meaning ascribed to them in the Notice of Extraordinary General Meeting and proxy statement for the EGM first mailed to
shareholders on or about 9 November 2023.
The amendments to the Second Amended
and Restated Memorandum of Association and Articles of Association of the Company set out in Annex A to the proxy statement, as referred
to in the foregoing resolution, are set out in full in Annex A hereto.
I, the undersigned, do hereby declare
that the above is a true and exact copy of an extract of the resolutions passed by the shareholders of the Company at the EGM.
The Second Amended and Restated Memorandum and Articles
of Association of the Company is amended by deleting Article 36.2 and replacing it in its entirety with the following:
The following summary of the material terms of
our securities as of December 31, 2023 is not intended to be a complete summary of the rights and preferences of such securities and is
subject to and qualified by reference to our second amended and restated memorandum and articles of association incorporated by reference
as an exhibit to this report, and applicable Cayman Islands law. We urge you to read our second amended and restated memorandum and articles
of association in their entirety for a complete description of the rights and preferences of our securities.
We are a Cayman Islands exempted company and our
affairs are governed by our second amended and restated memorandum and articles of association, the Companies Law and the common law of
the Cayman Islands. Pursuant to our second amended and restated memorandum and articles of association we are authorized to issue 200,000,000 Class A
ordinary shares and 10,000,000 Class B ordinary shares.
Each unit consists of one Class A ordinary share
and one-third of one warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of
$11.50 per share, subject to adjustment. Our units began trading on February 18, 2021 on Nasdaq under the symbol “QDROU.”
Commencing on April 12, 2021, the Class A ordinary shares and warrants comprising the units began separate trading on Nasdaq under the
symbols “QDRO” and “QDROW,” respectively. Those units not separated continue to trade on Nasdaq under the symbol
“QDROU.”
Ordinary shareholders of record are entitled to
one vote for each share held on all matters to be voted on by shareholders. Holders of Class A ordinary shares and holders of Class B
ordinary shares vote together as a single class on all matters submitted to a vote of our shareholders except as required by law. Unless
specified in our second amended and restated memorandum and articles of association, or as required by applicable provisions of the Companies
Law or applicable stock exchange rules, the affirmative vote of at least a majority of the votes cast by the holders of the issued ordinary
shares present in person or represented by proxy at a general meeting of the company and entitled to vote is required to approve any such
matter voted on by our shareholders. Approval of certain actions will require a special resolution under Cayman Islands law, being (i)
the affirmative vote of at least a two-thirds (2/3) majority of the votes cast by the holders of the issued ordinary shares present
in person or represented by proxy at a general meeting of the company and entitled to vote on such matter or (ii) a unanimous written
resolution of the shareholders; such actions include amending our second amended and restated memorandum and articles of association and
approving a statutory merger or consolidation with another company.
Our board of directors is divided into three classes,
each of which generally serves for a term of three years with only one class of directors being elected in each year. There is no cumulative
voting with respect to the appointment of directors, with the result that the holders of more than 50% of the shares voted for the appointment
of directors can elect all of the directors. Our shareholders are entitled to receive ratable dividends when, as and if declared by the
board of directors out of funds legally available therefor. Under our second amended and restated memorandum and articles of association,
a director may not be removed from office by a resolution of our shareholders prior to the consummation of our initial business combination.
Because our second amended and restated memorandum
and articles of association authorize the issuance of up to 200,000,000 Class A ordinary shares, if we were to enter into a business combination,
we may (depending on the terms of such a business combination) be required to increase the number of Class A ordinary shares which we
will be authorized to issue at the same time as our shareholders vote on the business combination to the extent we seek shareholder approval
in connection with our initial business combination.
In accordance with Nasdaq corporate governance
requirements, we are not required to hold an annual meeting until one year after our first fiscal year end following our listing on Nasdaq.
There is no requirement under the Companies Law for us to hold annual or extraordinary general meetings or appoint directors. We may not
hold an annual general meeting to appoint new directors prior to the completion of our initial business combination. Prior to the completion
of an initial business combination, the directors may by resolution appoint a replacement director to fill a casual vacancy arising on
the resignation, disqualification or death of a director. Under our second amended and restated memorandum and articles of association,
a director may not be removed from office by a resolution of our shareholders prior to the consummation of our initial business combination.
We will provide our shareholders with the opportunity
to redeem all or a portion of their public shares upon the completion of our initial business combination at a per-share price, payable
in cash, equal to the aggregate amount then on deposit in the trust account as of two business days prior to the consummation of our initial
business combination including interest earned on the funds held in the trust account and not previously released to us to pay our taxes,
if any, divided by the number of then outstanding public shares, subject to the limitations described herein. The amount in the trust
account was initially $10.00 per public share. The per-share amount we will distribute to investors who properly redeem their shares
will not be reduced by the deferred underwriting commissions we will pay to the underwriter. Our sponsor, officers and directors have
entered into respective letter agreements with us, pursuant to which our sponsor has agreed to waive its redemption rights with respect
to its founder shares, and our sponsor, officers and directors have agreed to waive their redemption rights with respect to any public
shares they may acquire during or after our initial public offering, in connection with the completion of our initial business combination.
Unlike many blank check companies that hold shareholder
votes and conduct proxy solicitations in conjunction with their initial business combinations and provide for related redemptions of public
shares for cash upon completion of such initial business combinations even when a vote is not required by law, if a shareholder vote is
not required by law and we do not decide to hold a shareholder vote for business or other legal reasons, we will, pursuant to our second
amended and restated memorandum and articles of association, conduct the redemptions pursuant to the tender offer rules of the SEC, and
file tender offer documents with the SEC prior to completing our initial business combination. Our second amended and restated memorandum
and articles of association requires these tender offer documents to contain substantially the same financial and other information about
the initial business combination and the redemption rights as is required under the SEC’s proxy rules. If, however, a shareholder
approval of the transaction is required by law, or we decide to obtain shareholder approval for business or other legal reasons, we will,
like many blank check companies, offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant
to the tender offer rules. If we seek shareholder approval, we will complete our initial business combination only if we obtain an ordinary
resolution under Cayman Islands law, being (i) the affirmative vote of at least a majority of the votes cast by the holders of the issued
ordinary shares present in person or represented by proxy at a general meeting of the company and entitled to vote on such matter or (ii)
a unanimous written resolution of the shareholders. However, the participation of our sponsor, officers, directors, advisors or their
affiliates in privately-negotiated transactions, if any, could result in the approval of our initial business combination even if
a majority of our public shareholders vote, or indicate their intention to vote, against such business combination. For purposes of seeking
approval of the majority of our outstanding ordinary shares, non-votes will have no effect on the approval of our initial business
combination once a quorum is obtained. We intend to give approximately 30 days (but not less than 10 days nor more than 60 days)
prior written notice of any such meeting, if required, at which a vote shall be taken to approve our initial business combination.
If we seek shareholder approval of our initial
business combination and we do not conduct redemptions in connection with our initial business combination pursuant to the tender offer
rules, our second amended and restated memorandum and articles of association provides that a public shareholder, together with any affiliate
of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under
Section 13 of the Exchange Act), will be restricted from redeeming its shares with respect to more than an aggregate of 20% of the
shares sold in our initial public offering, which we refer to as the Excess Shares. However, we would not be restricting our shareholders’
ability to vote all of their shares (including Excess Shares) for or against our initial business combination. Our shareholders’
inability to redeem the Excess Shares will reduce their influence over our ability to complete our initial business combination, and such
shareholders could suffer a material loss in their investment if they sell such Excess Shares on the open market. Additionally, such shareholders
will not receive redemption distributions with respect to the Excess Shares if we complete our initial business combination. And, as a
result, such shareholders will continue to hold that number of shares exceeding 20% and, in order to dispose such shares would be required
to sell their shares in open market transactions, potentially at a loss.
If we seek shareholder approval in connection
with our initial business combination, our sponsor has agreed to vote its founder shares and any public shares purchased during or after
our initial public offering in favor of our initial business combination. Additionally, each public shareholder may elect to redeem their
public shares irrespective of whether they vote for or against the proposed transaction.
Pursuant to our second amended and restated memorandum
and articles of association, if we are unable to complete our initial business combination by May 22, 2024, we will (i) cease all
operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter
subject to lawfully available funds therefor, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate
amount then on deposit in the trust account including interest earned on the funds held in the trust account and not previously released
to us to pay our taxes, if any (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding
public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive
further liquidation distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the
approval of our remaining shareholders and our board of directors, liquidate and dissolve, subject in the case of clauses (ii) and (iii),
to our obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. Our sponsor
has entered into a letter agreement with us, pursuant to which it has agreed to waive its rights to liquidating distributions from the
trust account with respect to its founder shares if we fail to complete our initial business combination by May 22, 202. However, if our
sponsor acquires public shares in or after our initial public offering, it will be entitled to liquidating distributions from the trust
account with respect to such public shares if we fail to complete our initial business combination within the prescribed time period.
In the event of a liquidation, dissolution or
winding up of the company after an initial business combination, our shareholders are entitled to share ratably in all assets remaining
available for distribution to them after payment of liabilities and after provision is made for each class of stock, if any, having preference
over the ordinary shares. Our shareholders have no preemptive or other subscription rights. There are no sinking fund provisions applicable
to the ordinary shares, except that we will provide our shareholders with the redemption rights set forth above.
The founder shares are identical to the Class
A ordinary shares included in the units that were sold in our initial public offering, and the holder of founder shares has the same shareholder
rights as public shareholders, except that (i) the founder shares are subject to certain transfer restrictions, as described in more
detail below, and (ii) our sponsor has entered into a letter agreement with us, pursuant to which it has agreed (A) to waive
its redemption rights with respect to its founder shares and public shares in connection with the completion of our initial business combination
and (B) to waive its rights to liquidating distributions from the trust account with respect to its founder shares if we fail to
complete our initial business combination by May 22, 202, although it will be entitled to liquidating distributions from the trust account
with respect to any public shares it holds if we fail to complete our initial business combination within such time period, (iii) the
founder shares will automatically convert into our Class A ordinary shares at the time of our initial business combination or earlier
at the option of the holders thereof as described herein; and (iv) the founder shares are entitled to registration rights. If we submit
our initial business combination to our public shareholders for a vote, our sponsor has agreed to vote its founder shares and any public
shares purchased during or after our initial public offering in favor of our initial business combination. In addition, our officers and
directors have agreed to (i) waive their redemption rights with respect to their public shares purchased during or after our initial public
offering in connection with the completion of our initial business combination and (ii) vote any public shares owned by them immediately
before our initial public offering as well as any public shares acquired in our initial public offering or in the aftermarket in favor
of our initial business combination.
Our sponsor has agreed not to transfer, assign
or sell any of the founder shares (except to certain permitted transferees as described below) until the earlier of (x) one year
after the date of the completion of our initial business combination or earlier if, subsequent to our initial business combination, the
last reported sale price of our Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share splits, share dividends,
reorganizations and recapitalizations) for any 20 trading days within any 30-trading day period commencing at least 150 days
after our initial business combination, or (y) we consummate a subsequent liquidation, merger, stock exchange or other similar transaction
which results in all of our shareholders having the right to exchange their ordinary shares for cash, securities or other property. The
founder shares are identical to the Class A ordinary shares included in the units that were sold in our initial public offering,
except as described herein. However, the holder has agreed (A) to vote any shares owned by it in favor of any proposed business combination
and (B) not to redeem any shares in connection with a shareholder vote or tender offer to approve or in connection with a proposed
initial business combination.
Under Cayman Islands law, we must keep a register
of members and there shall be entered therein:
For these purposes, “voting rights”
means rights conferred on shareholders in respect of their shares to vote at general meetings of the company on all or substantially all
matters. A voting right is conditional where the voting right arises only in certain circumstances.
Under Cayman Islands law, the register of members
of our company is prima facie evidence of the matters set out therein (i.e., the register of members will raise a presumption of
fact on the matters referred to above unless rebutted) and a member registered in the register of members will be deemed as a matter of
Cayman Islands law to have legal title to the shares as set against its name in the register of members. Upon the closing of our initial
public public offering, the register of members was immediately updated to reflect the issue of shares by us. Once our register of members
has been updated, the shareholders recorded in the register of members are deemed to have legal title to the shares set against their
name. However, there are certain limited circumstances where an application may be made to a Cayman Islands court for a determination
on whether the register of members reflects the correct legal position. Further, the Cayman Islands court has the power to order that
the register of members maintained by a company should be rectified where it considers that the register of members does not reflect the
correct legal position. If an application for an order for rectification of the register of members were made in respect of our ordinary
shares, then the validity of such shares may be subject to re-examination by a Cayman Islands court.
Each whole warrant entitles the registered holder
to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment as discussed below, at any time commencing
on the later of February 22, 2022 or 30 days after the completion of our initial business combination. Pursuant to the warrant agreement,
a warrant holder may exercise its warrants only for a whole number of Class A ordinary shares. This means that only a whole warrant may
be exercised at any given time by a warrant holder. No fractional warrants will be issued upon separation of the units and only whole
warrants will trade. Accordingly, unless you purchased at least three units, you will not be able to receive or trade a whole warrant.
The warrants will expire five years after the date on which they first became exercisable, at 5:00 p.m., New York City time,
or earlier upon redemption or liquidation.
We will not be obligated to deliver any Class
A ordinary shares pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration
statement under the Securities Act with respect to the Class A ordinary shares underlying the warrants is then effective and a prospectus
relating thereto is current, subject to our satisfying our obligations described below with respect to registration, or a valid exemption
from registration is available. No warrant will be exercisable and we will not be obligated to issue Class A ordinary shares upon exercise
of a warrant unless the Class A ordinary shares issuable upon such warrant exercise have been registered, qualified or deemed to be exempt
under the securities laws of the state of residence of the registered holder of the warrants. In the event that the conditions in the
two immediately preceding sentences are not satisfied with respect to a warrant, the holder of such warrant will not be entitled to exercise
such warrant and such warrant may have no value and expire worthless. In no event will we be required to net cash settle any warrant.
In the event that a registration statement is not effective for the exercised warrants, the purchaser of a unit containing such warrant
will have paid the full purchase price for the unit solely for the Class A ordinary share underlying such unit.
We have agreed that as soon as practicable, but
in no event later than 15 business days, after the closing of our initial business combination, we will use our commercially reasonable
efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the Class A ordinary shares issuable
upon exercise of the warrants. We will use our commercially reasonable efforts to cause the same to become effective and to maintain the
effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration or redemption of the warrants
in accordance with the provisions of the warrant agreement. Notwithstanding the above, if our Class A ordinary shares are at the time
of any exercise of a warrant not listed on a national securities exchange such that it satisfies the definition of a “covered security”
under Section 18(b)(1) of the Securities Act, we may, at our option, require holders of public warrants who exercise their warrants
to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event we so elect,
we will not be required to file or maintain in effect a registration statement or register or qualify the shares under applicable blue
sky laws to the extent an exemption is available. In such event, each holder would pay the exercise price by surrendering each such warrant
for that number of Class A ordinary shares equal to the lesser of (A) the quotient obtained by dividing (x) the product of the number
of Class A ordinary shares underlying the warrants, multiplied by the excess of the “fair market value” less the exercise
price of the warrants by (y) the fair market value and (B) 0.361. The “fair market value” shall mean the volume weighted average
price of our Class A ordinary shares for the 10 trading days ending on the trading day prior to the date on which the notice of exercise
is received by the warrant agent.
We will not redeem the warrants as described above
unless a registration statement under the Securities Act covering the issuance of the Class A ordinary shares issuable upon exercise of
the warrants is then effective and a current prospectus relating to those Class A ordinary shares is available throughout the 30-day redemption
period. If and when the warrants become redeemable by us, we may exercise our redemption right even if we are unable to register or qualify
the underlying securities for sale under all applicable state securities laws.
We have established the last of the redemption
criterion discussed above to prevent a redemption call unless there is at the time of the call a significant premium to the warrant exercise
price. If the foregoing conditions are satisfied and we issue a notice of redemption of the warrants, each warrant holder will be entitled
to exercise his, her or its warrant prior to the scheduled redemption date. However, the price of the Class A ordinary shares may fall
below the $18.00 redemption trigger price (as adjusted for share splits, share dividends, rights issuances, subdivisions, reorganizations,
recapitalizations and the like) as well as the $11.50 (for whole shares) warrant exercise price after the redemption notice is issued.
During the period beginning on the date the notice
of redemption is given, holders may elect to exercise their warrants on a cashless basis. The numbers in the table below represent the
number of Class A ordinary shares that a warrant holder will receive upon such cashless exercise in connection with a redemption by us
pursuant to this redemption feature, based on the “fair market value” of our Class A ordinary shares on the corresponding
redemption date (assuming holders elect to exercise their warrants and such warrants are not redeemed for $0.10 per warrant), determined
for these purposes based on volume weighted average price of our Class A ordinary shares during the 10 trading days immediately following
the date on which the notice of redemption is sent to the holders of warrants, and the number of months that the corresponding redemption
date precedes the expiration date of the warrants, each as set forth in the table below. We will provide our warrant holders with the
final fair market value no later than one business day after the 10-trading day period described above ends.
Pursuant to the warrant agreement, references
above to Class A ordinary shares shall include a security other than Class A ordinary shares into which the Class A ordinary shares have
been converted or exchanged for in the event we are not the surviving company in our initial business combination. The numbers in the
table below will not be adjusted when determining the number of Class A ordinary shares to be issued upon exercise of the warrants if
we are not the surviving entity following our initial business combination.
The share prices set forth in the column headings
of the table below will be adjusted as of any date on which the number of shares issuable upon exercise of a warrant or the exercise price
of the warrant is adjusted as set forth under the heading “—Anti-dilution Adjustments” below. If the number of
shares issuable upon exercise of a warrant is adjusted, the adjusted share prices in the column headings will equal the share prices immediately
prior to such adjustment, multiplied by a fraction, the numerator of which is the exercise price of the warrant after such adjustment
and the denominator of which is the price of the warrant immediately prior to such adjustment. In such an event, the number of shares
in the table below shall be adjusted by multiplying such share amounts by a fraction, the numerator of which is the number of shares deliverable
upon exercise of a warrant immediately prior to such adjustment and the denominator of which is the number of shares deliverable upon
exercise of a warrant as so adjusted. If the exercise price of the warrant is adjusted as a result of raising capital in connection with
the initial business combination, the adjusted stock prices in the column headings will by multiplied by a fraction, the numerator of
which is the higher of the Market Value and the Newly Issued Price as set forth under the heading “— Anti-dilution Adjustments”
and the denominator of which is $10.00.
The exact fair market value and redemption date
may not be set forth in the table above, in which case, if the fair market value is between two values in the table or the redemption
date is between two redemption dates in the table, the number of Class A ordinary shares to be issued for each warrant exercised will
be determined by a straight-line interpolation between the number of shares set forth for the higher and lower fair market values
and the earlier and later redemption dates, as applicable, based on a 365 or 366-day year, as applicable. For example, if the
volume weighted average price of our Class A ordinary shares during the 10 trading days immediately following the date on which the notice
of redemption is sent to the holders of the warrants is $11.00 per share, and at such time there are 57 months until the expiration
of the warrants, holders may choose to, in connection with this redemption feature, exercise their warrants for 0.277 Class A ordinary
shares for each whole warrant. For an example where the exact fair market value and redemption date are not as set forth in the table
above, if the volume weighted average price of our Class A ordinary shares during the 10 trading days immediately following the date on
which the notice of redemption is sent to the holders of the warrants is $13.50 per share, and at such time there are 38 months until
the expiration of the warrants, holders may choose to, in connection with this redemption feature, exercise their warrants for 0.298 Class
A ordinary shares for each whole warrant. In no event will the warrants be exercisable on a cashless basis in connection with
this redemption feature for more than 0.361 Class A ordinary shares per warrant (subject to adjustment). Finally, as reflected in the
table above, if the warrants are out of the money and about to expire, they cannot be exercised on a cashless basis in connection with
a redemption by us pursuant to this redemption feature, since they will not be exercisable for any Class A ordinary shares.
This redemption feature differs from the typical
warrant redemption features used in many other blank check offerings, which typically only provide for a redemption of warrants for cash
(other than the private placement warrants) when the trading price for the Class A ordinary shares exceeds $18.00 per share for a specified
period of time. This redemption feature is structured to allow for all of the outstanding warrants to be redeemed when the Class A ordinary
shares are trading at or above $10.00 per public share, which may be at a time when the trading price of our Class A ordinary shares is
below the exercise price of the warrants. We have established this redemption feature to provide us with the flexibility to redeem the
warrants without the warrants having to reach the $18.00 per share threshold set forth above under “— Redemption of warrants
when the price per Class A ordinary share equals or exceeds $18.00.” Holders choosing to exercise their warrants in connection with
a redemption pursuant to this feature will, in effect, receive a number of shares for their warrants based on an option pricing model
with a fixed volatility input as of February 17, 2022. This redemption right provides us with an additional mechanism by which to redeem
all of the outstanding warrants, and therefore have certainty as to our capital structure as the warrants would no longer be outstanding
and would have been exercised or redeemed. We will be required to pay the applicable redemption price to warrant holders if we choose
to exercise this redemption right and it will allow us to quickly proceed with a redemption of the warrants if we determine it is in our
best interest to do so. As such, we would redeem the warrants in this manner when we believe it is in our best interest to update our
capital structure to remove the warrants and pay the redemption price to the warrant holders.
As stated above, we can redeem the warrants when
the Class A ordinary shares are trading at a price starting at $10.00, which is below the exercise price of $11.50, because it will
provide certainty with respect to our capital structure and cash position while providing warrant holders with the opportunity to exercise
their warrants on a cashless basis for the applicable number of shares. If we choose to redeem the warrants when the Class A ordinary
shares are trading at a price below the exercise price of the warrants, this could result in the warrant holders receiving fewer Class A
ordinary shares than they would have received if they had chosen to wait to exercise their warrants for Class A ordinary shares if and
when such Class A ordinary shares were trading at a price higher than the exercise price of $11.50.
No fractional Class A ordinary shares will
be issued upon exercise. If, upon exercise, a holder would be entitled to receive a fractional interest in a share, we will round down
to the nearest whole number of the number of Class A ordinary shares to be issued to the holder. If, at the time of redemption, the warrants
are exercisable for a security other than the Class A ordinary shares pursuant to the warrant agreement (for instance, if we are
not the surviving company in our initial business combination), the warrants may be exercised for such security. At such time as the warrants
become exercisable for a security other than the Class A ordinary shares, the Company (or surviving company) will use its commercially
reasonable efforts to register under the Securities Act the security issuable upon the exercise of the warrants.
In addition, if we, at any time while the warrants
are outstanding and unexpired, pay a dividend or make a distribution in cash, securities or other assets to the holders of Class A
ordinary shares on account of such Class A ordinary shares (or other shares of our share capital into which the warrants are convertible),
other than (a) as described above, (b) any cash dividends or cash distributions which, when combined on a per share basis with
all other cash dividends and cash distributions paid on the Class A ordinary shares during the 365-day period ending on the
date of declaration of such dividend or distribution does not exceed $0.50 (as adjusted to appropriately reflect any other adjustments
and excluding cash dividends or cash distributions that resulted in an adjustment to the exercise price or to the number of Class A
ordinary shares issuable on exercise of each warrant) but only with respect to the amount of the aggregate cash dividends or cash distributions
equal to or less than $0.50 per share, (c) to satisfy the redemption rights of the holders of Class A ordinary shares in connection
with a proposed initial business combination, (d) to satisfy the redemption rights of the holders of Class A ordinary shares
in connection with a shareholder vote to amend our second amended and restated memorandum and articles of association (A) to modify the
substance or timing of our obligation to redeem 100% of our public shares if we do not complete our initial business combination by February
22, 2023 or (B) with respect to any other provision relating to shareholders’ rights or pre-initial business combination activity,
or (e) in connection with the redemption of our public shares upon our failure to complete our initial business combination, then
the warrant exercise price will be decreased, effective immediately after the effective date of such event, by the amount of cash and/or
the fair market value of any securities or other assets paid on each Class A ordinary share in respect of such event.
If the number of outstanding Class A ordinary
shares is decreased by a consolidation, combination, reverse share split or reclassification of Class A ordinary shares or other
similar event, then, on the effective date of such consolidation, combination, reverse share split, reclassification or similar event,
the number of Class A ordinary shares issuable on exercise of each warrant will be decreased in proportion to such decrease in outstanding
Class A ordinary shares.
Whenever the number of Class A ordinary shares
purchasable upon the exercise of the warrants is adjusted, as described above, the warrant exercise price will be adjusted by multiplying
the warrant exercise price immediately prior to such adjustment by a fraction (x) the numerator of which will be the number of Class A
ordinary shares purchasable upon the exercise of the warrants immediately prior to such adjustment, and (y) the denominator of which
will be the number of Class A ordinary shares so purchasable immediately thereafter.
In addition, if (x) we issue additional Class A
ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of our initial business combination
at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price
to be determined in good faith by our board of directors and, in the case of any such issuance to our sponsor or an affiliate of our sponsor,
without taking into account any founder shares held by our sponsor or an affiliate of our sponsor, as applicable, prior to such issuance),
or the Newly Issued Price, (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds,
and interest thereon, available for the funding of our initial business combination on the date of the completion of our initial business
combination (net of redemptions), and (z) the volume-weighted average trading price of our Class A ordinary shares during the
20 trading day period starting on the trading day prior to the day on which we complete our initial business combination (such price,
the Market Value) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115%
of the higher of the Market Value and the Newly Issued Price, and the $10.00 and $18.00 per share redemption trigger prices described
adjacent to “Redemption of warrants when the price per ordinary share equals or exceeds $18.00” and “Redemption of warrants
when the price per Class A ordinary share equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to 100%
and 180% of the higher of the Market Value and the Newly Issued Price, respectively.
In case of any reclassification or reorganization
of the outstanding Class A ordinary shares (other than those described above or that solely affects the par value of such Class A
ordinary shares), or in the case of any merger or consolidation of us with or into another corporation (other than a consolidation or
merger in which we are the continuing corporation and that does not result in any reclassification or reorganization of our outstanding
ordinary shares), or in the case of any sale or conveyance to another corporation or entity of the assets or other property of us as an
entirety or substantially as an entirety in connection with which we are dissolved, the holders of the warrants will thereafter have the
right to purchase and receive, upon the basis and upon the terms and conditions specified in the warrants and in lieu of the Class A
ordinary shares immediately theretofore purchasable and receivable upon the exercise of the rights represented thereby, the kind and amount
of shares or other securities or property (including cash) receivable upon such reclassification, reorganization, merger or consolidation,
or upon a dissolution following any such sale or transfer, that the holder of the warrants would have received if such holder had exercised
their warrants immediately prior to such event. If less than 70% of the consideration receivable by the holders of Class A ordinary
shares in such a transaction is payable in the form of shares in the successor entity that is listed for trading on a national securities
exchange or is quoted in an established over-the-counter market, or is to be so listed for trading or quoted immediately following
such event, and if the registered holder of the warrant properly exercises the warrant within thirty days following public disclosure
of such transaction, the warrant exercise price will be reduced as specified in the warrant agreement based on the Black-Scholes value
(as defined in the warrant agreement) of the warrant. The purpose of such exercise price reduction is to provide additional value to holders
of the warrants when an extraordinary transaction occurs during the exercise period of the warrants pursuant to which the holders of the
warrants otherwise do not receive the full potential value of the warrants.
The warrants were issued in registered form under
a warrant agreement between Continental Stock Transfer & Trust Company, as warrant agent, and us. You should review a copy of
the warrant agreement, which is filed as an exhibit to the registration statement of which this exhibit is a part, for a complete description
of the terms and conditions applicable to the warrants. The warrant agreement provides that the terms of the warrants may be amended without
the consent of any holder for the purpose of (i) curing any ambiguity or to correct any mistake, including to conform the provisions of
the warrant agreement to the description of the terms of the warrants and the warrant agreement set forth in the prospectus relating to
the initial public offering, or defective provision or (ii) adding or changing any provisions with respect to matters or questions arising
under the warrant agreement as the parties to the warrant agreement may deem necessary or desirable and that the parties deem to not adversely
affect the rights of the registered holders of the warrants, provided that the approval by the holders of at least 65% of the then-outstanding public
warrants is required to make any change that adversely affects the interests of the registered holders.
The warrants may be exercised upon surrender of
the warrant certificate on or prior to the expiration date at the offices of the warrant agent, with the exercise form on the reverse
side of the warrant certificate completed and executed as indicated, accompanied by full payment of the exercise price (or on a cashless
basis, if applicable), by certified or official bank check payable to us, for the number of warrants being exercised. The warrant holders
do not have the rights or privileges of holders of ordinary shares and any voting rights until they exercise their warrants and receive
ordinary shares. After the issuance of Class A ordinary shares upon exercise of the warrants, each holder will be entitled to one
vote for each share held of record on all matters to be voted on by shareholders.
Warrants may be exercised only for a whole number
of Class A ordinary shares. No fractional shares will be issued upon exercise of the warrants. If, upon exercise of the warrants, a holder
would be entitled to receive a fractional interest in a share, we will, upon exercise, round down to the nearest whole number of Class
A ordinary shares to be issued to the warrant holder.
The private placement warrants (including the
Class A ordinary shares issuable upon exercise of the private placement warrants) are not transferable, assignable or saleable (except,
among other limited exceptions to our officers and directors and other persons or entities affiliated with sponsor) and they are not redeemable
by us so long as they are held by the sponsor or its permitted transferees. Otherwise, the private placement warrants have terms and provisions
that are identical to those of the warrants sold as part of the units in our initial public offering. If the private placement warrants
are held by holders other than the initial purchasers or their permitted transferees, the private placement warrants will be redeemable
by us and exercisable by the holders on the same basis as the warrants included in the units sold in our initial public offering.
Except as described under “—Redemption
of warrants when the price per Class A ordinary share equals or exceeds $10.00,” if holders of the private placement warrants
elect to exercise them on a cashless basis, they would pay the exercise price by surrendering his, her or its warrants for that number
of Class A ordinary shares equal to the quotient obtained by dividing (x) the product of the number of Class A ordinary
shares underlying the warrants, multiplied by the difference between the exercise price of the warrants and the “fair market value”
(defined below) by (y) the fair market value. The “fair market value” shall mean the average last reported sale price
of the Class A ordinary shares for the 10 trading days ending on the third trading day prior to the date on which the notice of warrant
exercise is sent to the warrant agent. The reason that we have agreed that these warrants will be exercisable on a cashless basis so long
as they are held by our sponsor and permitted transferees is because it is not known at this time whether they will be affiliated with
us following a business combination. If our sponsor remains affiliated with us, its ability to sell our securities in the open market
will be significantly limited. We expect to have policies in place that prohibit insiders from selling our securities except during specific
periods of time. Even during such periods of time when insiders will be permitted to sell our securities, an insider cannot trade in our
securities if he or she is in possession of material non-public information. Accordingly, unlike public shareholders who could exercise
their warrants and sell the Class A ordinary shares received upon such exercise freely in the open market in order to recoup the
cost of such exercise, the insiders could be significantly restricted from selling such securities. As a result, we believe that allowing
the holders to exercise such warrants on a cashless basis is appropriate.
In order to finance transaction costs in connection
with an intended initial business combination, our sponsor or an affiliate of our sponsor or certain of our officers and directors may,
but are not obligated to, loan us funds as may be required. Up to $1,500,000 of such loans may be convertible into warrants at a price
of $1.50 per warrant at the option of the lender. Such warrants would be identical to the private placement warrants.
Our sponsor has agreed, and any of its assignees
or transferees will agree, not to transfer, assign or sell any of the private placement warrants (including the Class A ordinary
shares issuable upon exercise of any of these warrants) until the date that is 30 days after the date we complete our initial business
combination, except that, under limited exceptions transfers may be made to our officers and directors and other persons or entities affiliated
with our sponsor.
The transfer agent for our ordinary shares and
warrant agent for our warrants is Continental Stock Transfer & Trust Company. We have agreed to indemnify Continental Stock Transfer &
Trust Company in its roles as transfer agent and warrant agent, and its agents and each of its shareholders, directors, officers and employees
against all claims and losses that may arise out of acts performed or omitted for its activities in that capacity, except for any liability
due to any gross negligence or intentional misconduct of the indemnified person or entity.
Our second amended and restated memorandum and
articles of association contain provisions designed to provide certain rights and protections relating to our initial public offering
that apply to us until the completion of our initial business combination. These provisions cannot be amended without a special resolution
under Cayman Islands law. As a matter of Cayman Islands law, a resolution is deemed to be a special resolution where it has been approved
by either (i) the affirmative vote of at least two-thirds (or any higher threshold specified in a company’s articles
of association) of a company’s shareholders entitled to vote and so voting at a shareholder meeting for which notice specifying
the intention to propose the resolution as a special resolution has been given; or (ii) if so authorized by a company’s articles
of association, by a unanimous written resolution of all of the company’s shareholders. Other than as described above, our second
amended and restated memorandum and articles of association provides that special resolutions must be approved either by at least two-thirds of
our shareholders who attend and vote at a shareholder meeting of the company (i.e., the lowest threshold permissible under Cayman Islands
law), or by a unanimous written resolution of all of our shareholders. Our sponsor and its permitted transferees, if any, who collectively
beneficially owned approximately 20% of our ordinary shares upon the closing of our initial public offering, will participate in any vote
to amend our second amended and restated memorandum and articles of association and will have the discretion to vote in any manner they
choose.
Our sponsor, officers and directors have agreed,
each pursuant to a written letter agreement with us, that they will not propose any amendment to our second amended and restated memorandum
and articles of association that would affect the substance or timing of our obligation to redeem 100% of our public shares if we do not
complete our initial business combination by May 22, 2024, unless we provide our public shareholders with the opportunity to redeem their
Class A ordinary shares upon approval of any such amendment at a per-share price, payable in cash, equal to the aggregate amount
then on deposit in the trust account (less any interest released to us for taxes, if any), divided by the number of then outstanding public
shares.
Specifically, our second amended and restated
memorandum and articles of association provides, among other things, that:
In addition, our second amended and restated memorandum
and articles of association provides that under no circumstances will we redeem our public shares in an amount that would cause our net
tangible assets to be less than $5,000,001 prior to or upon the consummation of our initial business combination. This notwithstanding,
if the effect of any proposed amendment, if adopted, would be either to (i) reduce the amount in the trust account available to redeeming
shareholders to less than $10.00 per share, or (ii) delay the date on which a public shareholder could otherwise redeem shares for
such per share amount in the trust account, we will provide a right for dissenting public shareholders to redeem public shares if such
an amendment is approved.
Our sponsor, officers and directors have agreed,
each pursuant to a written agreement with us, that they will not propose any amendment to our second amended and restated memorandum and
articles of association that would affect the substance or timing of our obligation to redeem 100% of our public shares if we do not complete
our initial business combination by May 22, 2024, unless we provide our public shareholders with the opportunity to redeem their Class
A ordinary shares upon approval of any such amendment at a per-share price, payable in cash, equal to the aggregate amount then on
deposit in the trust account (less any interest previously released to us to pay taxes, if any, and less up to $100,000 in interest reserved
for expenses in connection with our dissolution), divided by the number of then outstanding public shares. These agreements are contained
in letter agreements that we entered into with our sponsor, officers and directors.
The Companies Law permits a company incorporated
in the Cayman Islands to amend its memorandum and articles of association with the approval of a special resolution being (i) the affirmative
vote of at least a two-thirds (2/3) majority of the votes cast by the holders of the issued ordinary shares present in person or
represented by proxy at a general meeting of the company and entitled to vote on such matter or (ii) a unanimous written resolution of
the shareholders. A company’s articles of association may specify that the approval of a higher majority is required but, provided
the approval of the required majority is obtained, any Cayman Islands exempted company may amend its memorandum and articles of association
regardless of whether its memorandum and articles of association provides otherwise. Accordingly, although we could amend any of the provisions
relating to our proposed offering, structure and business plan which are contained in our second amended and restated memorandum and articles
of association, we view all of these provisions as binding obligations to our shareholders and neither we, nor our officers or directors,
will take any action to amend or waive any of these provisions unless we provide dissenting public shareholders with the opportunity to
redeem their public shares.
Our second amended and restated memorandum and
articles of association provides that our board of directors will be classified into three classes of directors. As a result, in most
circumstances, a person can gain control of our board only by successfully engaging in a proxy contest at two or more annual shareholder
meetings.
Our authorized but unissued Class A ordinary
shares will be available for future issuances without shareholder approval and could be utilized for a variety of corporate purposes,
including future offerings to raise additional capital, acquisitions and employee benefit plans. The existence of authorized but unissued
and unreserved Class A ordinary shares could render more difficult or discourage an attempt to obtain control of us by means of a
proxy contest, tender offer, merger or otherwise.
The Board of Directors (the “Board”)
of Kismet Acquisition Two Corp. has adopted this code of ethics (this “Code”), as amended from time to time by the Board and
which is applicable to all directors, officers and employees of, and consultants and advisors to, the Company (as defined below), to:
This Code may be amended or modified only by resolution
of the Company’s Board of Directors. In this Code, references to the “Company” mean Kismet Acquisition Two Corp., and
in appropriate context, the Company’s subsidiaries, if any.
Each person owes a duty to the Company to act
with integrity. Integrity requires, among other things, being honest, fair and candid. Deceit, dishonesty and subordination of principle
are inconsistent with integrity. Service to the Company should never be subordinated to personal gain and advantage.
The Company strives to ensure that the contents
of and the disclosures in the reports and documents that the Company files with the SEC and other public communications shall be full,
fair, accurate, timely and understandable in accordance with applicable disclosure standards, including standards of materiality, where
appropriate. Each person must:
In addition to the foregoing, the Chief Executive
Officer and Chief Financial Officer of the Company and each subsidiary of the Company (or persons performing similar functions), if any,
and each other person that typically is involved in the financial reporting of the Company must familiarize himself or herself with the
disclosure requirements applicable to the Company as well as the business and financial operations of the Company.
Each person must promptly bring to the attention
of the Chairman of the Audit Committee of the Board (the “Audit Committee”) (or the Chairman of the Board if no Audit Committee
exists) any information he or she may have concerning (a) significant deficiencies in the design or operation of internal and/or disclosure
controls which could adversely affect the Company’s ability to record, process, summarize and report financial data or (b) any fraud,
whether or not material, that involves management or other employees who have a significant role in the Company’s financial reporting,
disclosures or internal controls.
It is the Company’s obligation and policy
to comply with all applicable governmental laws, rules and regulations. All directors, officers and employees of the Company are expected
to understand, respect and comply with all of the laws, regulations, policies and procedures that apply to them in their positions with
the Company. Employees are responsible for talking to their supervisors to determine which laws, regulations and Company policies apply
to their position and what training is necessary to understand and comply with them. Directors, officers and employees are directed to
specific policies and procedures available to persons they supervise.
The Board or Audit Committee, if one exists, is
responsible for applying this Code to specific situations in which questions are presented to it and has the authority to interpret this
Code in any particular situation. Any person who becomes aware of any existing or potential breach of this Code is required to notify
the Chairman of the Board or Audit Committee promptly. Failure to do so is itself a breach of this Code.
The Company will follow the following procedures
in investigating and enforcing this Code and in reporting on this Code:
No person following the above procedure shall,
as a result of following such procedure, be subject by the Company or any officer or employee thereof to discharge, demotion, suspension,
threat, harassment or, in any manner, discrimination, against such person in terms and conditions of employment.
Any waiver (defined below) or an implicit waiver
(defined below) from a provision of this Code for the principal executive officer, principal financial officer, principal accounting officer
or controller, and persons performing similar functions or any amendment (as defined below) to this Code is required to be disclosed in
the Company’s Annual Report on Form 10-K or in a Current Report on Form 8-K filed with the SEC. In lieu of filing a Form 8-K to
report any such waivers or amendments, the Company may provide such information on its website, in the event that it establishes one in
the future, and keep such information on the website for at least 12 months and disclose the website address as well as any intention
to provide such disclosures in this manner in its most recently filed Annual Report on Form 10-K.
A “waiver” means the approval by the
Board of a material departure from a provision of this Code. An “implicit waiver” means the Company’s failure to take
action within a reasonable period of time regarding a material departure from a provision of this Code that has been made known to an
executive officer of the Company. An “amendment” means any amendment to this Code other than minor technical, administrative
or other non-substantive amendments hereto.
The Company’s directors, officers or employees
who have access to material, non-public information are not permitted to use that information for securities trading purposes or for any
purpose unrelated to the Company’s business. It is also against the law to trade or to “tip” others who might make an
investment decision based on material, non-public information. For example, using material, non-public information to buy or sell the
Company securities, options in the Company securities or the securities of any Company supplier, customer, competitor, potential business
partner or potential target is prohibited. The consequences of insider trading violations can be severe. These rules also apply to the
use of material, nonpublic information about other companies (including, for example, the Company’s customers, competitors, potential
business partners and potential targets). In addition to directors, officers or employees, these rules apply to such person’s spouse,
children, parents and siblings, as well as any other family members living in such person’s home. The Company’s directors,
officers and employees should familiarize themselves with the Company’s policy on insider trading.
All of the Company’s books, records, accounts
and financial statements must be maintained in reasonable detail, must appropriately reflect the Company’s transactions and must
both conform to applicable legal requirements and to the Company’s system of internal controls. Unrecorded or “off the books”
funds or assets should not be maintained unless permitted by applicable law or regulation.
Records should always be retained or destroyed
according to the Company’s record retention policies. In accordance with those policies, in the event of litigation or governmental
investigation, please consult the Board or the Company’s internal or external legal counsel.
No director or officer, or any other person acting
under the direction thereof, shall directly or indirectly take any action to coerce, manipulate, mislead or fraudulently influence any
public or certified public accountant engaged in the performance of an audit or review of the financial statements of the Company or take
any action that such person knows or should know that if successful could result in rendering the Company’s financial statements
materially misleading. Any person who believes such improper influence is being exerted should report such action to such person’s
supervisor, or if that is impractical under the circumstances, to any of the Company’s directors.
Types of conduct that could constitute improper
influence include, but are not limited to, directly or indirectly:
The Company complies with the anti-corruption
laws of the countries in which it does business, including the U.S. Foreign Corrupt Practices Act of 1977 (“FCPA”). Directors,
officers, employees and agents, such as third party sales representatives, shall not take or cause to be taken any action that would reasonably
result in the Company not complying with such anti-corruption laws, including the FCPA. If you are authorized to engage agents on the
Company’s behalf, you are responsible for ensuring they are reputable and for obtaining a written agreement for them to uphold the
Company’s standards in this area.
Violation of this Code is grounds for disciplinary
action up to and including termination of employment. Such action is in addition to any civil or criminal liability which might be imposed
by any court or regulatory agency.
Any other policy or procedure set out by the Company
in writing or made generally known to employees, officers or directors of the Company prior to the date hereof or hereafter are separate
requirements and remain in full force and effect.
All inquiries and questions in relation to this
Code or its applicability to particular people or situations should be addressed to the Company’s Secretary, or such other compliance
officer as shall be designated from time to time by the Company.
The Chief Executive Officer and all senior financial
officers, including the Chief Financial Officer and principal accounting officer, are bound by the provisions set forth herein relating
to ethical conduct, conflicts of interest, and compliance with law. In addition to this Code, the Chief Executive Officer and senior financial
officers are subject to the following additional specific policies:
The Board will investigate any reported violations
and will oversee an appropriate response, including corrective action and preventative measures. Any officer who violates this Code will
face appropriate, case specific disciplinary action, which may include demotion or discharge.
Any request for a waiver of any provision of this
Code must be in writing and addressed to the Chairman of the Board. Any waiver of this Code will be disclosed as provided in Section 6
of this Code.
It is the policy of the Company that each officer
covered by this Code shall acknowledge and certify to the foregoing annually and file a copy of such certification with the Chairman of
the Board.
QUADRO ACQUISITION ONE CORP.
This Policy applies to all
members of the Company’s Board of Directors (collectively, “directors” and each, a “director”),
officers and employees of the Company and its subsidiaries. The Company may also determine that other persons should be subject to this
Policy, such as contractors or consultants who have access to material nonpublic information about the Company. With respect to any person
covered by this Policy, this Policy also applies to that person’s family members, other members of that person’s household,
and entities controlled by that person, as described below under “Transactions by Family Members and Others” and “Transactions
by Entities That You Influence or Control.”
Persons subject to this Policy
have ethical and legal obligations to maintain the confidentiality of information about the Company and to not engage in transactions
in Company Securities while in possession of material nonpublic information. Each individual is responsible for making sure that he or
she complies with this Policy, and that any family member, household member or related entity whose transactions are subject to this Policy,
as discussed below, also comply with this Policy. In all cases, the responsibility for determining whether an individual is in possession
of material nonpublic information rests with that individual, and any action on the part of the Company, the Administrator (as defined
below) or any other employee or director pursuant to this Policy (or otherwise) does not in any way constitute legal advice or insulate
an individual from liability under applicable securities laws. You could be subject to severe legal penalties and disciplinary action
by the Company for any conduct prohibited by this Policy or applicable securities laws, as described below under “Consequences of
Violations.”
(i) engage
in transactions in Company Securities, except as otherwise specified in this Policy under the heading “Limited Exceptions;”
(iii) disclose
material nonpublic information to persons within the Company whose jobs do not require them to have that information, or to persons outside
of the Company, including, but not limited to, family, friends, business associates, investors and consultants, except as required in
the performance of regular corporate duties and only to the extent appropriate confidentiality protections are effective and the disclosure
conforms to Company policies; or
(iv) assist
anyone engaged in the above activities.
As a general rule, information
should not be considered fully absorbed by the investing public until the second business day after the day on which the information is
released. If, for example, the Company makes an announcement at 9 am ET on Monday, a person subject to this Policy should not trade in
Company Securities until the market opens on Wednesday. If such an announcement were made at 6 pm ET on Monday, the person subject to
this Policy should not trade in Company Securities until the market opens on Thursday. Depending on the particular circumstances, the
Company may determine that a longer or shorter period should apply.
This Policy applies to your
family members who reside with you, anyone else who lives in your household and any family members who do not live in your household but
whose transactions in Company Securities are directed by you or are subject to your influence or control, such as parents or children
who consult with you before they trade in Company Securities (collectively, “Family Members”). You are responsible
for the transactions of your Family Members and therefore should make them aware of the need to confer with you before they trade in Company
Securities, and you should treat all such transactions for the purposes of this Policy and applicable securities laws as if the transactions
were for your own account. This Policy does not, however, apply to personal securities transactions of Family Members where the purchase
or sale decision is made by a third party not controlled by, influenced by or related to you or your Family Members.
This Policy applies to any
entities that you influence or control, including any corporations, partnerships or trusts (collectively, “Controlled Entities”),
and transactions by these Controlled Entities should be treated for the purposes of this Policy and applicable securities laws as if they
were for your own account.
This Policy does not apply
in the case of the following transactions (although these transactions may nevertheless be subject to the requirements of Section 16 of
the Securities Exchange Act of 1934, as amended (the “Exchange Act”), applicable to directors and executive officers):
The Company has determined
that there is a heightened legal risk and/or the appearance of improper or inappropriate conduct if the persons subject to this Policy
engage in certain types of transactions. Therefore, it is the Company’s policy that any persons covered by this Policy may not engage
in any of the following transactions, or should otherwise consider the Company’s preferences as described below:
The Company has established
additional procedures in order to assist the Company in the administration of this Policy, to facilitate compliance with laws prohibiting
insider trading while in possession of material nonpublic information, and to avoid the appearance of any impropriety. These additional
procedures are applicable only to those individuals described below.
When a request for pre-clearance
is made, the requestor should carefully consider whether he or she may be aware of any material nonpublic information about the Company
and should describe fully those circumstances to the Administrator. The requestor should also indicate whether he or she has effected
any non-exempt “opposite-way” transactions (e.g., an open market sale would be “opposite” any open market purchase,
and vice versa) within the past six months, and should be prepared to report the proposed transaction on an appropriate Form 4 or Form
5. The requestor should also be prepared to comply with SEC Rule 144 and file Form 144, if necessary, at the time of any sale.
A request for pre-clearance
must be made in writing, preferably by submission of a completed Request for Pre-Clearance in the form of Exhibit A to this Policy.
Pre-cleared transactions should be effected promptly. Requestors are required to refresh the request for pre-clearance if a pre-cleared
transaction is not effected within five business days after pre-clearance is received.
(i) The
quarterly trading restrictions and event-driven trading restrictions do not apply to those transactions to which this Policy does not
apply, as described above under the heading “Limited Exceptions,” nor do they apply to an election to participate in an employer
plan during an open enrollment period.
(ii) The
Administrator in his or her discretion may approve other or further exceptions to these requirements on a case-by-case basis in extraordinary
circumstances. Any request for an exception pursuant to this paragraph must be submitted in advance and in writing, and any approval must
be in writing.
This Policy continues to apply
to transactions in Company Securities even after termination of service to the Company. If an individual is in possession of material
nonpublic information when his or her service terminates, that individual may not trade in Company Securities until that information has
become public or is no longer material. The pre-clearance procedures specified under the heading “Additional Procedures” above
and applicable to Restricted Persons will continue to apply for a period of six months after a termination of service, in order to facilitate
compliance with Section 16 of the Exchange Act.
The purchase or sale of securities
while aware of material nonpublic information, or the disclosure of material nonpublic information to others who then trade in the Company’s
Securities, is prohibited by federal and state laws. Insider trading violations are pursued vigorously by the SEC, the U.S. Department
of Justice and state enforcement authorities. Punishment for insider trading violations is severe and could include significant fines
and imprisonment. While the regulatory authorities concentrate their efforts on the individuals who trade, or who tip inside information
to others who trade, the federal securities laws also impose potential liability on companies and other “controlling persons”
if they fail to take reasonable steps to prevent insider trading by company personnel.
In addition, an individual’s
failure to comply with this Policy may subject the individual to Company-imposed sanctions, up to and including termination of employment,
whether or not the employee’s failure to comply results in a violation of law. Needless to say, a violation of law, or even an SEC
investigation that does not result in prosecution, can tarnish a person’s reputation and irreparably damage a career.
Any person who violates this
Policy or any federal or state law governing insider trading or tipping, or who knows of or reasonably suspects any such violation by
another person, should report the matter immediately to his or her supervisor and/or to the Administrator identified in Section 5. Employees
are obligated to report suspected and actual violations of Company policy or the law. Doing so brings the concern into the open so that
it can be resolved quickly and more serious harm can be prevented. Failure to do so could result in disciplinary action up to and including
termination of employment.
If you encounter a situation
or are considering a course of action and its appropriateness is unclear, do not hesitate to reach out the Administrator with any questions;
even the appearance of impropriety can be very damaging and should be avoided, and the Administrator may be in the best position to provide
helpful information or other resources.
All persons subject to this
Policy may be required to certify and re-certify, from time to time, their understanding of, and intent to comply with, this Policy.
This Policy may be amended
by the Board of Directors or any committee or designee to which the Board of Directors delegates this authority.
The Administrator has the
authority to make determinations under, and interpretations of, this Policy, as specified in this Policy under the heading “Administration
of the Policy.” In addition, the Administrator is authorized to approve amendments to this Policy that: (i) correct obvious errors
(e.g., typographical or grammatical errors); (ii) are necessitated by changes in legal requirements; (iii) are necessary to clarify the
meaning of this Policy; or (iv) are administrative in nature, such as the provisions of this Policy under the heading “Additional
Procedures.”
Rule 10b5-1 under the Exchange
Act provides a defense from insider trading liability under Rule 10b-5. In order to be eligible to rely on this defense, a person subject
to our Insider Trading Policy must enter into a Rule 10b5-l Plan for transactions in Company Securities (as defined in the Insider Trading
Policy) that meets certain conditions specified in the Rule. If the plan meets the requirements of Rule 10b5-l, Company Securities may
be purchased or sold without regard to certain insider trading restrictions. In general, a Rule 10b5-l Plan must be entered into at a
time when the person entering into the plan is not aware of material nonpublic information. Once the plan is adopted, the person must
not exercise any influence over the amount of securities to be traded, the price at which they are to be traded or the date of the trade.
The plan must either specify the amount, pricing and timing of transactions in advance or delegate discretion on these matters to an independent
third party.
As specified in the Company’s
Insider Trading Policy, a Rule 10b5-l Plan must be approved by the Administrator and meet the requirements of Rule 10b5-l and these guidelines.
Any Rule 10b5-l Plan must be submitted for approval at least five business days prior to the entry into the Rule 10b5-l Plan. Once a 10b5-1
Plan is approved, no further pre-approval of transactions conducted pursuant to the plan will be required.
The approval or adoption of
a Rule 10b5-l Plan in no way reduces or eliminates a person’s obligations under Section 16 of the Exchange Act, including disclosure
obligations and liability for short-swing profits. Persons subject to Section 16 of the Exchange Act should consult with their own counsel
in implementing a Rule 10b5-l Plan.
I certify that I have fully disclosed the information
requested in this form, I have read the Quadro Acquisition One Corp. Insider Trading Policy, I am not in possession of material nonpublic
information, and to the best of my knowledge and belief the proposed transaction will not violate the Quadro Acquisition One Corp. Insider
Trading Policy.
The undersigned Chief Executive
Officer of Quadro Acquisition One Corp. (the “Company”), DOES HEREBY CERTIFY that:
IN WITNESS WHEREOF, the undersigned
has executed this statement on April 17, 2024.
A signed original of this written statement required
by Section 906 has been provided to Quadro Acquisition One Corp. and will be retained by Quadro Acquisition One Corp. and furnished to
the Securities and Exchange Commission or its staff upon request.
The forgoing certification is being furnished
to the Securities and Exchange Commission pursuant to § 18 U.S.C. Section 1350. It is not being filed for purposes of Section 18
of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether
made before or after the date hereof, regardless of any general incorporation language in such filing.
QUADRO ACQUISITION ONE CORP.
(1) In
the event of an Accounting Restatement, the Company will reasonably promptly recover the Erroneously Awarded Compensation Received in
accordance with the Nasdaq Rules and Rule 10D-1 as follows:
(2) Notwithstanding
anything herein to the contrary, the Company shall not be required to take the actions contemplated by Section B(1) above if the Committee
determines that recovery would be impracticable and any of the following three conditions are met:
The Company shall file all
disclosures with respect to this Policy required by applicable U.S. Securities and Exchange Commission (“SEC”) filings
and rules.
The Company shall not be permitted
to insure or indemnify any Executive Officer against (i) the loss of any Erroneously Awarded Compensation that is repaid, returned or
recovered pursuant to the terms of this Policy, or (ii) any claims relating to the Company’s enforcement of its rights under this
Policy. Further, the Company shall not enter into any agreement that exempts any Incentive-based Compensation that is granted, paid or
awarded to an Executive Officer from the application of this Policy or that waives the Company’s right to recovery of any Erroneously
Awarded Compensation, and this Policy shall supersede any such agreement (whether entered into before, on or after the Effective Date
of this Policy). It is hereby acknowledged that Rule 10D-1(b)(1)(v) and Nasdaq Rule 5608 provide that the Company is prohibited from indemnifying
any executive officer or former executive officer against the loss of erroneously awarded compensation. It is therefore acknowledged that
such indemnification is prohibited by applicable law for all purposes, including any and all such agreements.
This Policy shall be administered
by the Committee, and any determinations made by the Committee shall be final and binding on all affected individuals.
The Committee is authorized
to interpret and construe this Policy and to make all determinations necessary, appropriate, or advisable for the administration of this
Policy and for the Company’s compliance with the Nasdaq Rules, Section 10D, Rule 10D-1 and any other applicable law, regulation,
rule or interpretation of the SEC or Nasdaq promulgated or issued in connection therewith.
The Committee may amend this
Policy from time to time in its discretion and shall amend this Policy as it deems necessary. Notwithstanding anything in this Section
F to the contrary, no amendment or termination of this Policy shall be effective if such amendment or termination would (after taking
into account any actions taken by the Company contemporaneously with such amendment or termination) cause the Company to violate any federal
securities laws, SEC rule or the Nasdaq Rules.
This Policy shall be binding
and enforceable against all Executive Officers and, to the extent required by applicable law or guidance from the SEC or Nasdaq, their
beneficiaries, heirs, executors, administrators or other legal representatives. The Committee intends that this Policy will be applied
to the fullest extent required by applicable law. Any employment agreement, equity award agreement, compensatory plan or any other agreement
or arrangement with an Executive Officer shall be deemed to include, as a condition to the grant of any benefit thereunder, an agreement
by the Executive Officer to abide by the terms of this Policy. Any right of recovery under this Policy is in addition to, and not in lieu
of, any other remedies or rights of recovery that may be available to the Company under applicable law, regulation or rule or pursuant
to the terms of any policy of the Company or any provision in any employment agreement, equity award agreement, compensatory plan, agreement
or other arrangement.
For purposes of this Policy,
the following capitalized terms shall have the meanings set forth below.